Yaya tsawon lokacin da wannan ya kasance?
Kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman a shekarunka
Kuma da zazzabi.
Kuma abin da ya kamata ku duba shi ne yawan cholesterol a cikin jini.
kuma kana da zazzabi a yanzu?
kuma kuna da ciwon kirji a yanzu?
kuma a gefe guda kuna da wahalar numfashi?
Kuma za ku iya gaya mani wasu alamun da kuke fuskanta tare da wannan?
kuma yaya zafin jikinka yake
Kuma ina da tari.
kuma ina da ɗan sanyi da tari
Kuma kirji na ya yi zafi sosai yau
kuma shin lokaci ne mai kyau don cutar zazzabin rashin lafiyar ku?
kuma ya samu ciwon kirji
Kuma ina ganin ina da zazzabi kadan.
Kuma ina so ku zana hoto na ciwon kirji.
Kuma suna da zazzabi kadan.
kuma da tarihin ciwon sukari
Kuma ka san na kirji ji kamar zai karya
kuma ka san mutane tari a kan ni a duk tsawon lokacin
kuma kuna da ciwon kirji
kuma ka ce akwai wani matsa lamba a kan kirjinka
duk wani a cikin iyalinka da ke da ciwon zuciya cututtukan zuciya bugun zuciya high cholesterol high jini
Shin akwai wasu alamun ko matsaloli da kuka lura da su a cikin ciwon tsoka?
Shin akwai wani mutum a gida da ke fama da irin wannan rashin lafiya da ke nuna alamun cutar?
Shin kuna da wasu alamun cutar?
Shin kuna da wani ciwon numfashi?
Shin har yanzu kuna da ciwon kirji
saboda wannan shine lokacin mura
Amma kuma bai kamata mu bar ciwon kirji ba wanda ya samo asali daga zuciya.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi
amma na san mutane da yawa suna tari a kaina
Amma dole ne mu dauki duk wani ciwon kirji da muhimmanci.
Amma kana numfashi da kyau yanzu, ba haka ba?
Na manta da shi saboda ciwon kirji.
Shin kana jin kamar wani yana matsawa kirjinka
Shin har yanzu kuna jin kamar kun sha wahala?
Shin suna fama da ciwo da alamun da suka yi kama da juna?
Shin kuna da wata cuta ta kullum kamar hawan jini ko wani abu makamancin haka?
kuna da wata cuta ko wata cuta ta kullum kamar ciwon sukari?
Shin kuna da wani ciwon numfashi tare da ciwon kirji?
kuna da hawan jini?
Shin kana da wani shortness na numfashi da cewa?
Shin kun san alamun da yake fama da su?
Shin kun ga wannan hoton?
sha ruwa da yawa a yau
Amma sai na yi gwajin ciwon sukari.
Amma sai ta sami alamun da suka yi kama da nawa.
Yaya zafin jikinka yake?
Yaya karfin jininka yake?
idan kana da ciwon zazzabi
idan kana da zazzabi da ke da yawan zafin jiki na ɗari biyu ko sama da haka
idan kana jin alamun ko matsala kana bukatar ƙarin bincike
Ina da zazzabi a daren jiya.
Ina da zazzabi kadan ma
Ina da zazzabi a daren jiya.
Ina da ciwon kai a nan a kirji.
Ina da ɗan wahalar numfashi kuma.
Zan aiko muku da hoton.
Ina da ɗan ciwon kirji a yau
Ina da ɗan ciwon kai da zazzabi a yau.
A ganina, yana da mura.
A ganina, wannan cutar mura ce mai laushi.
Shin yana jin kamar mai nauyi mai nauyi yana zaune a kan kirjinka?
duk ya fara da ciwon kai da zazzabi a lokaci guda
ciwo a tsakiyar kirji
jin zafi kamar ciwon kirji
Yana cikin kirji na
Yana tsakiyar kirji na
Yana tsakiyar kirji.
Ina jin zafi a kirji
Ina matukar damuwa game da wannan ciwon kirji
Ina so ka gaya mini ta kwatanta wannan ciwon kirji
kamar hawan jini ko ciwon sukari.
kamar daidai a tsakiyar kirji
Yanzu ga zazzabi za ka iya yi da Tachipirina candy
Yanzu Mary, kwana nawa ne ka yi da alamun?
Yanzu ka ce kana da ciwon kirji
Wani lokaci ina fama da ciwon kirji
ok kana da ciwon wani sauran bayyanar cututtuka tare da wannan daya fãce kawai ciwo
Ko kuma wani yana zaune a kan kirjinka?
kusan kamar zazzabi da tari da ciwon kai da ciwon tsoka
daidai a tsakiyar kirji
Nuna mini a cikin wannan hoton inda kake jin zafi.
Tun da kana da zazzabi
Shin kana ganin wasu daga cikin waɗannan cututtukan na iya kasancewa da alaƙa da yanayin da kake ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mani game da ciwon kirjinka
zazzabi yana ƙaruwa da dare
zazzabin da na samu a cikin kwanaki biyu da suka gabata
Zazzabi ya fara tashi a daren jiya.
Wannan shi ne Dr. Porter a cikin gaggawa dakin triage cibiyar
Za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a gaban jikina a kirji na
Ina da ciwo mai tsanani a kirji
lokacin da na ji ciwon kirji
Abin da kuke ji a kirjinku?
Yaushe wannan ciwon kirji ya fara?
A ina kake da ciwon kirji?
NS
Kana jin kamar numfashi yana matsewa a kirjinka.
Ka san ina da ciwon sukari da sauransu.
Ka ce kana da ciwon kirji.
Yawan kamuwa da cutar coronavirus (COVID-19) da ke karuwa cikin sauri a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da United Kingdom, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Abubuwan da suka faru na cutar coronavirus (COVID-19) sun nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila wanda ke tabbatar da cewa, duk da cewa yana da bambanci tsakanin ƙasashe, annobar COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da cibiyoyin kulawa na gaggawa ya kamata su haɓaka shirye-shiryen su don ƙaruwar yawan marasa lafiya tare da COVID-19 waɗanda za su buƙaci kulawar kiwon lafiya, musamman kulawar gaggawa.
A ranar 31 ga Disamba, 2019, an bayar da rahoton wani tarin cututtukan huhu na rashin sani a Wuhan, Lardin Hubei, China.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa mai haddasa cutar shine sabon coronavirus wanda yanzu ake kira coronavirus acute respiratory syndrome 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Ya zuwa yanzu an tabbatar da cewa kusan kashi 80% na mutanen da ke da COVID-19 suna da rashin lafiya mai sauƙi, watau kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan marasa lafiya sun warke.
A cikin kusan kashi 14% na lokuta, COVID-19 yana ci gaba zuwa mummunan cuta wanda ke buƙatar kulawar asibiti yayin da sauran kashi 6% na lokuta ke da mummunan cuta wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke cikin asibiti saboda COVID-19 kusan kashi 4 ne.
A cikin wannan binciken, mun kimanta yanayin haɗuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da United Kingdom (UK) kuma mun kwatanta waɗannan ƙasashe da Lardin Hubei, China.
Mun kuma kwatanta adadin adadin masu cutar COVID-19 a cikin EU/EEA da UK da na Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 ta sami ƙarin yaduwar ƙasa da kuma yanayin cutar ta COVID-19 a duk duniya a halin yanzu bisa ga yanayin ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbataccen yanayin COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon shari'o'in uku da aka tabbatar a ranar 24 ga Janairu, 2020 a cikin waɗanda suka dawo daga Wuhan, Lardin Hubei, China.
Zuwa 15 ga Maris, 2020, an gano shari'ar COVID-19 a duk ƙasashen EU/EEA 30 da United Kingdom (UK), wanda tsakanin 31 ga Disamba, 2019 da kuma haɗa da wannan kwanan wata, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samu yawan adadin masu kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC), ana samun adadin adadin masu cutar COVID-19 a kowace ƙasa a duniya, daga tushen hukuma kawai kamar Ma'aikatar Lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, ana sabunta su kowace rana da ƙarfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU/EEA da UK, tare da kwatanta bayanan da Italiya.
A matsayin mai wakiltar yaduwar cutar COVID-19, mun lissafa yawan adadin cututtukan COVID-19 na kwanaki 14, saboda haka muna la'akari da yanayin yanayin COVID-19, a kowace ƙasa ta EU/EEA da Burtaniya, a lokacin Janairu 1 zuwa Maris 15, 2020.
Mun kuma gabatar da adadin adadin cututtukan da aka ruwaito ga kowace ƙasa a ranar 15 ga Maris, 2020 da ƙarfe 8:00 na safe idan aka kwatanta da adadin adadin cututtukan Italiya na lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Yanayin da ake samu na yawan kamuwa da cutar COVID-19 a cikin kwanaki 14 a cikin ƙasashen EU/EEA da UK gabaɗaya yana bin yanayin da ke cikin Lardin Hubei (China) (Hadisin 1).
Ga EU/EEA da UK baki ɗaya, yawan haɗarin COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu sannan ya ƙaru sosai a kusan 28 ga Fabrairu 2020 (Ƙarin bayani).
Wannan galibi ana haifar da saurin ƙaruwa a cikin adadin shari'o'in da aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya suna nuna irin wannan ci gaban haɓakar abubuwan da ke faruwa na COVID-19 (Ƙarin bayani).
Figure 2 ya nuna yawan adadin masu kamuwa da COVID-19, a cikin ƙasashen EU/EEA da UK dangane da waɗanda ke Italiya a lokacin Janairu 31 zuwa Maris 15, 2020.
Ya jaddada cewa, a ranar 15 ga Maris da ƙarfe 8:00 na safe, sauran ƙasashe 15 na EU/EEA da Burtaniya sun ba da rahoton adadin adadin adadin shari'o'in kamar Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin masu kamuwa da COVID-19 da aka ruwaito suna karuwa cikin sauri a EU/EEA da UK.
Hanyoyin da aka lura na haɗuwa da cutar COVID-19 sun nuna cewa annobar tana yaduwa a daidai wannan saurin a duk ƙasashe.
Duk da cewa ƙasashe suna cikin matakai daban-daban, bambance-bambance a cikin amsar lafiyar jama'a ta ƙasa da ma'anar shari'ar na iya bambanta a cikin ƙasashe da kuma ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin biyo baya.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke fama da COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da raka'a kulawa mai tsanani a yankin sun riga sun kai iyakar ƙarfin su.
Bayanai kan karɓar COVID-19 a asibiti da/ko cibiyoyin kulawa na gaggawa a halin yanzu suna samuwa a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (ba a nuna bayanai ba).
Koyaya, dole ne a tattara bayanan a cikin tsari don tallafawa bayanan sa ido na yanzu wanda ya mai da hankali kan yawan adadin rahotannin da aka bayar da kuma yawan mutuwar.
Binciken da aka gudanar a 2010-11 ya nuna bambancin bambancin da ke cikin wadatar gadaje na kulawa da kulawa a Turai, daga 29.2 a Jamus zuwa gadaje 4.2 a kowace mazauna 100,000 a Portugal.
Wannan yana nufin cewa ƙasar tana da albarkatu fiye da Italiya (12.5 gadaje na kulawa da kulawa da kulawa da hankali ga kowane mazauna 100,000 a 201011).
Yanayin samfurin da ya shafi ƙarancin ƙarfin kiwon lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da UK na yaduwar COVID-19 da aka shigar da asibiti wanda ke da alaƙa da > 90% haɗarin wucewa da ƙarfin gadajen kulawa, an samar da su a cikin sabuntawa na shida na ƙimar haɗarin gaggawa game da COVID-19 ta ECDC.
Ganin cewa har yanzu an samar da ƙwayoyin cuta a cikin wasu yankuna a cikin EU/EEA da UK, kuma asibitoci da cibiyoyin kulawa na musamman galibi suna aiki da ƙididdigar yawan jama'a, ya kamata a samar da bayanai game da shari'o'i da gadajen kulawa a cikin Tatanama don rukunin yanki na ƙididdigar 2 (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da UK.
Saboda haka, ƙasashe, asibitoci da cibiyoyin kula da gaggawa dole ne su kasance a shirye don yanayin yaduwar al'umma na SARS-CoV-2 da karuwar yawan marasa lafiya da ke fama da COVID-19 da ke buƙatar kulawar kiwon lafiya, musamman kulawar gaggawa, kamar yadda yake faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka jaddada a cikin sabon kimantawa na haɗarin ECDC, hanzari, aiki da kuma cikakkiyar hanya yana da mahimmanci don rage saurin yaduwar SARS-CoV-2, tare da sauyawa daga tsarin hanawa zuwa ragewa, saboda tsammanin saurin ƙaruwa a cikin adadin shari'o'in na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita martani idan ba a aiwatar da su ba da wuri.
Har ila yau, binciken haɗarin gaggawa ya lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai gajeren lokacin da ƙasashe za su iya ci gaba da haɓaka ƙoƙarin sarrafawa don rage saurin yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan wannan ya gaza, yana yiwuwa sauran tsarin kiwon lafiyar EU/EEA na iya fuskantar karuwar marasa lafiya da ke buƙatar kulawa mai mahimmanci a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar Coronavirus 2019 (COVID-19), wacce ke haifar da mummunar cutar cututtukan numfashi (SARS) coronavirus 2 (SARS-CoV-2), ya zuwa yanzu ya kashe mutane sama da 3,000 kuma ya kamu da mutane sama da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga bil'adama.
Kamar dai kwayar cutar ta SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga barbashi kuma yana haifar da irin wannan alamun ta hanyar irin wannan hanyar.
Koyaya, COVID-19 yana da ƙananan cututtuka da mutuwar fiye da SARS amma yana da sauƙin kamuwa da cutar kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Domin yawan littattafai da ake bugawa game da wannan cuta, wannan talifin ya yi ƙoƙari ya ba da cikakken bayani game da wannan cibiyar bincike.
Za mu tattauna game da ilimin annoba, ilimin cututtuka, ilimin ƙwayoyin cuta, ganewar asali, magani, tsinkaya da rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan bita zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai barazana.
Bikin bazara na ranar 25 ga Janairun 2020 ya zama abin tunawa ga Sinawa da ba za su taɓa mantawa da shi ba yayin da aka tilasta musu su zauna a gida a lokacin hutu da kuma makonni bayan haka saboda barkewar cutar kwayar cutar.
Kwayar cutar tana da kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar saurin kamuwa da cutar numfashi (SARS) a shekara ta 2003; saboda haka, an kira ta SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu 2020 kuma an kira cutar da ke da alaƙa da cutar CoV Disease-19 (COVID-19).
Wannan annobar ta fara ne a Wuhan, China kuma nan take ta bazu ko'ina cikin ƙasar da kusan ƙasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, kwayar cutar ta haifar da sama da mutane 80,000 da aka tabbatar da cutar COVID-19, tare da an bar sama da mutane 40,000 da su koma gida kuma sama da mutane 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 "magabcin jama'a ne na 1" kuma yana da yuwuwar zama mafi ƙarfi fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 2000 game da COVID-19 gami da ilimin ƙwayoyin cuta, cututtukan cututtukan cututtuka, ilimin ilmin halitta, ganewar asali da magani tun lokacin da aka fara bayar da rahoto a ranar 7 ga Janairu 2020 wanda ya ƙayyade jerin ƙwayoyin cuta da aka ware daga wasu marasa lafiya.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a cikin sabon kuma saurin girma batun.
Idan ya dace, za mu gwada COVID-19 da SARS da wata cuta da ke haifar da CoV, cututtukan numfashi na Gabas ta Tsakiya (MERS, wanda ya ɓarke a cikin 2012).
Za mu kuma tattauna abin da muka sani game da rigakafi da kuma tsinkayar cutar da kuma wasu tambayoyi masu muhimmanci.
CoVs a al'adance ana ɗaukar su a matsayin ƙwayoyin cuta marasa haɗari ga mutane, yawanci suna haifar da kusan 15% na mura mai yawa 4.
Koyaya, a wannan karni, mun sami CoVs na mutum masu cutarwa sau biyu, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar barkewar cutar a China a 2003 da Saudi Arabiya a 2012, kuma nan ba da daɗewa ba suka bazu zuwa wasu ƙasashe da yawa tare da mummunan yanayin rashin lafiya da mutuwa.
Saboda haka, COVID-19 na yanzu shine annobar CoV ta uku a tarihin ɗan adam da aka rubuta.
Kamar yadda aka nuna a Figure 1.1, an fara bayar da rahoton tarin fuka-fukan da ba a san asalin su ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Kiwon Lafiyar Kasa ta kasar Sin.
Bayan kwana bakwai, an fitar da kwayar cutar.
A ranar 15 ga Janairun 2020 ne aka samu rahoton mutuwar mutum na farko daga Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe maƙwabta.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da cuta a tsakanin ma'aikatan kiwon lafiya, wanda ke nuna cewa kamuwa da cutar ɗan adam ga ɗan adam na iya faruwa.
A ranar 23 ga watan Janairu, an sanya dokar hana fita a birnin Wuhan tare da dakatar da duk ayyukan sufuri na jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda ake ganin asalin cutar daga asalin dabbobi ne da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta bazu ko'ina cikin China da kusan wasu ƙasashe 50 a duniya (Hoto (Hoto 2).2).
Ganin yadda lamarin ke ci gaba cikin sauri, ba a san iyakar cutar ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa na marasa lafiya 8,866 ciki har da 4,021 masu cutar COVID-19 da aka tabbatar sun ba da ƙarin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da marasa lafiya na kowane zamani, amma yawanci suna tsakanin shekaru 30-65.
Kusan rabin (47.7%) na marasa lafiyar da ke dauke da cutar sun haura shekaru 50, kaɗan ne a ƙarƙashin shekaru 20 kuma mutane 14 ne kawai ke dauke da cutar da shekarunsu suka kai 10.
SARS-CoV-2 yana kamuwa da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 yana ci gaba a cikin rukuni da yawa a cikin da ke kewaye da Hubei.
COVID-19 yana ɗaukar matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin da aka yi amfani da shi shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farawa zuwa mutuwa shine kwanaki 9.5 (4.8-13).
Ƙididdigar yawan haifuwa (R0) shine 3.77 (95% CI: 3.51-4.05), kuma RO mai daidaitawa shine 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin ranar 23 ga Janairun 2020, wanda ya yi daidai da lokacin motsi mai yawa kafin bikin bazara a China.
Yawan mutuwar marasa lafiya tare da tabbatar da shari'ar shine 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen mutuwar ga dukkan marasa lafiya shine 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan bincike guda uku don COVID-19 sune jinsi (maza), shekaru (≥60) da kuma cutar huhu mai tsanani.
CoVs suna cikin ƙananan ƙwayoyin cuta masu girma da ke ɗauke da RNA guda ɗaya.
Ana iya raba kwayar cutar zuwa jinsuna huɗu, cth., alpha, beta, gamma, da delta, daga cikin dukkanin alpha- da beta-CoVs da aka sani suna kamuwa da mutane.
Spike (S) glycoprotein surface yana ɗaure ga masu karɓar salula na ƙwayoyin cuta masu canza angiotensin 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoVs, sannan haɗuwa da membrane yana faruwa.
Ana sakin kwayar cutar RNA zuwa cikin cytoplasm; bayan kwayar cutar ta kwayar cutar, RNA ta kwayar halitta tana tare da glycoproteins na surface da kuma nucleocapsid proteins suna samar da vesicles dauke da virions, wanda daga bisani ya haɗu da membrane plasma don saki kwayar cutar.
An ba da rahoton farkon tsarin halittar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 an gano cewa sabon nau'in beta-CoV ne tare da fiye da kashi 99.98% na asalin kwayoyin halitta a cikin samfuran 10 da aka tattara daga asalin cutar, Kasuwar Abinci ta Kifi ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscope na lantarki, an gano SARS-CoV-2 a cikin mafi ƙanƙantar ɓangaren ƙwayoyin cuta na mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da ACE2 cikin rauni fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙarancin kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabbin furotin masu sauƙi waɗanda aka tsara ta hanyar orf3b da furotin da aka ɓoye wanda aka tsara ta hanyar orf8.
orf3b don SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cutar kuma yana da bayanin IFNβ; duk da haka, orf8 ba ya ƙunshe da kowane yanki ko dalili mai aiki.
A ranar 18 ga Fabrairun 2020, Zhou, et al., sun ba da rahoton cewa tsarin cyro-EM na ACE2 na ɗan adam gaba ɗaya yana da ƙuduri na 2.9 Å a cikin hadaddun tare da jigilar amino acid B0AT1.
Sun gano cewa hadaddun, waɗanda ke da buɗewa da rufewa, an haɗa su azaman dimers kuma hadaddun ACE-BOAT2 na iya haɗa sunadarai biyu na S, wanda ke ba da hujja don ganowa da kamuwa da CoV.
B0AT1 na iya zama maƙasudin magani don tace magunguna don hana kamuwa da SARS-CoV-2.
Tushen asali da na tsakiya
An san cewa SARS-CoV da MERS Cov sun samo asali ne daga barbashi kuma an watsa su ga mutane ta hanyar fox da raƙumi.
Ta hanyar kwatanta tsarin halittar SARS-CoV-2 da sauran CoVs, ana ganin cewa barbashi ne asalin SARS-CoV-2 saboda sabon kwayar cutar tana da kamanni 96% da SARS-like CoVs biyu daga barbashi da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, matsakaicin mai watsa shiri wanda ke taimaka wa ƙwayoyin cuta su ƙetare shingen jinsin don kamuwa da mutane ya kasance ba a sani ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar maciji a matsayin mai ɗaukar hoto na kwayar cutar daga bargo zuwa mutum wanda ya shafi sake haɗuwa da homolog a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun ba da shawarar cewa tururuwa - dabbobi masu tsayi masu cin tururuwa waɗanda aka saba amfani da su a cikin maganin gargajiya na kasar Sin - sune masu karɓar bakuncin matsakaiciyar hanya ga SARS-CoV-2 bisa ga 99% na kwayoyin halittar CoV da aka samo a cikin tururuwa da SARS-CoV-2.
Duk da haka, bambancin 1% da ke yadawa a cikin dukkanin kwayoyin halitta biyu har yanzu yana da bambanci mai yawa; saboda haka, an jira sakamakon ƙarshe don tattara hujjoji masu mahimmanci (Fig.33).
Har yanzu ba a san ainihin yanayin kimiyyar SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na tsawon awanni 48 a cikin bushewa da har zuwa kwanaki 45 a ƙarƙashin 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan halaye.
An bayar da rahoton cewa SARS-CoV-2 yana da ƙarancin haske da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, disinfectant mai ɗauke da chlorine, peracetic acid, chloroforum, da sauran magudanar mai, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Gabaɗaya yawan mutanen da ke cikin duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka ana ɗaukar su masu saukin kamuwa da sabon ƙwayar cuta.
A halin yanzu, babu cikakken binciken da aka ruwaito game da amsar rigakafi ga SARS-CoV-2.
Don haka, zamu iya komawa ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto na 4).4).
Gabaɗaya, bayan ƙwayoyin cuta sun mamaye host, ƙwayoyin cuta sun fara ganowa ta hanyar tsarin rigakafin jiki na host ta hanyar masu karɓar karɓar alamun (PRRs) waɗanda suka haɗa da masu karɓar karɓar nau'in C, masu karɓar Tol (TLR), masu karɓar NOD (NLR), da masu karɓar RIG-I (RLR).
Duk da bambancin hanyoyi, ƙwayoyin cuta suna haifar da bayyanar cututtuka, ƙwayoyin dendritic cell maturation da kuma interferon type I (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na kwayar cutar antigen.
Koyaya, furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta guje wa amsawar rigakafi.
Ba da daɗewa ba, tsarin garkuwar jiki ya fara aiki don yaƙi da kwayar.
T lymphocytes ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa a cikin tsaro.
CD4+ T-cell yana motsa B-cell don samar da ƙwayoyin rigakafi na musamman na kwayar cutar kuma CD8+ T-cell yana ci gaba da kashe ƙwayoyin da ke dauke da kwayar cutar.
Kwayoyin T masu taimakawa suna samar da cytokines masu cutarwa don taimakawa kwayoyin kariya.
Koyaya, CoVs na iya hana aikin T-cell ta hanyar haifar da apoptosis na T-cell.
Tsarin rigakafi na humoral wanda ya hada da kari kamar C3a da C5a da kuma ƙwayoyin cuta suna da mahimmanci wajen yaƙar kamuwa da kwayar cuta.
Misali, ƙwayoyin cuta da aka ware daga marasa lafiya da suka warke sun kawar da MERS-CoV.
A gefe guda, yawan amsawar tsarin garkuwar jiki yana haifar da yawan adadin 'yanci a cikin jiki wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin, kuma, a cikin mafi munin yanayin, gazawar wasu gabobin, har ma da mutuwa.
Kamuwa da cutar SARS-CoV-2, bisa ga farkon rukuni, ya fi shafar tsofaffi tare da haɗuwa da mata masu juna biyu.
Ya zama ruwan dare gama gari ga waɗanda ke fuskantar yawan ƙwayoyin cuta ko waɗanda ke da lalacewar tsarin garkuwar jiki, suna da damar kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin da aka kiyasta na SARS-CoV-2 shine kwanaki 1-14, yawanci kwanaki 3-7 bisa ga nazarin farkon shari'o'in 425 a Wuhan.
Koyaya, nazarin shari'o'i 1,099 ya nuna cewa tsawon lokacin daskarewa shine kwanaki 3 a matsakaici kuma ya kasance daga kwanaki 0 zuwa 24.
Wani sabon binciken da aka yi, kamar yadda aka ambata a sama, ya nuna cewa tsawon lokacin da aka yi shi ne kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866.
Yana da mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓewa mai tasiri bisa ga mafi kyawun lokacin keɓewa, yayin hana waɗanda ke da cutar amma ba su da alamun cutar daga yada kwayar cutar ga wasu.
A matsayin al'ada, mutane da ke fama da cutar, ko kuma ke kamuwa da cutar, yawanci ana buƙatar keɓe su na kwanaki 14.
Shin ya kamata a kara wa'adin killacewa zuwa kwanaki 24?
Cutar zazzabi yawanci ita ce babban alamun farko na COVID-19, wanda zai iya kasancewa ba tare da wata alama ba ko wasu alamun kamar bushewar tari, numfashi, ciwon tsoka, jiri, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya da amai.
Wasu marasa lafiya suna fama da dyspnea da / ko hypoxemia mako guda bayan farawar cutar.
A cikin mawuyacin hali, yanayin mai haƙuri yana ci gaba da hanzari zuwa ciwon huhu mai tsanani, ƙwayoyin cuta, acidosis na metabolic da coagulopathy.
Marasa lafiya da ke fama da zazzabi da/ko cututtukan numfashi da zazzabi mai tsanani, koda ba tare da wani abu ba na hoto na huhu, ya kamata a bincika su don cutar don ganewar asali.
Binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar shine 98% don zazzabi, 76% don bushewar tari, 55% don dyspnea, da 3% don zawo; 8% na marasa lafiya suna buƙatar taimakon numfashi.
An bayar da rahoton irin wannan binciken a cikin binciken kwanan nan na iyali da kuma tarin yawa wanda ya haifar da yaduwa daga mutane marasa alamun cutar.
A kwatancen, nazarin alƙaluma a cikin 2012 ya nuna cewa marasa lafiya na MERS-CoV suma suna da zazzabi (98%), bushewar tari (47%), da dyspnea (55%) a matsayin manyan alamun su.
Duk da haka, kashi 80% na su na buƙatar taimakon numfashi, wanda ya fi na marasa lafiyar COVID-19 yawa kuma ya dace da ƙimar da MERS ke da ita fiye da COVID-19.
Diarrhea (26%) da ciwon makogwaro (21%) an kuma gani a cikin marasa lafiya na MERS.
A cikin marasa lafiyar SARS, an nuna cewa zazzabi (99%-100%), tari mai bushewa (29%-75%), dyspnea (40%-42%), zawo (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun bayyanar cututtuka kuma ana buƙatar taimakon numfashi don kimanin 14%-20% na marasa lafiya.
Har zuwa 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai kashi 2 cikin ɗari yayin da aka tabbatar da adadin masu cutar ya kai 66,576 a duniya.
A kwatankwacin haka, yawan mutuwar SARS har zuwa Nuwamba 2002 ya kasance 10% na 8,096 da aka tabbatar.
Ga MERS, bisa ga binciken alƙaluma a watan Yunin 2012, yawan mutuwar ya kai kashi 37% na mutane 2,494 da aka tabbatar.
Binciken da aka yi a baya ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da 95% confidence margin (CI) na 5.71-7.23, yayin da R0 na SARS-CoV kawai ya kasance tsakanin 2 zuwa 4.
Kwatanta tsakanin SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomi, yawan mutuwa da RO na cutar an nuna su a cikin Table Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar kamuwa da cuta fiye da MERS-CoV da SARS-CoV, amma ba shi da kisa kamar cututtukan biyu.
Saboda haka, yana da matukar wahala a sarrafa annobar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Farawa a cikin rukuni sau da yawa yakan faru ne a cikin iyali ɗaya ko daga taro ɗaya ko kuma daga abin hawa kamar jirgin ruwa.
Masu cutar galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna masu cutar ko kuma sun kasance tare da masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu da suka gabata kafin su kamu da cutar.
Koyaya, an ba da rahoton cewa marasa lafiya na iya ɗaukar kwayar cutar ba tare da alamomi ba fiye da makonni biyu kuma marasa lafiya da suka warke waɗanda aka bar su daga asibiti na iya ɗaukar kwayar cutar, wanda ke ba da gargaɗi don ƙara lokacin keɓewa.
Marasa lafiya suna da adadin ƙwayoyin farin jini na waje (musamman lymphocytes) wanda ya zama al'ada ko raguwa a farkon matakin.
Misali, lymphopenia tare da ƙididdigar ƙwayoyin farin jini < 4×109/L ciki har da ƙididdigar lymphocytes < 1×109/L, da ƙaruwa a cikin matakan aminotransferase aspartate da viremia an gano su a cikin marasa lafiya 1,099 na COVID-19.
Matakan enzymes na hanta da tsoka da kuma myoglobin sun karu a cikin jinin wasu marasa lafiya, kuma sun karu da furotin C-reactive da kuma lalatawar erythrocytes a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakan D-dimer, samfurin lalacewar fibrin a cikin jini, sun karu, kuma ƙididdigar lymphocytes ya ragu sosai.
An gano rashin daidaito a cikin radiography na kirji a cikin yawancin marasa lafiyar COVID-19 kuma ana nuna su ta hanyar inuwa mai ɓoyewa ta biyu ko ɓoye gilashin ƙasa a cikin huhu.
Marasa lafiya galibi suna fama da cutar huhu, raunin huhu da cutar numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, rashin kulawa da kumburi, tarin ruwa da saurin fibrosis suna shafar musayar gas sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, gano mummunan ƙwayar kirji na kirji yana dacewa da mafi munin yanayin cutar.
A ranar 18 ga Fabrairun 2020, nazarin ilimin pathology na farko na COVID-19 ya nuna ƙarancin ƙwayoyin cuta, samuwar membrane na hyaline da shiga cikin ƙwayoyin lymphocytes da ƙwayoyin sinadarin sinucetium na multinucleated a cikin huhu na marasa lafiya da suka mutu daga cutar, wanda ya dace da cututtukan cututtukan cututtukan ƙwayar cuta da ARDS kuma yayi kama da cututtukan marasa lafiya na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar juyawa-mai juyawa polymerase chain reaction (RT-PCR) an yi amfani dashi azaman babban ma'auni don ganewar asali na COVID-19.
Koyaya, saboda yawan ƙarancin ƙarya, wanda zai iya haifar da barkewar annoba, bayyanar asibiti ta fara amfani da ita don ganewar asali (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Haka ma yake da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da binciken radiology suna da mahimmanci kuma wajibi ne don yin ganewar asali.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafin kowane microliter na shigarwar) ta amfani da sandar tsoma cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu rikitarwa ba.
Da fatan, wannan sabuwar fasahar za ta iya haɓaka ƙwarewa da sauƙi idan an tabbatar da ita a cikin samfurin asibiti.
Saboda rashin gogewa tare da sabon CoVs, likitoci gaba ɗaya suna iya ba da kulawa mai goyan baya ga marasa lafiya na COVID-19, yayin da suke gwada magungunan da aka yi amfani da su ko aka ba da shawarar a baya don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Wadannan magungunan sun hada da maganin yau da kullun da kuma yiwuwar maganin rigakafi, maganin rigakafi, steroids, jini daga marasa lafiya da suka warke, maganin kasar Sin da kuma tallafin tunani.
Har ma an ba da shawarar yin amfani da jini na marasa lafiya da suka warke.
Kamfanonin magunguna suna ta kokarin samar da rigakafi da allurar rigakafi ga cutar.
SARS-CoV-2 yawanci yana kaiwa huhu hari a matakin farko kuma yana iya kaiwa, a ƙananan matakan, wasu gabobin da ke samar da ACE2, kamar tsarin gastrointestinal da kodan.
Duk da haka, rashin aiki da rashin numfashi suna da barazana ga marasa lafiya kuma sune manyan sanadin mutuwa.
Don haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun cututtuka da ceton rai kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai ƙarancin iska da iska mai ƙarfi dangane da tsananin cutar.
Marasa lafiya da ke da mummunan cututtukan numfashi suna buƙatar tallafawa ta hanyar oxygenation na membrane na extracorporeal (ECMO), fasahar zane-zane na zuciya da na numfashi wanda aka yi amfani da shi don magance zuciya ko rashin ƙarfi.
Bugu da ƙari, kiyaye daidaiton electrolyte, rigakafi da kula da kamuwa da cuta ta biyu da harin sepsis, da kuma kare ayyukan gabobin jiki ma ma'amaloli ne masu mahimmanci ga marasa lafiya SARS-CoV-2.
An san cewa guguwar cytokine tana haifar da halayen tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cytokine hauka wani nau'i ne na amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da kwayoyin cuta don saki yawancin 'yancin radicals wanda shine babban dalilin ARDS da rashin cin nasara na gabobin jiki.
Magungunan rigakafi suna da mahimmanci a cikin maganin tashin hankali na cytokine, musamman ga marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tocilizumab, ƙwayoyin rigakafin IL6 na monoclonal, don magance tashin hankali na cytokine.
Sauran maganin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin
Ana amfani da steroids, a matsayin masu hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a manyan allurai ba su da fa'ida ga mummunan raunin huhu a cikin marasa lafiya SARS da COVID-19.
A gefe guda, steroids a cikin manyan allurai na iya haifar da mummunan sakamako masu illa, musamman osteonecrosis avascular, yana shafar hangen nesa sosai.
Koyaya, an ba da shawarar amfani da ƙananan allurai na ƙananan ƙwayar cuta na ɗan gajeren lokaci tare da taka tsantsan ga marasa lafiya masu cutar COVID-19.
A lokacin da aka rubuta wannan labarin, babu maganin rigakafi mai tasiri da aka tabbatar.
Koyaya, amfani da allurar cikin jijiya tare da remdesivir, analog na nucleotide, an same shi da tasiri a kan wani mai cutar Amurka mai cutar COVID-19.
Remdesivir wani magani ne na rigakafin cutar da Gilead ta fara samarwa don magance cututtukan da cutar Ebola da Marlburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana sauran ƙwayoyin cuta na RNA guda ɗaya ciki har da MERS da SARS.
Bisa ga wannan lura, Gilead ta ba da cakuda ga China don gudanar da wasu gwaje-gwaje a kan mutanen da ke da cutar SARS-CoV-2, kuma ana jiran sakamakon.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su zama magunguna masu yuwuwa ga marasa lafiya tare da alamun cututtukan numfashi.
Diarrhoea, tashin zuciya, vomiting, cutar hanta da sauran cututtuka na iya faruwa bayan maganin haɗin lopinavir/ ritonavir.
Ya kamata a lura da wannan maganin tare da sauran magungunan da aka ba da su ga marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da kwayoyin cutar
Tattara jini daga marasa lafiya da suka warke daga cututtukan cututtuka don kula da wasu marasa lafiya da ke fama da irin wannan cuta ko don kare lafiyayyun mutane daga kamuwa da cutar yana da dogon tarihi.
Hakika, marasa lafiya da suka warke suna da yawan ƙwayoyin cuta a cikin jinin su.
Kwayar cuta ita ce immunoglobulin (Ig) wanda kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na waje kuma yana gano kwayoyin halitta na musamman a cikin ƙwayoyin cuta sannan ya kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10 da ke cikin mawuyacin hali.
Alamun su sun inganta cikin awanni 24, tare da raguwar kumburi da raguwar kwayar cutar da kuma karuwar jini.
Duk da haka, ana buƙatar tabbaci da bayani don bayar da shawarar irin wannan hanyar don amfani da yawa kafin a ci gaba da maganin da ba a riga an tsara ba.
Bugu da ƙari, saboda tasirin maganin, wasu rashin lafiyar da ke tattare da plasma ya kamata a yi la'akari da su sosai.
Misali, ƙwayoyin cuta na iya haifar da halayen rigakafi da haifar da cututtukan ƙwayar cuta, wanda shine guba mai haɗari.
Yawan adadin ƙwayoyin cuta a cikin jini yawanci ƙasa ne kuma buƙatar plasma yana da girma don kula da marasa lafiya masu mahimmanci.
Yana da wuya a samar da takamaiman maganin rigakafi da sauri don yaƙar annobar duniya.
Saboda haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke da kuma gano lambar kwayoyin da ke ƙunshe da ƙwayoyin cuta masu tasiri ko kuma tace ƙwayoyin cuta masu tasiri ga mahimman ƙwayoyin cuta.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin rigakafi.
An yi amfani da TCM don magance cututtuka daban-daban a China tsawon dubban shekaru.
Koyaya, tasirin ya dogara da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta bisa ga ganewar asali na cutar bisa ga ka'idar TCM.
Yawancin abubuwan da ke da tasiri sun kasance ba a sani ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwa ko kuma mafi kyawun haɗuwa.
A halin yanzu, saboda rashin takamaiman magani mai tasiri don COVID-19, TCM ya zama ɗayan manyan magunguna masu madadin marasa lafiya tare da alamun rashin lafiya mai sauƙi zuwa matsakaici ko waɗanda suka warke daga mawuyacin hali.
Misali, an gano Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules masu tasiri wajen maganin COVID-19.
An ga mafi yawan adadin warkewa a cikin kula da marasa lafiya na COVID-19 a wasu larduna a China waɗanda ke amfani da TCM a cikin kashi 87% na marasa lafiyarsu, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan kashi 30% na marasa lafiyar COVID-19, yana da mafi ƙarancin adadin warkewa (13%).
Duk da haka, wannan kwatancen yana da ɗan tsada saboda yawancin sauran abubuwan tasiri kamar yawan marasa lafiya da kuma tsananin cutar dole ne a haɗa su cikin ƙimar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin yamma (WM) kawai tare da haɗin maganin WM da TCM.
Sun gano cewa lokacin da ake buƙata don dawo da zafin jiki, rashin alamun bayyanar cututtuka da kuma asibiti ya fi guntu a cikin rukunin WM + TCM fiye da rukunin WM kawai.
Mafi ban mamaki, yawan yanayin bayyanar cututtuka ya zama mafi muni (daga mai sauƙi zuwa mai tsanani) ya fi ƙasa da ƙananan ƙungiyoyi na WM+TCM fiye da ƙungiyar WM kawai (7.4% vs 46.2%) da ƙananan mutuwar a cikin ƙungiyar WM+TCM fiye da ƙungiyar WM kawai (8.8% vs 39%).
Koyaya, inganci da amincin TCM har yanzu suna jiran gwaji mai sarrafawa a kan manyan sikelin da kuma a cikin cibiyoyi da yawa.
Zai zama mai ban sha'awa kuma don bayyana tsarin aikin da kuma bayyana abubuwan da ke aiki a cikin maganin TCM ko haɗin maganin idan zai yiwu.
Marasa lafiya da ake zargi ko tabbatar da su da cutar COVID-19 galibi suna da tsananin tsoron cutar da ke da saurin yaduwa kuma tana iya haifar da mutuwa, yayin da waɗanda ke keɓewa ke fuskantar rashin jin daɗi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia da tari da kuma mummunan sakamako na magani kamar rashin bacci wanda corticosteroids ke haifarwa na iya haifar da ƙarin damuwa da damuwa.
A farkon lokacin barkewar cutar SARS, an bayar da rahoton cututtukan cututtukan ƙwaƙwalwa da yawa ciki har da ci gaba da baƙin ciki, damuwa, harin firgici, tashin hankali, alamun psychotic, delirium, har ma da kashe kansa.
Bukatun ganowa da keɓewa, a matsayin ɓangare na amsar lafiyar jama'a ga cutar COVID-19, na iya sa mutane su ƙara damuwa da laifi game da tasirin kamuwa da cuta, keɓewa da kuma nuna wariya ga danginsu da abokansu.
Saboda haka, ya kamata a ba da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, mutane da ake zargi da su da kuma mutanen da ke hulɗa da su da kuma jama'a waɗanda ke buƙatar ta.
Tallafin ilimin halayyar ɗan adam ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar ƙwaƙwalwa da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma dacewa game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don kauce wa kusanci da juna.
Magungunan rigakafi masu tasiri suna da mahimmanci don katse sarkar watsawa daga yankunan dabbobin da ke fama da cutar zuwa ƙwayoyin cuta kuma yawanci suna haɓaka maganin rigakafi a cikin kula da annoba da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari ta hanyar haɓaka allurar rigakafin S-protein don samar da antibodies masu tasiri na dogon lokaci da tasiri da kuma / ko rigakafin kariya daga SARS-CoV.
An gwada allurar rigakafin cutar ta SARS a cikin samfurin dabbobi.
Koyaya, ingancin in vivo na waɗannan alluran rigakafi a cikin tsofaffi da ƙirar ƙalubalen haɗari da kariyar su daga kamuwa da cutar kwayar cuta ta dabbobi dole ne a ƙayyade kafin a fara binciken asibiti.
Wannan na iya zama saboda SARS ya ƙare shekaru 17 da suka gabata kuma babu wani sabon shari'ar da aka ruwaito tun daga lokacin.
A akasin wannan, lokuta na MERS da kuma rukuni-rukuni suna ci gaba da faruwa a Gabas ta Tsakiya da kuma yaduwa zuwa wasu yankuna saboda ci gaba da tushen zoonotic a cikin yankunan da ke da iyaka.
An haɓaka dabarun allurar rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta kamar ƙwayoyin cuta da ƙwayoyin cuta masu haɗuwa kuma an gwada wasu a cikin samfurin dabbobi.
Samar da allurar rigakafi mai inganci da aminci ga SARS-CoV-2 ga mutanen da ba su da kariya shine aiki mai mahimmanci da ake buƙata don sarrafa annobar da ke gudana.
Koyaya, yana da ƙalubale don shawo kan wahalar saboda dogon lokaci (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da canjin yanayin CoV.
A matsayin sabuwar cuta, COVID-19 ta nuna cikakkiyar hanyar asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna warkewa a hankali ba tare da sake kamuwa da cutar ba.
Koyaya, kamar SARS da MERS, COVID-19 kuma yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya masu fama da cutar.
Don haka, gina samfurin hangen nesa ga cutar yana da mahimmanci ga hukumomin kiwon lafiya don ba da fifiko ga ayyukansu, musamman a yankunan da ba su da albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan masu zuwa na iya tasiri ko alaƙa da tsinkayen marasa lafiya na COVID-19 (Table (Table33)):
Shekaru: Shekaru sune mafi mahimmancin mahimmancin hangen nesa na SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 yawanci yana faruwa ne tsakanin shekaru 30 zuwa 65 tare da kashi 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken da aka yi na shari'o'in 8,866 da aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci suna da yuwuwar samun ɓoyayyun cututtuka da rikitarwa kuma sun fi tsufa fiye da waɗanda ba su buƙata ba (a matsakaicin shekaru 66 da 51), suna ba da shawarar shekaru a matsayin babban abin da ke haifar da sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka ambata a sama.
Cutar da ke tattare da ita da kuma rikitarwa: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani suna iya samun rauni na zuciya da arrhythmia.
Matsalar zuciya ma ta fi haifar da mutuwa a cikin marasa lafiya da SARS.
An ba da rahoton cewa SARS-CoV-2 na iya ɗaure kansa ga cholangitis mai kyau ACE2, wanda zai iya haifar da cutar hanta a cikin marasa lafiya COVID-19.
Yana da kyau a lura cewa shekaru da kuma cututtuka suna da nasaba kuma suna iya shafan juna.
Binciken dakin gwaje-gwaje mara kyau: Matsayin furotin mai amsa C (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar a matsayin mai yiwuwar hangen nesa ga cuta, amsawa ga magani da kuma warkarwa ta ƙarshe.
An kuma ba da shawarar alaƙar haɗin CRP da tsananin cutar da kuma tsinkayar COVID-19.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana fitar da wannan enzyme a cikin kwayoyin halitta, musamman a zuciya da hanta, kuma ana fitar da shi a lokacin lalacewar nama.
Saboda haka, ya zama alama ta gargajiya don ciwon zuciya ko hanta.
Manyan alamun asibiti: X-ray na kirji da ci gaban alamun asibiti a kan lokaci dole ne a yi la'akari da su tare da sauran batutuwa don hango sakamakon da kuma rikitarwa na COVID-19.
Amfani da steroid: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi wanda aka saba amfani dasu azaman maganin adjunct don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Ganin cewa an yi amfani da allurai masu yawa na corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin tsofaffin marasa lafiya suna fama da cutar osteonecrosis tare da nakasa na rayuwa da rashin ingancin rayuwa.
Don haka, idan ya cancanta, ya kamata a yi amfani da steroid a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya COVID-19.
Matsin lamba: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19 yawancin marasa lafiya sun sha wahala daga matsanancin damuwa saboda suna fuskantar tsawon lokacin keɓewa da rashin tabbas mai tsanani da kuma ganin mutuwar dangin marasa lafiya da abokan aiki.
Yana da mahimmanci a samar da shawarwari na tunani da tallafi na dogon lokaci don taimakawa wannan mai haƙuri ya dawo daga damuwa da komawa rayuwar yau da kullun.
Dangane da binciken alƙaluma da aka yi zuwa yanzu, COVID-19 ya bayyana yana da halaye na annoba daban-daban daga SARS.
Baya ga ninkawa a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya ninkawa cikin inganci a cikin hanyoyin numfashi na sama kuma yana haifar da alamun bayyanar cututtuka ko rashin alamun bayyanar cututtuka a farkon lokacin kamuwa da cuta, kamar sauran CoVs da ke haifar da mura.
Saboda haka, marasa lafiya da ke kamuwa da cutar a farkon lokaci ko lokacin kamuwa da cutar na iya samar da kwayar cutar da yawa yayin yin ayyukan yau da kullun, yana sa ya zama da wahala a sarrafa annobar.
Koyaya, ana ɗaukar kamuwa da SARS-CoV yana faruwa ne yayin da marasa lafiya ke cikin mummunan rashin lafiya, yayin da yawancin kamuwa da cutar ba sa faruwa a farkon lokacin.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani da kuma wahalar sarrafawa.
Ana ci gaba da yin gagarumin ƙoƙari a China ciki har da dokar hana fita a Wuhan da biranen da ke kewaye da ita da kuma keɓewar kusan dukkanin jama'a a cikin fatan yanke hukuncin yaduwar SARS-CoV-2.
Duk da cewa wannan matakin ya lalata tattalin arzikin kasar da sauran bangarorin kasar sosai, yawan sabbin masu cutar ya ragu, wanda ke nuna cewa annobar ta fara.
Mafi kyawun hasashen shine cutar za ta ƙare a ƙarshen Maris kuma za a ci gaba da raguwa na tsawon watanni 3-4.
Amma wasu masana ba su da tabbaci.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya fi SARS saukin kamuwa da cuta, ba zai ƙare a cikin 2020 ba.
Ira Longini, et al., sun kirkiro samfurin don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata kungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin duka swabs na tsakiya da na makogwaro na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon ƙwayoyin cutar da aka gano na iya zama wani abu mai kama da mura.
Duk da haka, alamun da ke tabbatar da hakan sun faru a China dangane da yawan sabbin cututtukan da ke raguwa, wanda ke nuna cewa dabarun da ake amfani da su a yanzu na iya yin tasiri.
Ebola da farko an yi hasashen zai haifar da kusan mutum miliyan daya da mutuwar mutane miliyan daya da rabi.
Amma, tare da keɓewa da keɓewa, cutar ta sami nasara.
Don haka, kamar SARS-CoV, yana yiwuwa kamuwa da cutar SARS-CoV-2 ya zama mai rauni kuma daga ƙarshe ya ƙare ko ya zama ƙarancin ƙwayar cuta wanda ke tare da ɗan adam.
Kwatanta tsakanin annobar COVID-19 da SARS da MERS an bayar da su a ƙasa (Graph (Graph55).
SARS-CoV-2 yana yaduwa ta hanyar tari ko hancinsa, kuma yana iya yaduwa ta hanyar tuntuɓar abubuwa da suka kamu da cutar.
An kuma gano kwayar cutar a cikin fitsari, wanda hakan ya haifar da wata sabuwar hanyar yaduwar cutar daga fitsari zuwa baki.
Wani bincike na kwanan nan akan shari'o'i 138 ya ba da rahoton cewa kashi 41% na shari'o'in na iya zama saboda kamuwa da cuta ta nosocomal, gami da marasa lafiya 17 da wasu cututtuka da ma'aikatan kiwon lafiya 40.
Don haka, dole ne a yi amfani da matakan kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangin, abokai, har ma da mutanen da ke kan hanya da ke hulɗa da marasa lafiya ko mutanen da ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska; amfani da masks na tiyata da masks na numfashi N95 (jerin # 1860) suna taimakawa wajen sarrafa yaduwar kwayar cutar.
Masks na tiyata suna hana ɗigon ruwa daga wani mutum mai yuwuwar kamuwa da cutar daga yaduwa ta hanyar iska ko mannewa da kayan abu, wanda hakan zai iya yaduwa ga wasu.
Koyaya, kawai masks na nau'in N95 (jerin #1860s) na iya karewa daga shan virions masu ƙanƙanta 10 zuwa 80 nm, tare da kawai 5% na virions waɗanda zasu iya shiga cikin masks na nau'in N95; SARS-CoV-2 yayi kama da SARS-CoV ta fuskar girman su duka suna da girman kusan 85 nm.
Tunda ƙwayoyin cuta na iya shiga cikin masks na tiyata guda biyar da aka saka tare, ma'aikatan kiwon lafiya da ke hulɗa da marasa lafiya kai tsaye suna buƙatar sanya masks na N95 (jerin #1860s) maimakon masks na tiyata.
Baya ga rufe fuska, ma'aikatan kiwon lafiya suna buƙatar sanya kayan kariya na mutum don rage haɗuwa da kwayar cutar.
Kwayar cutar na iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
A wannan yanayin, ma'aikatan kiwon lafiya suma suna buƙatar sanya abin rufe fuska mai haske ko tabarau na tsaro yayin hulɗa da marasa lafiya.
Ga jama'a a yankunan da ke fama da cutar ko kuma za su iya kamuwa da ita, an shawarci dukkan mazauna da su wanke hannayensu da sabulu mai kashe kwayoyin cuta akai-akai, su zauna a gida kuma su rage hulɗa da mutanen da za su iya kamuwa da cutar.
An yi la'akari da nesa da ƙafa uku don nisantar da mutum daga marasa lafiya.
Wadannan matakan sune hanya mai tasiri wajen rage hadarin kamuwa da cutar ban da hana yaduwar kwayar cutar.
Duk da cewa SARS-CoV-2 sabuwar kwayar cuta ce, babban kamannin da aka ruwaito a ranar 7 ga Janairu 2020 ya ba da gargadi ga China kamar yadda cutar SARS ta yi a 2003.
Koyaya, kawai a ranar 19 ga Janairun 2020 ne Daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Wuhan ya yi ƙoƙarin rage damuwar jama'a ta hanyar cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakantaccen haifuwa a cikin mutane kuma rigakafi da hana cutar ba matsala.
Wannan sakon ya taimaka wajen rage damuwar jama'a, musamman a lokacin da ake shirin bikin bazara a kasar, kuma ba za a iya maraba da shi ba don rage yaduwar cutar a Wuhan.
Hukumar kula da cututtuka ta kasar Sin za ta iya koyon darasi daga wannan kuma ta inganta a nan gaba.
Misali, hukumomi masu dacewa (1) sun fi taka tsantsan wajen yin sanarwa ga jama'a saboda kowane daki-daki da aka gabatar yana tasiri ga halayen jama'a da yanke shawara; (2) sun fi saukin kai da kuma amsawa ga bayanan da aka karɓa daga asibiti fiye da jiran rahoto na yau da kullun daga likita ko jami'in; (3) sun fi tsaurara gwiwa wajen dakile cutar fiye da kwantar da hankalin jama'a; da kuma (4) suna gudanar da horo akai-akai don wayar da kan jama'a game da cututtukan annoba da gwadawa da inganta tsarin amsawar jama'a akai-akai.
Cutar COVID-19 ta samo asali ne daga sabon kwayar cutar SARS-CoV-2 wanda ya fara a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya yadu zuwa duk kasar Sin da kusan kasashe 50 a duniya a lokacin da nake rubuta wannan.
Tunda kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da SARS, yaduwar COVID-19 ya haifar da jin cewa barkewar SARS ta sake faruwa.
Koyaya, akwai bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci wajen hana yaduwar cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa kuma yana shafar maza fiye da mata, kuma mawuyacin hali da yawan mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mace-mace fiye da COVID-19 (10.91% vs 1.44%).
Marasa lafiya na COVID-19 na iya yada kwayar cutar ba tare da nuna wata alama ba yayin da marasa lafiya na SARS ke yada kwayar cutar yayin rashin lafiya, wanda ke haifar da wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ya yadu cikin sauri da kuma yaduwa fiye da SARS-CoV.
Sakamakon gwajin RNA don SARS-CoV-2 na iya zama mara kyau ga marasa lafiya na COVID-19.
Koyaya, marasa lafiya da suka warke suna iya sake samun kwayar cutar.
Wannan binciken ya kara hadarin kamuwa da cutar.
Bisa ga ci gaban da aka samu cikin bincike kan COVID-19, akwai wasu batutuwa masu mahimmanci da za a magance, ciki har da:
Daga ina ne SARS-CoV-2 ya fito?
Kodayake an gano kashi 96% na kwayoyin halittar SARS-CoV-2 da kuma wasu CoVs guda biyu kamar SARS na Batman, ba za mu iya yanke shawarar cewa SARS-CoV-2 ma ya samo asali ne daga Batman ba.
Shin dabbobi ne ke daukar kwayar cutar daga gida, kamar su bat, zuwa mutane?
Idan ba mu san amsoshin tambayoyi na farko da na biyu ba, ba za mu iya tantance yadda ake yaduwar cutar ba, kuma annobar za ta iya sake faruwa a kowane lokaci.
Kodayake gwajin samfurin kwayoyin halitta da nazarin halittu sun nuna cewa SARS-CoV-2 ya ɗaure kansa ga ACE2, ta yaya kwayar cutar za ta iya shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na cututtuka?
Shin kwayar cutar ta iya ɗaure kwayoyin halittar ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin, ba za mu iya samun saurin ganewar asali da kuma magani mai inganci ba.
Har yaushe wannan annobar za ta ci gaba?
Ta yaya kwayar cutar ke yaduwa ta hanyar kwayar halitta ta hanyar yaduwar mutane?
Shin za ta zama annoba a duniya, ta ƙare kamar SARS ko kuma ta sake dawowa a kai a kai kamar mura?
Wannan yana da muhimmanci amma zai ɗauki lokaci don neman amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Koyaya, komai tsadar kuɗin da za a kashe, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu ga al'ada.
Asalin cutar coronavirus na mutum
Juyin halitta da daidaitawa sun haifar da juyin halitta tare da coronavirus (CoV) da manyan rundunoninsa, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa mutum biyu da ke dauke da kwayar cutar korona (HCoV) suna haifar da cututtuka masu saurin kamawa, kamar mura.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar SARS-CoV-2 a China a ƙarshen 2019 ya jawo hankali ga CoV kuma ya ba mu mamaki da sauƙin kamuwa da cutar amma ba shi da cutarwa kamar SARS-CoV.
Cutar HCoV ta zama cutar dabbobi kuma fahimtar asalin HCoV na iya taimaka mana.
Yawancin HCoVs sun fito ne daga barbashi.
An kuma san matsakaicin gidan ajiyar wasu HCoVs.
Gano ƙwayoyin dabbobi yana da tasiri kai tsaye kan rigakafin cututtukan mutane.
Binciken hulɗar da ke tsakanin rundunar CoV a cikin dabbobi ya ba da damar fahimtar mahimmancin cutar CoV a cikin mutane.
A cikin wannan binciken, mun ba da cikakken bayani game da ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin zoonotic da watsa tsakanin jinsuna.
A cikin wannan binciken, mun gano cewa HCoVs suna da bambanci tsakanin kwayoyin halitta da kuma kwayoyin halitta.
An tattauna cutar ta COVID-19 a halin yanzu a cikin wannan mahallin.
Bugu da kari, an jaddada bukatar musayar bakuncin mai nasara da kuma tasirin juyin halittar kwayar cutar akan tsananin cutar.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae, waɗanda ke kunshe da rukuni na ƙwayoyin cuta masu ɗauke da RNA guda ɗaya, masu ɗauke da ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta.
Wannan kwayar halitta tana tsakanin kilobases 26 zuwa 32 a tsawonta kuma ita ce mafi girman kwayar halitta a cikin ƙwayoyin cuta na RNA kuma an ba ta suna "CoV" saboda siffar ta ta siffar da ke kama da kambi a ƙarƙashin madubin lantarki.
A tsarin, CoVs suna da kwayoyin halitta marasa rarrabuwa waɗanda ke raba tsari iri ɗaya.
An kiyasta cewa kashi biyu cikin uku na wannan kwayoyin halitta suna da manyan manyan furanni biyu (ORF1a da ORF1b) da ke rufe juna, wanda aka fassara zuwa pp1a da pp1ab polyprotein replicase.
Ana sarrafa polyproteins sannan a samar da sunadarai 16 marasa tsari, wanda aka sani da nsp1~16.
Rashin kwayoyin halitta ya ƙunshi ORFs don gina jiki, ciki har da sutura (S), shinge (E), membrane (M) da nucleoprotein (N).
Wasu ƙwayoyin cuta na ƙwayoyin cuta na musamman na masu karɓar kwayar cuta suna ƙayyadewa ta hanyar masu karɓar CoV daban-daban.
Dangane da bambance-bambance a cikin jerin sunayen sunadarai, an rarraba CoVs zuwa jinsi huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), inda beta-Cov jinsuna suka ƙunshi yawancin HCoVs kuma an raba su zuwa jinsi huɗu (A, B, C da D).
Shaidar phylogenetic ta nuna cewa barbashi da beraye suna aiki a matsayin tushen kwayoyin halitta ga yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban ma'ajiyar gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs sun shawo kan ƙalubalen jinsuna kuma wasu sun zama manyan cututtukan ɗan adam.
A yau, an gano mutum bakwai da suka kamu da cutar korona.
Daga cikin su akwai HCoV-229E da HCoV-NL63 wanda shine alpha-CoV.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS-CoV-2).
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar mura da/ko zawo.
A gefe guda, sabbin SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano suna da cutarwa sosai, suna haifar da mummunan kamuwa da cututtukan ƙananan iska a cikin marasa lafiya waɗanda ke da babban yiwuwar samun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
An ware HCoV-229E na farko, B814, daga ɓarkewar hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun rashin kulawa.
An yarda da ra'ayin cewa kamuwa da cutar HCoV ba ta da haɗari har sai barkewar cutar SARS.
Cutar SARS ta barke a 2003 kuma ta kasance daya daga cikin bala'i mafi muni a tarihi, ta kamu da mutane sama da 8,000 tare da mutuwar kusan 10%.
Shekaru goma bayan haka, barkewar cutar murar numfashi ta Gabas ta Tsakiya (MERS) ta haifar da ci gaba da yaduwa a yankin Larabawa tare da yaduwar duniya a wasu lokuta.
Sabuwar HCoV 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, ita ce mai haifar da ci gaba da cutar ta cutar coronavirus ta 2010 (COVID-1), wanda ya kashe rayuka sama da 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris 2020.
An ba da gargaɗi kuma dole ne duniya ta shirya don fuskantar cutar SARS-CoV-2.
Dukkanin HCoVs bakwai suna da asalin zoonotic daga barbashi, beraye da dabbobin gida.
Shaida mai yawa tana tallafawa asalin juyin halitta na dukkan HCov daga barbashi, inda ƙwayoyin cuta ke da sauƙin daidaitawa kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-2019 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da sauran duniya.
Binciken asalin HCoV na dabbobi yana ba da tsarin fahimtar tarihin halitta, abubuwan motsawa da abubuwan da ke hana tsalle-tsalle na jinsuna.
Hakanan yana iya jagorantar da sauƙaƙe binciken ƙwayoyin cuta na masu tanadi, masu shiga tsakani da masu haɓaka SARS-CoV-2, tare da mahimman bayanai game da rigakafin yaduwar gaba.
A cikin wannan bita mun gabatar da cikakken bayani game da asalin zoonotic, watsa tsakanin jinsuna da kuma cututtukan HCoV.
Musamman, mun bayyana da kuma tattauna batun da ya shafi HCoVs inda kwayoyin HCoV ba su da cutar a cikin yanayin halitta na mai watsa shiri amma sun zama masu cutarwa bayan watsawa tsakanin sababbin masu watsawa.
Mun kuma sake nazarin yanayin juyin halittar HCoVs inda yawan kamuwa da cuta ke faruwa tare da raguwar cututtukan.
Hakanan an tattauna sakamakon barkewar cutar SARS-CoV-2 a cikin wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware HCoV-229E na B814 daga ɓoyayyen hancin marasa lafiya da ke fama da mura, an ware CoV daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da kaji, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano HCoV bakwai.
A takaice dai, tarihin gano HCoV a cikin tsarin lokaci (Table 1) na iya ba da bayani da koyarwa.
An fara ware kwayar HCoV-229E daga cikin hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar ta sama a cikin 1966, kuma an daidaita ta don girma a cikin layin ƙwayoyin WI-38 na huhu.
Marasa lafiya da ke dauke da HCoV-229E suna da alamun mura, gami da ciwon kai, hancin, rashin ƙarfi da ciwon makogwaro, tare da zazzabi da tari a cikin kashi 10 ~ 20%.
Daga baya a cikin 1967, HCoV-OC43 an ware shi daga al'adun gabbai kuma daga baya ya wuce cikin kwakwalwar beraye masu shayarwa.
Bayanan asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da kamuwa da cutar ta HCoV-229E, wanda ba za a iya bambance shi da alamun cututtuka daga kamuwa da wasu cututtukan cututtukan numfashi kamar su cutar mura A da rhinovirus ba.
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duk duniya kuma suna da saurin yaduwa yayin hunturu a yankunan da ke da yanayi mai laushi.
Yawancin lokaci, tsawon lokacin da aka yi amfani da su a cikin waɗannan ƙwayoyin cuta biyu ba su wuce mako guda ba, sannan kuma cutar ta kasance kusan makonni biyu.
A cewar binciken da aka yi kan masu sa kai, lafiyayyun mutane da ke dauke da kwayar cutar HCoV-229E sun kamu da mura mai laushi.
Wasu marasa lafiya masu fama da cutar sun nuna mummunan cututtukan ƙananan iska.
SARS, wanda aka fi sani da atypical pneumonia, annoba ce ta farko da aka fara gano HCoV a tarihin ɗan adam kuma mai cutar ta SARS-CoV, HCoV ta uku da aka gano.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar ta SARS ta haifar da rahotanni 8,096 da mutuwar 774, wanda ya bazu a ƙasashe da nahiyoyi da yawa.
Baya ga kasancewa mai yaduwa, an kiyasta cewa kowace shari'a na iya haifar da kusan shari'o'i biyu na biyu, tare da lokacin da ke tsakanin kwanaki 4 zuwa 7 da kuma ƙwanƙwasawar ƙarancin ƙwayar cuta ta bayyana a ranar 10th na rashin lafiya.
Marasa lafiya da ke dauke da SARS-CoV sun fara nuna ciwon myalgia, ciwon kai, zazzabi, zazzabi da sanyi, sannan ana samun rashin numfashi, tari da tashin hankali na numfashi a matsayin alamun rashin lafiya.
Lymphopenia, gwajin aikin hanta da karuwar creatine kinase sune abubuwan da suka saba da SARS.
Hakanan an lura da lalacewar alveolar difus, haɓakar ƙwayoyin epithelium da haɓaka macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa da hankali da kuma iska mai aiki.
Baya ga kamuwa da cututtukan ƙananan iska, gabobin da suka haɗa da gastrointestinal tract, hanta da kodan na iya kamuwa da cutar a cikin wannan mummunan yanayin, yawanci ana tare da guguwar cytokine, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya masu kamuwa da cuta.
An fara ware kwayar cutar ne daga kwayar cutar huhu ta wani dangin wani mai cutar da ke tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga wani yaro ɗan wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cutar tana yaduwa tsakanin yara, tsofaffi da marasa lafiya masu fama da cututtukan numfashi.
Kasancewar choriasis, conjunctivitis, zazzabi da kuma bronchiolitis sun zama ruwan dare gama gari a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike mai zaman kansa ya bayyana yadda aka ware irin wannan kwayar cutar daga samfurin hanci na wani yaro mai wata takwas wanda ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, cutar ta yadu a duk duniya.
An kiyasta cewa HCoV-NL63 shine ke haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma lokacin da cutar ke faruwa shine lokacin farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cututtukan laryngitis, wanda ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga cututtukan huhu da cututtukan huhu da ke cikin al'umma, an kuma ba da rahoton cewa HCoV-HKU1 yana da alaƙa da matsanancin cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 ana samun su a duk duniya, suna haifar da rashin lafiyar numfashi mai sauƙi.
Dukkanin HCoVs huɗu da ke kamuwa da cutar a cikin wannan al'umma sun dace da mutane kuma gabaɗaya ba sa iya canzawa kuma suna haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Gabaɗaya, lokacin da waɗannan HCoVs suka sami ikon yaduwa cikin inganci da ci gaba da kasancewa cikin jikin mutum, ƙwayoyin cuta ma sun zama marasa cutarwa ko cututtuka.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ke fama da ciwon huhu da ciwon koda a Saudi Arabia.
Kodayake yawancin magungunan da aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ba da rahoton wasu lokuta na shigo da cutar ta biyu zuwa kusanci a ƙasashen Turai da Tunisia.
Wani annobar ta biyu ta faru a Koriya ta Kudu a 2015 tare da tabbatar da shari'o'i 186.
Bayyanar asibiti ga MERS yayi kama da SARS, wanda ke nuna ciwon huhu mai saurin ci gaba.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS suna fama da ciwon koda mai tsanani, wanda ya kasance na musamman ga MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna nuna alamun cututtukan gastrointestinal, kamar zawo da amai.
Zuwa 14 ga Fabrairun 2020, an ba da rahoton sama da shari'o'in da aka tabbatar da labaran 2500 tare da mutuwar kashi 34.4%, yana mai da MERS-CoV ɗayan mafi munin ƙwayoyin cuta da ke damun ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wani rukunin marasa lafiya na cutar huhu da aka sani da baya dangane da kamuwa da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan numfashi ta ƙasa da ke faruwa ta hanyar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a ta duniya kuma ta sanya wa cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an ba da rahoton shari'o'i 90,053 a duk duniya, tare da mutuwar mummunan yanayin da ya kai kashi 3.4%.
A bayyane yake, mutuwar cutar a Hubei, China ya kai kashi 4.2%, yayin da mutuwar cutar a wajen yankin ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunan kamuwa da cuta na numfashi kamar SARS-CoV da MERS-CoV, yana bayyana a matsayin zazzabi, tari da dyspnea.
Diarrhea ma yana faruwa ga wasu marasa lafiya.
Ciwon huhu yana daya daga cikin munanan alamun cutar kuma yana iya saurin bunkasa zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan kwayar halittar nucleotide da ke da kashi 82%, ƙwayoyin cuta sun haɗu zuwa rassa daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 ya bayyana ba shi da ƙwayoyin cuta amma yana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton mutane marasa alamun kamuwa da SARS-CoV-2 kuma suna iya taimakawa ga saurin yaduwar cutar a duniya.
Kwatanta da bambance-bambance tsakanin SARS-CoV-2 da sauran HCoVs shida sun nuna kamanceceniya da banbanci mai ban sha'awa.
Da farko dai, lokacin kamuwa da cutar HCoV da tsawon lokacin kamuwa da cutar sun yi kama sosai.
A wannan yanayin, SARS-CoV-2 ya bi tsarin hali na sauran HCoVs shida.
Na biyu, tsananin alamun COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu da aka samo daga al'umma (cth. HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da ake gani sau da yawa yayin kamuwa da cutar ta HCoV da aka samo daga al'umma, gami da kasancewar alamun bayyanar cututtuka marasa ƙarancin alamomi, masu laushi ko babu alamun bayyanar cututtuka.
A wani bangare kuma, ƙananan ƙananan ƙananan cututtukan COVID-19 masu tsanani ana iya ganin su kamar yadda suke a cikin SARS-CoV, kodayake ƙananan ƙananan ƙananan.
Na uku, yaduwar SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa ga duka HCoVs da aka samo daga al'umma da SARS-CoV.
A gefe guda, kamuwa da SARS-CoV-2 ya kasance aƙalla kamar yadda HCoVs ke samu daga al'umma.
A gefe guda, yana da wahala a tabbatar da ko kamuwa da SARS-CoV-2 ya ragu bayan ya wuce mutum kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin ƙwayoyin cuta.
Ko canja wurin stool zuwa baki don SARS-CoV-2 yana taka muhimmiyar rawa kamar yadda yake a cikin yanayin SARS-CoV aƙalla a ƙarƙashin wasu yanayi yana jiran haske ta hanyar nazarin gaba.
Hakanan yana da ban sha'awa sosai ganin ko SARS-CoV-2 na iya ɓarkewa ta yanayi kamar yadda yake a cikin yanayin HCoVs masu kamuwa da cutar a cikin al'umma.
Koyaya, halaye na SARS-CoV-2 gami da kamuwa da cuta, cututtukan cututtuka da ci gaba da yaduwa bayan wucewar ɗan adam zai shafi ƙarshen barkewar cutar COVID-19.
Dukkanin HCoVs huɗu da ke kamuwa da cutar a cikin al'umma suna haifar da alamun bayyanar cututtuka sun dace da mutane.
A wani bangare kuma, yana iya zama gaskiya ne cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya tsira daga cutar HCoV ta baya.
An kawar da HCoVs da ke haifar da mummunan cuta a cikin mutane da kuma mutanen da ke fama da mummunan cutar HCoV.
Don ba da damar wannan ya faru, HCoVs dole ne su ninka a cikin mutane har zuwa matakin da ya isa don ba da damar tarin kwayoyin halittar da ke yaƙi da abubuwan hanawa.
Saboda haka, tsawon lokacin da cutar SARS-CoV-2 ke ci gaba da wanzuwa kuma mutane da yawa ke kamuwa da ita, mafi girman damar cutar ta dace da mutane.
Idan kwayar cutar ta daidaita sosai, zai yi wuya a hana yaduwar ta cikin mutane ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
A tsawon shekaru, wasu CAV guda huɗu da ke kamuwa da cutar a cikin al'umma suna yawo a cikin yawan mutane, suna haifar da mura a cikin masu kamuwa da cutar.
Wannan kwayar cutar ba ta bukatar wani dabba mai ajiya.
A gefe guda, SARS-CoV da MERS-CoV ba su daidaita da kyau ga mutane ba kuma ba za a iya ci gaba da yaduwar cutar a cikin mutane ba.
Kwayar cutar tana buƙatar zama da haɓaka a cikin ramin da ke tattare da dabbobi da kuma neman damar yaduwa zuwa maƙasudin ɗan adam mai saurin kamuwa da cuta, mai yiwuwa ta hanyar ɗaya ko fiye da matsakaici da masu rarrabawa.
SARS-CoV-2 yana da halaye iri ɗaya da na SARS-CoV/MERS-CoV da HCoVs huɗu da ke kamuwa da cutar a cikin al'umma.
Yana da saukin yaduwa kamar HCoVs da ke kamuwa da cutar a cikin al'umma, aƙalla a yanzu.
Duk da haka, kwayar cutar ta fi cutar HCoVs kamuwa da cuta a cikin al'umma kuma ba ta da cutarwa kamar SARS-CoV ko MERS-CoV.
Lokaci ne zai nuna ko kwayar cutar za ta iya daidaitawa ga mutane kuma ta bazu tsakanin mutane ba tare da wani tanki ko dabba mai shiga tsakani ba.
Kafin tattauna asalin dabbobi masu haifar da HCoV, zai fi kyau mu tattauna ma'anar da halayen masu juyin halitta, na halitta, masu adanawa, masu matsakaici da kuma masu samar da HCoV.
Wani dabba yana aiki a matsayin mai karɓar juyin halitta don HCoV idan yana da magada mai kusa wanda ke raba homology mai yawa a matakin juzu'in nucleotide.
Kwayoyin cutar da ke cikin zuriya suna da kyau kuma ba su da cutarwa a cikin wannan host.
Hakazalika, masu riƙe da HCoVs suna riƙe da su a cikin dogon lokaci.
A cikin waɗannan lokuta biyu, baƙi suna kamuwa da cutar ta halitta kuma suna zama baƙi na halitta ga HCoV ko virions.
A gefe guda, idan an gabatar da sabon HCoV zuwa wani mai watsa shiri kafin ko a kusa da gabatarwar da aka yi wa mutane, kwayar cutar ba ta dace da sabon mai watsa shiri ba kuma yawanci cutar ce.
Wadannan matsakaitan runduna na iya zama tushen asalin mutum don kamuwa da cuta kuma suna taka rawa a matsayin rundunar haifuwa ta hanyar barin kwayar cutar ta ninka na ɗan lokaci sannan kuma ta yada kwayar cutar ga mutane don ƙarfafa sikelin kamuwa da cutar ga mutane.
HCoVs na iya kamuwa da cutar ta hanyar mutuwa idan ba za su iya ci gaba da kamuwa da cutar ba a cikin matsakaiciyar host.
A gefe guda, HCoVs na iya daidaitawa ga mai watsa shiri na tsakiya kuma suna haifar da rashin lafiya na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanan cututtukan cututtuka sun nuna cewa SARS yana da tarihin haɗuwa da dabbobi masu farauta.
Binciken ƙarin sashin cutar ya nuna cewa masu sayar da dabbobi suna da ƙarancin cutar anti-SARS-CoV IgG fiye da sauran jama'a.
An fara gano cewa fox lamri (Paguma larvata) da karnukan raccoon a kasuwar dabbobi masu rai suna dauke da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan yana da goyan baya ta hanyar cewa babu wani SARS da aka ruwaito bayan kashe duk foxes a kasuwa.
Koyaya, an ba da rahoton cewa foxes daga gandun daji ko gonaki ba tare da fallasa su zuwa kasuwannin dabbobi masu rai ba galibi ba su da kyau ga SARS-CoV, yana ba da shawarar cewa foxes na iya zama kawai matsakaiciyar mai karfafawa amma ba mai tanadin SARS-CoV na halitta ba.
Mafi mahimmanci, tunda kashi 80% na dabbobi daban-daban a kasuwa a Guangzhou suna da ƙwayoyin rigakafin SARS-CoV, ba za a iya kawar da yiwuwar cewa ƙananan ƙananan dabbobi masu shayarwa na iya zama masu karɓar bakuncin SARS-CoV ba.
Duk waɗannan sun zama matattarar SARS-CoV.
Binciken da aka yi na dabbobi na SARS-CoV ya nuna cewa akwai wata kwayar cuta mai kama da ta SARS, wato SARSr-Rh-BatCoV HKU3 (Rhinolophus bat CoV) wadda ke cikin kwayar cuta ta kasar Sin.
Wannan ɗan damisa ya sami sakamako mai kyau ga ƙwayoyin cuta na SARS-CoV da kuma jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Wannan da sauran ƙwayoyin cuta na CoV suna da kashi 88-92% na nucleotide sequence homology tare da SARS-CoV.
Wannan binciken ya samar da tushen sabon ra'ayi cewa ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na mutum.
Wasu CoVs kamar SARS (SL-CoVs) an kuma gano su daga barbashi, amma babu wanda aka kira WIV1 wanda za'a iya ware shi azaman kwayar cuta mai rai.
An san enzyme mai canza angiotensin 2 (ACE2) na mutum a matsayin mai karɓar SARS-CoV.
WIV1 da aka samo daga samfurin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Abin sha'awa, an gano cewa ƙwayar SARS mai warkewa tana iya kawar da WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar mafi yawan zuriya masu alaƙa da SARS-CoV a cikin barbashi, suna raba kashi 95% na haɗin nucleotide.
Duk da cewa akwai babban kamani tsakanin ƙwayoyin cuta biyu, an yarda da cewa WIV1 ba kwayar cutar mahaifa ce ta SARS-CoV kai tsaye ba kuma cewa barbashi ba shine mai karɓar bakuncin SARS-CoV kai tsaye ba.
Binciken ilimin halitta ya sanya MERS-CoV a cikin rukuni ɗaya kamar yadda CoV-HKU4 da CoV-HKU5 ke.
CoV-HKU4 da MERS-CoV na bat suna amfani da irin wannan mai karɓar mai karɓar, dipeptidyl peptidase 4 (DPP4), don shigar da ƙwayoyin cuta.
Hanyar RNA polymerase mai dogaro da RNA daga MERS-CoV ta fi kusa da kwayar cutar a cikin beta-CoVs na bat da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a sami MERS-CoV mai rai a cikin 'yan damisa ba.
MERS-CoV da dangin CoV-HKU25 na bakin wake suna da kashi 87% na kwayar halittar nucleotide.
Don haka, ƙila ba ƙwayoyin cuta ba ne ke ɗaukar MERS-CoV kai tsaye.
A gefe guda, nazarin Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa suna da tasiri mai kyau akan ƙwayoyin cuta na MERS-CoV, kamar raƙuman Gabas ta Tsakiya waɗanda suka fito daga ƙasashen Afirka daban-daban.
An ware MERS-CoV mai rai wanda yayi kama da kwayar cutar da aka samo a cikin mutane ta hanyar swabs na hancin raƙumi na Larabawa, wanda ya nuna cewa raƙumi yana aiki a matsayin mai riƙe da MERS-CoV mai tsabta.
Hakanan ya kamata a lura cewa a gaba ɗaya ana nuna alamun rashin lafiya amma an lura da raguwar kwayar cutar a cikin raƙuman da ke dauke da MERS-CoV.
Musamman, raƙuman da suka kamu da cutar suna fitar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba amma ta hanyar hanyar ƙwayoyin cuta, wanda kuma shine hanyar da za a fitar da ƙwayoyin cuta daga cikin bat.
Koyaya, tambayoyi sun kasance tun da yawancin shari'o'in MERS da aka tabbatar ba su da tarihin haɗuwa da rakumi kafin bayyanar cututtuka, mai yiwuwa ana danganta su da hanyar watsawa ta mutum zuwa mutum ko hanyar watsawa da ba a sani ba wanda ya shafi nau'in dabba da ba a sani ba wanda ke ɗaukar MERS-CoV.
SARS-CoV-2 ya raba 96.2% na nucleotides masu kama da CoV RaTG13 na bat wanda aka ware daga bat Rhinolophus affinis.
A cikin shari'o'in SARS-CoV da MERS-CoV, bambancin jeri tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don ƙayyade dangantakar iyaye.
A cewarsa, baƙar fata ba za ta iya zama mafi kusa ba ga SARS-CoV-2 amma kusan irin wannan CoV na bat da aka gano a nan gaba.
Wataƙila, mai karɓar baƙi na SARS-CoV-2 ya kasance daga dabbobin daji da aka siyar da su kuma aka kashe su a Kasuwar Kasuwancin Kifi ta Huanan, wanda ke da alaƙa da yawancin farkon shari'o'in COVID-19, yana nuna yiwuwar yiwuwar watsawar dabbobi ga mutane.
Wasu binciken kwanan nan da aka yi dangane da bin metagenomics sun ba da shawarar cewa ƙananan ƙananan dabbobi masu shayarwa da ake kira tangerines (Manis javanica) na iya ɗaukar zuriyar beta-CoVs da ke da alaƙa da SARS-CoV-2.
Kwayoyin halittar CoV na kwayar halitta suna da kashi 85-92% na kwayar halittar nucleotide tare da SARS-CoV-2.
Duk da haka, dukansu suna da alaƙa da RaTG13 tare da kusan 90% na ainihi a matakin jerin nucleotide.
An tattara su cikin ƙwayoyin cuta guda biyu na ƙwayoyin cuta kamar SARS-CoV-2 a cikin bishiyar pilogenetic, ɗayan ɗayan suna da alaƙa da yankin haɗin mai karɓar mai karɓa (RDB) wanda ya fi kama da SARS-CoV-2, tare da 97.4% na asalin amino acid.
A cikin bambance-bambance na gaske, RBD daga SARS-CoV-2 da RaTG13 sun fi karkata, duk da cewa suna da mafi girman digiri na homology na yanki.
Binciken da aka yi a baya game da cututtukan da ke cikin jijiyoyin jiki ya kuma ba da rahoton gano ƙwayoyin cuta daga samfurin huhu, wanda daga baya aka gano yana da alaƙa da SARS-CoV-2.
Wannan binciken yayi amfani da hanyar tattarawa da kuma zaɓar tsari na hannu don samar da wani ɓangare na ɓangaren ƙwayoyin halitta wanda ya ƙunshi kimanin 86.3% na cikakken kwayar cutar.
Ba za mu iya watsi da yiwuwar cewa giwayen suna ɗaya daga cikin dabbobin da ke karɓar bakuncin SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa SARS-CoV-2 ya samo asali ne daga lardunan saboda bambancin juzu'i tsakanin SARS-CoV-2 da beta-CoV da ke da alaƙa da SARS-COV-2 lardunan.
Bugu da kari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi guntu fiye da tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da SARS-COV-2 lard.
Har yanzu ba a gano hanyar juyin halitta na SARS-CoV-2 a cikin barbashi, tangerines da sauran dabbobi masu shayarwa ba.
Yayinda aka sami jerin homologs mafi girma a cikin RBD tsakanin SARS-COV-2 da shingles, beta-CoVs suna da alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG12 waɗanda ke da haɗin homologs mafi girma a cikin tsarin kwayoyin halitta.
Ana yin hasashe mai ƙarfi cewa babban kamanceceniya tsakanin RBDs na SARS-CoV-2 da SARS-CoV-2 beta-CoVs masu alaƙa da larura da SARS-CoV-2 ana motsa su ne ta hanyar juyin halitta mai ma'ana tsakanin zaɓuɓɓuka.
Wani shawarwarin amsawa ya goyi bayan sake haɗuwa tsakanin SARS-CoV-2 da ke da alaƙa da beta-CoVs da ke cikin gangar jikin da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin mai motsa juyin halitta, sakewa yana faruwa sosai a cikin beta-CoVs.
Har yanzu ana ci gaba da bincike kan asalin SARS-CoV-2 na zoonotic kai tsaye.
Baya ga HCoVs masu cutarwa, an kuma bincika asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoV na bat, yayin da aka gano ƙwayoyin HCoV-OC43 da HCov-HKU1 a cikin beraye.
An ba da rahoton cewa CoV na bat da aka kira ARCoV.2 (Appalachian Ridge CoV) wanda aka gano a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
A gefe guda, HCoV-229E yana da alaƙa da wata ƙwayar cuta ta CoV, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zargin cewa camellids ma wakilai ne.
Don ƙarin bayani, ilimin yanzu game da asalin dabbobi na sanannun HCoVs an tsara su a cikin Hoto 1 da Tebur 2.
Binciken ilimin halittu ya ba da hujja ga abubuwan da suka faru na HCoVs tsakanin jinsuna a tarihi.
Lokacin da HCoV-OC43 ya wuce jinsuna don ya kamu da mutane daga dabbobin gida a kusan 1890, an rubuta barkewar cutar ta numfashi.
Tarihin HCoV-229E tsakanin jinsuna ba shi da tabbas.
Amma an gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikin su akwai alpaca alpha-CoV.
Akwai wasu shaidu da ke nuna cewa kwayar cutar ta bazu daga harin da aka yi wa mutane kai tsaye.
Na farko, mutane amma ba alpacas ba zasu iya saduwa da bat a cikin wani yanki na muhalli.
A gefe guda kuma, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, alpha-CoV na bat da ke da alaƙa da HCoV-229E yana da yawa kuma ba shi da cutar a cikin bat, yayin da alpha-CoV na alpaca ke haifar da cututtukan numfashi a cikin dabbobi masu tsammanin.
A ƙarshe, ba a gano alpha-CoV na alpaca a cikin dabbobin daji ba.
Saboda haka, ba za a iya kawar da yiwuwar alpacas sun sami alpha-CoV mai alaƙa da HCoV-229E daga mutane ba.
A gaskiya, jemage ne tushen kai tsaye na ƙwayoyin cuta masu cutar ɗan adam ciki har da cutar hauka, Ebola, Nipah da Hendra.
Saboda haka ba abin mamaki bane cewa barbashi na iya watsa HCoV-229E ga mutane kai tsaye.
A madadin haka, kodayake alpha-CoVs na bat suna dauke da kwayoyin HCoV-229E, alpacas da raƙuman Larabawa na iya zama matsakaitan runduna waɗanda ke watsa kwayar cutar ga mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV ya zama mafi kyawun misali na yaduwar jinsuna daga bargo zuwa raƙumi na Larabawa da kuma daga raƙumi na Larabawa zuwa mutane.
An san asalin MERS-CoV daga barbashi a farkon lokacin da aka gano shi kuma an ƙarfafa shi tare da binciken da ya biyo baya.
A bayyane yake cewa jemage yana samar da wani nau'i na kwayar cutar don musayar sassan kwayoyin halitta tsakanin jinsuna da kuma yaduwar jinsuna.
Tsawon rai, ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen.
Bugu da ƙari, an gabatar da MERS-CoV ga raƙuman Larabawa shekaru da yawa.
Ya dace da waɗannan raƙuman da suka canza daga matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakai matsakai matsakaiciyar matsakai matsakai matsakai
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙananan ƙimar maye gurbi a cikin waɗannan dabbobi.
Yaduwar sa ga mutane ba ta da gangan kuma mutane sun kasance masu karɓar MERS-CoV saboda rashin iyawar sa.
Ba kamar yadda raƙumi ke aiki a cikin yaduwar MERS-CoV ba, aikin ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwarar ƙwarƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwarƙwarƙwarƙwarƙwararƙwararƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwararƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwar
Musamman, beta-CoVs na kirji suna da cutarwa sosai a cikin kirji.
Suna iya zama ƙarshen masu karɓar SARS-CoV-2 beta-CoVs, kamar yadda foxes suke a cikin yanayin SARS-CoV.
Wasu yiwuwar yaduwar SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane ya kamata a karɓa ko a ƙi a cikin binciken nan gaba.
Na farko, jemage na iya zama mai riƙe da kwayar cutar SARS-CoV-2 mai kama da SARS-CoV-2.
Mutane na iya raba wani wuri mai tsabta tare da bat ta hanyar kashewa ko hakar ma'adinai.
Na biyu, kwayar halitta na iya zama ɗaya daga cikin sabbin ƙwayoyin cuta masu haɓaka ƙwayoyin cuta da aka sani da cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar yanka da cin nama.
Wataƙila dabbobi masu shayarwa da yawa sun kamu da SARS-CoV-2.
Ana buƙatar binciken dabbobi na gida da na daji don ƙwayoyin cuta.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Binciken asalin dabbobi don SARS-CoV-2 yana ci gaba.
Baya ga nau'ikan dabbobi daban-daban, manyan abubuwa uku a cikin ɓangaren kwayar cutar suna da mahimmanci wajen sauƙaƙe CoVs don ƙetare shingen jinsuna.
Na farko, suna da yawan canjin halittar RNA.
Idan aka kwatanta da ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar juyin halittar CoV za a iya ɗauka a matsayin "mai sauƙi" zuwa "mai girma" tare da matsakaicin canjin canji na ~10-4 sauyawa a kowace shekara a kowane shafuka 2, dangane da lokacin daidaitawar CoV zuwa sabon mai masaukin baki.
CoVs suna da ƙwayoyin cuta masu ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Abin sha'awa, ana san analog ɗin nucleotide na Remdesivir don hana ninkawar CoV ta hanyar hana wannan exoribonuclease da RNA-dogara RNA polymerase.
Remdesivir yana ɗaya daga cikin mafi kyawun wakilai masu hana SARS-CoV-2 da aka gwada a cikin gwaji na asibiti.
Duk da haka, yawan canjin kwayar cutar CoV ya ninka na wanda ya dauke ta sau miliyan.
Bugu da ƙari, yawan canjin yana da yawa lokacin da CoVs ba su dace da mai watsa shiri ba.
Idan aka kwatanta da SARS-CoV tare da yawan canjin halittar, yawan canjin halittar SARS-CoV-2 ya zama ƙasa, yana ba da shawarar babban matakin daidaitawa ga ɗan adam.
Wataƙila ya riga ya saba da sauran rundunonin da ke kusa da 'yan Adam.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman Larabawa.
A ka'idar, ba zai yiwu ba cewa maye gurbin kwayoyin halitta zai sa alluran rigakafi da rigakafin SARS-CoV-2 su zama marasa tasiri a cikin ɗan gajeren lokaci.
Na biyu, mafi girman kwayoyin RNA a cikin CoVs suna amfani da ƙarin filastik a cikin canjin kwayoyin don maye gurbi da sake haɗuwa, yayin da haɓaka yiwuwar juyin halitta tsakanin jinsuna, wanda ke da amfani ga fitowar sabon CoVs lokacin da yanayi ya dace.
Wannan yana da goyon baya ta hanyar tsarin karatun budewa na musamman da kuma aikin gina jiki wanda aka tsara zuwa ƙarshen 3 'na kwayoyin halitta.
Na uku, CoVs suna canza samfuran su bazuwar kuma sau da yawa yayin kwafin RNA ta hanyar tsarin "kwafi-zaɓi" na musamman.
A cikin jijiyoyin da ke aiki a matsayin mahaɗin mahaɗin, musayar zaren yana faruwa sau da yawa yayin fassarar RNA CoV.
Ana iya sake haɗa RNA mai ƙarancin ƙwayoyin cuta da cikakke don samar da sabon CoV.
An gano hujja ta asali game da haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43, da kuma dabbobi CoVs kamar SL-CoV na bat da CoV-HKU9 na bat.
Hadin gwiwar kwayar cutar tana da alaƙa da yaduwar cuta.
Baya ga abubuwan ƙwayoyin cuta guda uku da aka ambata a sama, hulɗar ƙwayoyin cuta tare da masu karɓar baƙi shine babban abin da ke tasiri ga yaduwar jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na musamman, wanda kuma ya nuna hujja na zaɓi mai kyau yayin abubuwan da ke faruwa na watsawa tsakanin jinsuna.
Bisa ga nazarin kwatancen tsakanin ƙwayar ɗan adam da SARS-CoV na fox, ana tsammanin SARS-CoV yana fuskantar saurin daidaitawa a cikin baƙi daban-daban, musamman tare da maye gurbi a cikin RBD akan furotin S.
Gabaɗaya, RBD akan sunadarin S akan CoV yana hulɗa da ƙwayoyin halitta kuma ana zaɓar shi sosai ta hanyar amsawar ƙwayoyin cuta na mai masaukin baki.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan S1 faya-fayan, wanda ke ɗaure ga ACE2 na ɗan adam da kuma masu karɓar rabuwa don shigar da kwayar.
RBD daga SARS-CoV ya iya gano masu karɓar ACE2 daga dabbobi daban-daban, gami da barbashi, fox, beraye da karnukan raccoon, yana ba da damar yaduwar kwayar cutar tsakanin jinsuna.
A zahiri, ragowar amino acid guda 6 ne kawai aka lura da su daban-daban daga keɓaɓɓun ƙwayoyin cuta na ɗan adam da fox a cikin RBD kuma 4 daga cikinsu suna cikin ƙirar haɗin mai karɓar don hulɗa tare da mai karɓar ACE2.
SARS-CoV fox yana da maye gurbi K479N da S487T a cikin RBD, wanda zai iya haɓaka alaƙar hulɗar furotin mai haɗawa da mai karɓar ACE2 na ɗan adam.
A wasu kalmomin, musayar amino acid biyu na iya zama mahimmanci ga daidaitawar kwayar cutar ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da ƙwayoyin ƙwayoyin ƙwayoyin cuta iri ɗaya da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nuna cewa haɗin haɗin S-protein ɗin ga ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken cryo-EM ya nuna cewa wannan haɗin yana da ƙarfi sau 10 zuwa 20 fiye da na ACE2 na ɗan adam da kuma furotin SARS-CoV S.
Hakanan yana da ban sha'awa don sanin ko ana buƙatar wasu masu karɓar ra'ayi tare don yaduwar SARS-CoV-2.
Mafi ban sha'awa, HCoV-NL63 kuma yana ɗaure da ACE2 amma tare da sassan S daban.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da sialic acid 9-O acetyltherase don HCoV-OC43.
Hakanan yana iya zama alhakin nasarar daidaita wannan CoV a cikin mutane bayan yaduwar jinsuna daga mai masaukin sa.
Baya ga masu karɓar salula, sakamakon yaduwar HCoV tsakanin jinsuna ya dogara da dogaro da mai karɓar baƙi da sauran abubuwan hanawa.
Bambancin wannan furotin mai kwakwalwa tsakanin mutane da kuma masu kula da HCoV na halitta kamar su bat, raƙumi na Larabawa da rodents na iya haifar da shinge ga watsa tsakanin jinsuna.
HCoVs suna buƙatar ɗaukar nauyin tushen tushen tushen kuma su kawar da abubuwan da ke hana masu watsawa don samun nasarar watsawa tsakanin jinsuna.
A wannan yanayin, ƙayyadaddun kwayoyin halitta a cikin mahimman yankunan hulɗar ƙwayoyin cuta ba a gano su ba kuma ba a bayyana su ba.
Tacewar da ba ta da son zuciya game da kwayar halitta don dogaro da mai karɓar baƙi da kuma abubuwan ƙuntatawa ga SARS-CoV-2 ta amfani da fasahar CRISPR mai tasowa na iya haifar da sakamako.
Fitowar sabon HCoV: komawa zuwa farkon
Bambancin CoVs na bat yana ba da babbar dama ga fitowar sabon HCoV.
A wannan yanayin, CoVs na bat suna aiki a matsayin gene pool na HCoVs.
Bugu da ƙari, saurin maye gurbi da sake haɗuwa da kwayoyin halitta suna motsa juyin halittar HCoVs kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, samun ko rasa kwayar halittar kwayar halitta mai kwayar halitta yana da damar canza yanayin kwayar cutar sosai.
Daga cikin furotin na SARS-CoV, ORF8 an ɗauka yana da mahimmanci wajen daidaitawa da ɗan adam, saboda an ware ƙwayoyin cuta masu alaƙa da SARS-CoV amma an same su suna ɓoye furotin mai ƙyama na ORF8.
An gano wata alama ta kawar da nucleotide-29 na SARS-CoV a cikin nau'in da aka ware a farkon cutar ɗan adam.
Wannan kashewa ya raba ORF8 zuwa ORF8a da ORF8b kuma an dauke shi maye gurbin daidaitawa wanda ke ba da damar musayar wakili.
Bugu da ƙari, SARS-CoV yana da yiwuwar tarihin sake haɗuwa tare da zuriyar CoVs na alpha da gamma, wanda yawancin ƙananan yankuna na sake haɗuwa an gano su a cikin RNA-dogara RNA polymerase.
An kuma gano wurin sake haɗuwa a cikin nsp9, mafi yawan nsp10 da kuma wani ɓangare na nsp14.
Hakazalika, an nuna barkewar cutar MERS-CoV ta sake haɗuwa tsakanin jinsi daban-daban, wanda ya faru a cikin raƙuman Larabawa a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da sake haɗuwa a cikin wasu HCoVs, wanda ke ganin HCoVs sun sake haɗuwa da sauran CoVs na dabbobi a cikin kwayoyin halitta.
Hakanan ya kamata a yi gargadi cewa zaɓin ƙarya na iya ba da gudummawa ga canje-canje na bazuwar cikin kwayar cutar, wanda zai iya haifar da sakewar kwayar cutar daga matsin lambar da aka sanya, kamar ta tsarin rigakafin mai masaukin baki.
Misali na wannan tasirin shine asarar cikakken tsawon ORF4 a cikin zaren samfurin HCoV-229E, sakamakon kashewar nucleotide biyu.
Yayin da ake ganin ƙarfin ORF4 a cikin ƙwayoyin cuta da raƙuman da ke da alaƙa da HCoV-229E, alpha-CoVs na alpaca suna nuna shigar da nucleotide guda ɗaya, wanda ke haifar da jujjuyawar tsarin.
A ƙarshe, juyin halitta na sabon HCoVs kuma yana motsawa ta hanyar zaɓin zaɓin a cikin rukunin ajiyar su.
An gano alamun rashin alamun cutar ko kuma alamu masu laushi lokacin da bat ya kamu da CoV, yana nuna daidaituwa tsakanin CoV da bat.
Ya bayyana cewa jemage ya dace da cutar Corona sosai a fannin ilimin halitta da kuma ilimin halayyar mutum.
Misali, lalacewar kunnawar amsawar kumburi a cikin barbashi yana rage cututtukan da CoV ke haifar da su.
Bugu da ƙari, aikin ƙwayoyin halitta na halitta a cikin kullun yana ƙuntatawa saboda karuwar ƙwayoyin halitta na ƙwayoyin halitta na NKG2/CD94 da ƙananan maganganu na ƙwayoyin halitta na 1 na manyan kwayoyin halitta.
Bugu da ƙari, babban matakin kwayoyin oxygen masu aiki (ROS) da aka samar daga babban aikin metabolism na bat zai iya hana CoVs ninkawa da kuma shafar karatun ƙwayoyin cuta ta hanyar exoribonuclease, yayin da yake ba da matsin lamba don kula da ƙwayar cutar ta cutar ta cutar lokacin da aka gabatar da ita ga sabon mai masauki.
Ƙarin ƙwayar CoV mai cutarwa na iya haɓaka ta hanyar sake haɗuwa, yana haifar da samun sabon furotin ko halayen furotin don daidaitawar mai watsa shiri.
Saboda haka, ba daidaituwa ba ne cewa sabbin HCoVs uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko haifar da ƙananan cututtuka a cikin ramin ramin su kamar barbashi da raƙumi.
Yana ninkawa cikin sauri ba tare da haifar da amsawar rigakafi mai ƙarfi ba.
Wannan shine asirin dalilin da yasa ake ganin masu dauke da cutar ba tare da alamomi ba kuma shine dalilin da yasa ake samun mummunan kamuwa da cutar a cikin mutane.
Mafi yawan bayyanar cututtuka suna haifar da kunnawar hawan jini da kuma hadarin cytokine inda mafi ƙarfin amsawar rigakafi, mafi muni lalacewar huhu.
A gefe guda, a cikin masu ɗaukar hoto, amsar rigakafi ta kasance ta raguwa daga ninka CoV.
Irin wannan dabarun da ke hana amsawar rigakafi na iya samun sakamako mai amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin bat.
Saboda haka, bayar da nau'in interferon 1 aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam ya kamata ya zama mai fa'ida.
Bugu da ƙari, kunnawar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Saboda wannan dalili, hana NLRP3 ƙwayoyin cuta tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Fitowar SARS-CoV-2 ya biyo bayan taken bayyanar SARS-CoV da MERS-CoV.
Kodayake an gano beta-CoVs na bat wanda ke raba kashi 95% na nucleotide homology tare da SARS-CoV, akwai kuma CoVs na bat waɗanda ke raba kashi 96% na nucleotide homology tare da SARS-CoV-2.
Kodayake an gano cewa foxes da sauran dabbobi a kasuwa suna da kwayar cutar da ta yi kama da SARS-CoV, ba a gano ainihin mai watsa shiri na SARS-CoV-2 ba.
An gano beta-CoVs na ganglion waɗanda ke da alaƙa da SARS-CoV-2, wanda ke nuna cewa ganglion na iya zama ɗayan matsakaitan runduna ko kuma beta-CoVs na ganglion na iya ba da gudummawar gashin gashin gashi zuwa ƙarshen sigar SARS-CoV-2.
Duk da tambayoyin, babu wata hujja da ke nuna cewa SARS-CoV-2 an samar da shi ne ta hanyar gangan ko kuma ba da gangan ba.
An sake mayar da hankali kan CoVs sakamakon barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin barbashi da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin dabbobi da kuma ma'adinan dabbobi don HCoVs a cikin yaduwar ɗan adam.
Shaida mai zurfi ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga barbashi kuma an watsa su ga mutane ta hanyar matsakaiciyar runduna.
Ganin cewa kamuwa da SARS-CoV ya samo asali ne daga hulɗar ɗan adam da fox a kasuwa, rufe kasuwar rigar da kashe fox ya kamata ya kawo ƙarshen cutar SARS yadda ya kamata.
Saboda wannan dalili, ya kamata a cire tururuwa daga kasuwar rigar don hana yaduwar cututtukan dabbobi, saboda gano yawancin zuriyar beta-CoV na tururuwa da ke da alaƙa da SARS-CoV-2.
Koyaya, yanayin yanayi da yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar giwayen giwayen da sauran dabbobi masu shayarwa ya kamata a bayyana a cikin binciken nan gaba.
A gefe guda, MERS-CoV ya wanzu a cikin raƙuman Larabawa na dogon lokaci.
Waɗannan raƙuman sun kasance muhimmin kayan aiki don sufuri da kuma babban tushen nama, madara, fata da kayayyakin ulu ga al'ummomin yankin.
Ana samun raƙuman a duk Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a kashe dukkan raƙuman ba don sarrafa MERS, kamar yadda ake yi a kasuwar namun daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake yaduwar cutar MERS, ya kamata a ɗauki cikakkiyar hanyar haɓaka allurar rigakafi mai tasiri don yaƙar MERS-CoV ga raƙuma, haɗe da sauran matakan kula da kamuwa da cuta.
Tun da ba za mu iya kawar da wannan cutar ba, sabon nau'in zai iya haifar da annoba.
An samu CAV masu cutar dabbobi a cikin daji.
Musamman, ƙwayoyin cuta na bat da ke da yiwuwar cutar dabbobi sun bambanta sosai.
Akwai damar da yawa ga waɗannan CoVs na zoonotic don haɓaka da sake haɗuwa, yana haifar da fitowar sabon CoV wanda zai iya zama mai saurin yaduwa da / ko kisa a cikin mutane a nan gaba.
Dole ne a dakatar da al'adun cin namun daji a wasu wurare a kasar Sin don rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
Tare da mummunan kwarewar SARS, MERS da COVID-19, ya kamata a tsara shirye-shirye da shirye-shiryen amsawa mafi kyau.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniyar nan tun da daɗewa.
Kwayar cutar tana cikin tafkin halitta har sai an sami damar yaduwa.
Kodayake barbashi suna da halaye da yawa waɗanda ke sauƙaƙa yaduwar kwayar cutar, damar ɗan adam na samun hulɗa da barbashi da sauran nau'ikan namun daji za a iya rage su idan an ilimantar da jama'a su nisanta kansu da waɗannan dabbobin.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoV da yanayin yanayin su, wanda zai tabbatar da amfani wajen hana watsa dabbobi ga mutane da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar kwayar cutar ta mutum ita ce ta hanyar nisantar da mutane daga yanayin muhalli na halitta don ƙwayoyin cuta na zoonotic.
Wasu tambayoyi game da asalin SARS-CoV-2 ba a amsa su ba.
Na farko, idan har barkonon doki ya yada kwayar cutar SARS-CoV-2 ga giwayen, zai zama mai ban sha'awa ganin yadda barkonon doki da giwayen zasu iya raba abubuwan da suka shafi muhalli.
Na biyu, idan har jemage na taka muhimmiyar rawa wajen yada cutar ga mutane, to dole ne mu yi bincike kan yadda mutane ke hulɗa da jemage.
Na uku, idan dabbobi masu shayarwa na uku suna aiki a matsayin masu watsa shirye-shirye na gaskiya, yadda suke hulɗa da nau'o'in jinsuna daban-daban ciki har da mutane, bats da tangerines ya kamata a bayyana.
A ƙarshe, tunda yawancin dabbobi masu shayarwa ciki har da dabbobi na waje na iya fuskantar SARS-CoV-2, ana buƙatar gudanar da sa ido da kuma kamuwa da cuta ta gwaji.
Ko dai daga cikin barbashi, tururuwa ko wasu dabbobi masu shayarwa, ana tsammanin cewa SARS-CoV-2 ko kuma irin wannan kwayar cutar ta asali za a gano a cikin masu saurin halitta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai game da rigakafi da kula da COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin bincike na "lambar da ake zargi" da "lambar da aka tabbatar" don COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin shawarwari masu sauri don ganewa da kuma kula da cutar coronavirus ta 2019 (2019-nCoV), kuma waɗannan jagororin suna ba da kwarewarmu don zama kyakkyawan tunani don yaƙar cutar a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma hankalinmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma ƙwarewar aikin asibiti; saboda haka, ana sabunta dabarun bincike da magani koyaushe.
A cikin wannan wasikar, mun amsa ga wani sharhi game da jagororinmu kuma mun samar da sababbin ka'idojin bincike don "al'amuran da ake zargi" da "al'amuran da aka tabbatar" bisa ga sabuwar Jagorar Ganowa da Kula da COVID-19 (siffa ta bakwai) da Hukumar Kiwon Lafiyar Jama'ar Sin ta bayar.
A watan Disamba na 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu aka sanya wa suna coronavirus cuta ta 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan coronavirus mai saurin kamuwa da cutar numfashi mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-10 a matsayin annoba.
Don yaƙar kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari na gaggawa kuma an buga su a cikin binciken lafiyar soja a ranar 6 ga Fabrairu, 2020.
An yi amfani da wannan littafin wajen koyar da mutane game da Allah.
Koyaya, don Allah a lura cewa COVID-19 sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma ƙwarewar aikin asibiti; saboda haka, hanyoyin bincike da hanyoyin magani don sabuntawa koyaushe.
Misali, Jagorar Ganowa da Kula da COVID-19 da Hukumar Lafiya ta Jamhuriyar Jama'ar Sin ta bayar (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ta fitar da fitowar fitowa bakwai tare da wasu abubuwan da suka shafi canji.
Yanzu da aka sake nazarin jagororinmu ta Zhou et al., sun gabatar da shawarwari masu sauƙi na ƙididdiga bisa ga kwarewarsu ta asibiti.
Ƙoƙarin da suka yi ya ƙara sabon shaida ga jagororinmu kuma ya zama abin tunani mai mahimmanci ga wannan annoba a duk duniya.
Mun san muhimmancin ƙoƙarce-ƙoƙarcen da suke yi kuma mun gode musu.
Koyaya, ƙoƙarin su kuma yana buƙatar sabuntawa bisa ga sabon Jagoran Ganowa da Kulawa don COVID-19 (Fitarwa ta bakwai na gwaji) da sabbin karatu.
A cewar fitowar ta bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwa daga tarihin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Tarihin cututtukan cututtuka: (1) Tarihin tafiya ko zama a cikin garin Wuhan da kewaye, ko wasu al'ummomin da aka ruwaito cutar COVID-19 a cikin kwanaki 14 kafin fara alamun bayyanar cututtuka; (2) tarihin tuntuɓar kamuwa da cutar ta SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko cututtukan numfashi daga garin Wuhan da kewaye, ko wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 kafin fara alamun bayyanar cututtuka; (4) tarihin da ya shafi rukunin tabbatar da shari'ar ((> 2 lokuta tare da zazzabi da/ko cututtukan numfashi sun faru a cikin makonni 2 a cikin ƙaramin yanki, kamar gida, ofis, aji a makaranta, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da alamun hoto na kamuwa da COVID-19; (3) yawan adadin ƙwayoyin farin jini yana nuna al'ada, raguwa, ko rage ƙididdigar ƙwayoyin lymphocytes a farkon farawa.
Binciken da aka tabbatar na shari'ar ya kamata ya dogara ne akan yanayin da ake zargi da ɗayan abubuwa masu cutarwa ko hujjojin serological kamar haka: (1) gwajin PCR na ainihi wanda ya kasance mai kyau ga SARS-CoV-2; (2) jerin kwayoyin halittar kwayar cutar gaba ɗaya yana nuna babban daidaito ga sanannen sabon coronavirus; (3) tabbatacce ga IgM antibodies da IgG antibodies na SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko musayar SaRS-CoV-2 na IgG antibodies daga mara kyau zuwa tabbatacce, ko karuwar titer > 4 sau a lokacin farfadowa akan lokacin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin hanyoyin numfashi ko samfurin jini zuwa bugu na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An haɗa ganowar cututtukan cututtuka daga samfurin jini a cikin bugu na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); sannan an haɗa hujjojin serology a cikin bugu na bakwai.
Wannan gyare-gyaren ya dogara ne akan ci gaba da aikin masu bincike da ke neman mafi kyawun kayan aikin gano nucleic acid don ganowa nan da nan, da kuma samfurori daga hanyoyin numfashi ciki har da samfurin jini, wanda ke haɓaka wadatar samfuran daban-daban, da kuma tallafawa kawo sakamako mai kyau na takamaiman ƙwayoyin cuta a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaidu da ke tunatar da mu mu yi taka tsantsan da marasa lafiya masu alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun alamun
Don haka, ana buƙatar sabunta jadawalin kwararar daga Zhou et al., saboda sun rarraba masu cutar ba tare da alamun asibiti ba a matsayin "mai haɗari".
Hakanan tsarin ƙididdiga zai buƙaci a tabbatar dashi a aikace da kuma binciken asibiti na gaba.
A ƙarshe, muna fatan ƙarin shaidu na kai tsaye za su zo kuma muna kira ga masu karatu su ba da ra'ayi.
Don tantancewa ga "lamuran da ake zargi" da "lamuran da aka tabbatar", muna ba da shawarar ganowa da bin sabbin jagororin ƙasarsu.
Hakanan ƙungiyarmu za ta sabunta ƙa'idodinmu lokaci-lokaci don ba da taimako.
Bangladesh ta samu sabbin mutuwar COVID-19 biyar, adadin da ya fi yawa a rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 biyar a ranar.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Nazarin Bangladesh (IEDCR) ta ba da rahoton yawan kamuwa da cutar da aka rubuta ciki har da masu aiki 114 da kuma 33 da suka warke a gida.
An samu mutuwar mutane 17.
A wani sanarwar ta yanar gizo, darektan IEDCR, Dr Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutane biyu sun haura shekaru 60, biyu kuma sun haura shekaru 51 da 60, da kuma 41 da 50.
Ya kuma ce duka biyu daga cikin wadanda aka kashe daga birnin Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID 19 a matsayin annoba a ranar 11 ga Maris.
Jami'an asibitin sun fadawa wata majiyar labarai ta gida, Kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka kamu da cutar shine Jalal Saifur Rahman, darektan Hukumar Hana Cin Hanci da Rashawa ta Bengal, wanda ake kula da shi a Asibitin Maitree na Kuwait.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri da Mota na Bangladesh, Obaidul Quader ya ce za a rufe zirga-zirgar jama'a na tsawon lokacin da aka tsara, har zuwa Asabar mai zuwa.
An fara rufe wannan hanyar sufuri a ranar 26 ga Maris kuma an shirya za a ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci - magunguna, mai da abinci.
An fara samun cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu.
A ranar 19 ga watan Maris, dukkansu uku sun warke.
SARS-CoV-2 ya wuce kamuwa da kamuwa da cuta miliyan a duk duniya.
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus SARS-CoV-2 ya zarce miliyan ɗaya a duk duniya, a cewar bayanai daga Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19, wadda cutar korona ta haifar.
Wannan ci gaban ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko kuma Zambiya ta sami mutuwar farko da ta shafi cutar korona.
Koriya ta Arewa ta yi ikirarin cewa, har zuwa ranar Alhamis, tana cikin ƙasashe kalilan da ba su da cutar coronavirus.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton cewa an tabbatar da shari'o'i 1,051,635, gami da 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe agogon Turai na tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, wanda ya yi sanadiyar mutuwar mutane 5,900.
CBS News ta ruwaito, ta nakalto bayanan Jami'ar Johns Hopkins, sama da mutuwar 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana cutar yaduwa.
A ranar Alhamis, Sergey Sobyanin, magajin garin Moscow, ya tsawaita dokar rufe garin har zuwa ranar 1 ga Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya sanar da cewa ana iya ci gaba da biyan albashi ga 'yan kasar ba tare da sun je aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar Portugal ta kada kuri'ar tsawaita dokar ta baci zuwa kwanaki 15; an amince da kuri'ar da kuri'u 215 suka goyi bayan, goma sun ki, daya kuma ya ki amincewa.
Saudiyya ta tsawaita dokar hana fita a cikin biranen alfarma Makka da Madina zuwa yini; a baya, dokar hana fita tana aiki ne kawai tsakanin 3 na yamma da 6 na safe.
Thailand na shirin aiwatar da dokar hana fita tsakanin karfe 10 na dare da 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shaguna a Australia sun rage yawan adadin tawul din da za a iya amfani da su a lokacin sayayya.
A ranar Lahadi da Asabar da yamma, dillalan Australiya Woolworths da Coles sun rage takunkumin siyan kayan wanka zuwa biyu da kuma kunshin daya-da-daya a duk shagunan da ke kasar.
ALDI kuma ta gabatar da iyakar kunshin daya, a ranar Litinin.
Wannan iyaka an buga shi a matsayin sako a kan jerin sunayen fita, da kuma shafin Facebook na sarkar.
An bayar da rahoton cewa masu sayayya sun sayi hannun jari ne saboda tsoron COVID-19 idan mutum ya keɓe kansa.
A ranar Laraba, Woolworths kuma ya iyakance sayen tawul din wanka don sayen jigilar kaya zuwa gida zuwa kunshin daya a kowane tsari.
Wannan canjin ya biyo bayan takunkumin kunshin hudu a kowane ma'amala da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris.
Coles, a cikin wata sanarwa da aka fitar a ranar 8 ga Maris, ya ba da rahoton cewa tare da aiwatar da takunkumin kunshin guda huɗu, "shaguna da yawa har yanzu suna ƙarancin kaya a cikin awa ɗaya bayan isarwa", kuma ya kira buƙatun "ba a taɓa gani ba", yayin da ALDI, a cikin saƙon Facebook a ranar Talata, ta kira shi "ba zato ba tsammani".
Sayarwa ta tashi cikin "hawan gaggawa" a makon da ya gabata, a cewar wani kakakin Woolworths.
Costco's a Canberra ma sun iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don ci gaba da rage ƙarancin, Coles ya ba da umarnin manyan fakiti daga masu samarwa kuma ya ƙara yawan jigilar kaya, Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ke ba da kaya don shirin na musamman na ranar Laraba wanda za'a iya samu da wuri.
Russell Zimmerman, darektan zartarwa na kungiyar 'yan kasuwa ta Australiya, ya ce' yan kasuwa suna kokarin kara kaya amma takunkumin majalisa na gida kan lokacin jigilar kaya ta hanyar motoci ya sa hakan ya zama da wahala.
Ya yi tsammanin farashin samfur zai karu, yayin da masu samar da kayayyaki ke ƙoƙarin biyan bukatun, kuma kadan ne na musamman.
A ranar Talata, ALDI ta sanar da cewa sakamakon farkon fitar da kaya, wasu shaguna ba za su iya gudanar da abubuwan musamman na ranar Laraba ba.
A wani rahoto da News.com.au ta wallafa, Dr Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce kantuna suna cika kaya a kowane dare.
Ya gaya wa wankin wanka babban abu ne, yana haifar da ƙananan adadin a cikin adadi, kuma, lokacin da aka sayar da shi, ya bar sararin samaniya, yana ƙarfafa rashin jin dadi.
Coles da Woolworths suna da ra'ayi [cewa] idan akwai abubuwa da yawa a kan ɗakunan ajiya, idan samfurori kamar tawul ɗin bayan gida da kayan wanka suna samuwa kuma suna da yawa, za ku iya rage tsoro, "in ji Russell Zimmerman a ABC News.
Wani kamfanin kera kayan wanka ya sake amfani da kayan aikin da ya kera su a ranar Laraba.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissue, da Solaris Paper wanda ke yin Sorbent, sun tabbatar da cewa suna aiki 24/7 don ci gaba da wadatar, a cewar rahoton New.com.au.
Domain.com, shafin yanar gizon ƙasa, ya ba da rahoton cewa wasu masu siyar da ƙasa suna ba da tawul ɗin gidan wanka kyauta ga masu ba da kyauta na farko a lokacin taron gwanjon a Melbourne, lokacin da aka gudanar da karamin gwanjo saboda masu siye suna fuskantar hutu a lokacin hutun ranar aiki.
A ranar Alhamis na NT News, jaridar yau da kullum a Darwin, ta haɗa da ƙarin shafuka takwas na takarda da aka yi niyya don yankewa da amfani da su a matsayin tawul.
Shagunan sun kasance masu ƙin saka takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris wanda ya ga sun ce ba su da shirin gabatar da iyakancewar sayayya.
Russell Zimmerman ya kara da cewa sauran kayayyakin ma suna da tsananin buƙata, gami da masks, kayan shafawa, abinci mai bushewa, kayan wanke hannu da benaye.
Hakazalika a wajen Ostiraliya, a ranar Lahadi da yammacin ranar da aka ga babban kanti na kan layi na Ocado ya iyakance sayan kayan wanka na Andres zuwa fakiti biyu na 12 na Rolls.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar cutar COVID-19  cuta da ke haifar da coronavirus SARS-CoV-2  a matsayin annoba.
Duk da cewa kalmar "annoba" tana nufin kawai yadda cutar ta yadu, ba yadda hatsarin wani lamari yake ba, WHO ta fahimci bukatar da ake da ita na tilasta wa gwamnatoci su dauki mataki:
Dukkan kasashen duniya na iya canza yanayin annobar.
Idan kasashe suka gano, gwada, kula, killace, sa ido da kuma motsa al'ummarsu su dauki mataki, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa game da duka matakan kamuwa da cutar da kuma mummunan aiki da kuma rashin aiki.
A cewar Dokta Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar "ba ta taɓa faruwa ba".
Ya ce, a cikin wani bayani da CNN ta wallafa a watan Fabrairu, "ban da mura, ba a gano wasu ƙwayoyin cuta na numfashi ba daga fitowarsu zuwa ci gaba da yaduwa a duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba".
Ya ci gaba, "kuma ba mu taɓa ganin annoba da za a iya sarrafa ta a lokaci guda ba".
Sabon matsayin cutar ya biyo bayan shawarar da WHO ta yanke a watan Janairu don ayyana cutar a matsayin gaggawa ta lafiyar jama'a a duniya.
Daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka, Dr. Anthony Fauci, ya ce game da annobar, "a takaice, yanayin zai kara muni".
A ranar Alhamis, Associated Press ta ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4,600.
Cutar kwayar cutar coronavirus ta 201920 cuta ce ta cutar kwayar cutar coronavirus ta 2019 (COVID-19), wacce ke faruwa, sakamakon mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An gano cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta kiwon lafiya a matakin duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar cutar a China da kashi 4%, yayin da a duniya ta ke tsakanin 13.04% a Algeria zuwa .08% a New Zealand.
Alamomin da suka fi yawa sun hada da zazzabi, tari da kuma numfashi.
Matsaloli na iya haɗawa da ciwon huhu da kuma ciwon huhu mai tsanani.
Lokaci daga bayyanar cututtuka zuwa bayyanar cututtuka yawanci yana da kwanaki biyar, amma zai iya kasancewa tsakanin kwana biyu zuwa goma sha huɗu.
Babu wani rigakafi ko maganin rigakafi na musamman da aka sani.
Babban magani shine maganin alamun cututtuka da tallafi. Matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin tari, nisantar wasu, da saka idanu da keɓe kai ga waɗanda ake zargin sun kamu da cutar.
Hukumomi a duk faɗin duniya sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe wuraren aiki.
Cutar ta haifar da rikicewar zamantakewar tattalin arziki a duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma karancin kayayyaki da ake samu ta hanyar sayayya.
An rufe makarantu da jami'o'i ko dai a duk faɗin ƙasa ko a matakin gida a cikin ƙasashe 193, yana shafar kusan kashi 99.4 na yawan ɗaliban duniya.
Labaran karya game da kwayar cutar sun bazu a yanar gizo, kuma akwai abubuwan nuna kyamar baki da nuna bambanci ga Sinawa, wasu mutanen da ke da asalin Gabas da Kudu maso gabashin Asiya da kuma bayyanarsu, da kuma waɗanda suka fito daga yankunan da ke da manyan cututtukan cutar.
Sakamakon rage tafiye-tafiye da rufe masana'antun masana'antu, akwai raguwa a cikin gurɓatar iska da kuma sakin carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan cututtukan huhu daga asalin da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an ƙaddamar da bincike a farkon Janairu, 2020.
Yawancin shari'o'in suna da alaƙa da Kasuwar Abinci ta Kifi ta Huanan kuma suna haifar da cutar da ake tsammanin ta zoonotic.
Kwayar cutar da ta haifar da annobar ta zama sananniya a matsayin SARS-CoV-2, sabuwar kwayar cutar da aka gano wacce ke da alaƙa da kwayar cutar coronavirus, coronavirus na harsashi, da SARS-CoV. Mutumin da aka fara sanin yana da alamun cutar daga baya an gano cewa ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da wata alaƙa da za a iya gani tare da rukunin kasuwar da ta biyo baya.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya ba da shawarar cewa wani lamari da aka gano tun daga ranar 17 ga Nuwamba, 2019, a cikin wani mai shekaru 55 daga lardin Hubei, na iya zama na farko.A ranar 26 ga Fabrairun, 2020, WHO ta ba da rahoton cewa, yayin da sabbin shari'o'in da aka ruwaito a China amma suka karu ba zato ba tsammani a Italiya, Iran da Koriya ta Kudu, yawan sabbin shari'o'in da ke wajen China ya zarce adadin sabbin shari'o'in da ke China a karon farko.
Akwai yiwuwar akwai adadin marasa rahoto masu dacewa, musamman a cikin waɗanda ke da ƙananan alamun.
Har zuwa 26 ga Fabrairu, ƙananan ƙananan lokuta ne kawai aka ruwaito a cikin matasa, tare da waɗanda shekarunsu 19 da ƙasa da suka kai kashi 2.4% na shari'o'in a duk duniya.Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a sami ingantacciyar garken garken garken.
Lamarin yana nufin yawan mutanen da aka gwada don COVID-19, kuma waɗanda aka tabbatar da gwajin su na tabbatacce bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma ƙasashe da yawa da ke da ƙa'idodin doka na ba da gwaji ga waɗanda ke da alamun cutar kawai, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a China, har zuwa 23 ga watan Janairu, kimanin kashi 86% na kamuwa da COVID-19 ba a gano su ba, kuma wannan kamuwa da cutar da ba a rubuta ba ita ce tushen kashi 79% na adadin masu kamuwa da cutar.
Binciken kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa yawan kamuwa da cutar a Italiya ya fi adadin wadanda aka ruwaito.
Hasashen farko na ƙimar haɓaka (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya nuna cewa wannan adadi zai iya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 sun warke.
Ga waɗanda ba su da shi, lokacin bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, har zuwa ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka haura shekaru 60, kuma kashi 75% suna da matsalolin kiwon lafiya na yau da kullun ciki har da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba za a iya haɗa waɗanda suka mutu ba tare da an gwada su ba - watau a gida, a cibiyoyin kulawa, da sauransu.
Bayanai na ɓangare daga Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar COVID na hukuma da kashi 4-5x.
Wata mai magana da yawun cibiyar kula da cututtuka da rigakafi ta Amurka (CDC) ta bayyana cewa "Mun san cewa [yawan mutuwar da aka bayyana] an rage su ne", wata sanarwa da ke da goyan bayan rahotannin da ke nuna rashin ƙididdigar a Amurka. Irin wannan rashin ƙididdigar yana faruwa sau da yawa a cikin annoba, kamar lokacin annobar cutar sankarar alade H1N1 H1N1.
Mutuwar farko a wajen babban yankin China ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
Har zuwa ranar 28 ga watan Fabrairu, a wajen babban yankin China, sama da mutum dozin ne suka mutu a kowace kasa da aka rubuta a Iran, Koriya ta Kudu, da Italiya.
Har zuwa ranar 13 ga Maris, sama da ƙasashe arba'in da yankuna sun ba da rahoton mutuwar, a kowace nahiya sai Antarctica.
Wannan adadi ya bambanta ta yanki da lokaci, kuma ana shafar shi ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓin magani, lokaci tun farkon barkewar cutar, da kuma halaye na al'umma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar da ke tattare da cutar a duniya ya kai 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu 2020.
Adadin ya bambanta daga yanki zuwa yanki.
A China, ƙididdigar yawan mutuwar da aka samu ta ragu daga kashi 17.3% (ga waɗanda ke da alamun bayyanar cututtuka daga 110 ga Janairu 2020) zuwa 0.7% (ga waɗanda ke da alamun bayyanar cututtuka daga bayan 1 ga Fabrairu 2020).Sauran ma'aunin sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan waɗanda aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan waɗanda suka kamu da cutar (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna bin takamaiman al'umma daga kamuwa da cuta ta hanyar warwarewar shari'ar.
Wasu masana kimiyya sun yi ƙoƙari su ƙididdige wannan adadi don wasu mutane.
Cibiyar Nazarin Magungunan Bayanai ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar ga annobar gaba ɗaya ya kasance tsakanin 0.1% da 0.39%.
Babban kimantawa don wannan zangon ya kasance daidai da sakamakon gwajin farko na bazuwar COVID-19 a Jamus, da kuma nazarin ƙididdigar nazarin tasirin gwajin akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta tabbatar da cewa cutar ta zama mai sarrafawa.
Lokacin da cutar ta fi girma da kuma lokacin da ta fi girma ba shi da tabbas kuma zai iya bambanta daga wuri zuwa wuri.
Maciej Boni na Jami'ar Jihar Penn ya ce, "Idan ba a bincika su ba, cutar za ta iya zama a kwance sannan ta fara raguwa idan cutar ta ƙare gidajen da ake da su.
Amma kusan ba zai yiwu a yi wani zato mai ma'ana yanzu game da lokacin da hakan zai faru ba".
Babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa "ana iya kawo karshen annobar a watan Yuni" idan aka tura dukkan kasashen su bi shawarar WHO kan matakan da za su dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Tropical na London ya bayyana cewa SARS-CoV-2 "zai ci gaba da yawo, mai yiwuwa na shekara ɗaya ko biyu".
A cewar wani binciken da Neil Ferguson na kwalejin Imperial ya jagoranta, za a buƙaci nisantar jiki da sauran matakan "har sai an samu allurar rigakafi (wataƙila watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan coronavirus ba saboda yana da saukin kamuwa da cuta kuma zai iya ɓacewa gaba ɗaya" kuma "yana iya zama cuta ta yanayi, yana sake dawowa kowace shekara".
Amma cutar za ta dogara ne akan yawan garken da ke fama da cutar.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma mutanen da ke kamuwa da cutar na iya zama marasa alamun cutar.
Alamun biyu da suka fi yawa sune zazzabi (88%) da bushewar tari (68%).
Alamun da ba su da yawa sun haɗa da gajiya, samar da ƙanshin numfashi (ƙura), asarar ƙanshi, numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, haemoptysis, diarrhea ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida ya zama mai ciwo sosai kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta lissafa alamun gaggawa kamar wahalar numfashi, ci gaba da ciwo ko matsin lamba a kirji, rikicewa kwatsam, wahalar farkawa, da idanu ko lebe suna zama bluish; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun sun kasance.
Wasu mutane da suka kamu da cutar na iya zama marasa alamun cutar, ba tare da alamun asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda ke da kusanci da mutanen da aka tabbatar da kamuwa da cutar su sa ido sosai kuma a bincika su don tabbatar da rashin kamuwa da cutar.
Kasar Sin ta kiyasta yawan marasa alamun cutar da ke tsakanin kashi 44 zuwa 100.
Lokacin da aka saba da shi (lokacin da ke tsakanin kamuwa da cuta da fara alamun bayyanar cututtuka) ya kasance daga ɗaya zuwa 14 days; mafi yawan lokuta kwanaki biyar.A matsayin misali na rashin tabbas, ƙididdigar kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su da farko 30% sannan ya ragu zuwa 15%.
Wasu bayanai kan yadda cutar ke yaduwa har yanzu ana ci gaba da tantancewa.
Ana ganin cutar tana yaduwa ne a lokacin kusanci da kuma ta hanyar ƙananan ɗigon da ke faruwa yayin tari, hancinsa, ko magana; tare da kusanci yana tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya gano cewa tari mara kariya zai haifar da digo na ai yana motsawa zuwa mita 4.5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu mutane sun ba da shawarar cewa ana iya ɗaukar kwayar cutar ta hanyar ƙananan ɗigon ruwa waɗanda ke kasancewa na dogon lokaci a cikin iska, waɗanda za a iya samarwa yayin magana.
Ruwa yana iya sauka a bakin ko hancin wanda yake kusa da shi ko kuma ya shiga cikin huhu.
Wasu hanyoyin kiwon lafiya kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓoyewar numfashi kuma don haka haifar da yaduwar iska.
Hakanan za'a iya yada kwayar cutar idan mutum ya taɓa gurbataccen abu, gami da fata, sannan kuma ya taɓa idanunsa, hancinsa ko bakinsa.
Duk da cewa akwai damuwa cewa kwayar cutar na iya yaduwa ta hanyar bargo, ana ganin cewa wannan haɗarin yana da ƙarancin gaske.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2 ta hanyar baki da baki. Kwayar cutar tana da saukin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma kamuwa da cuta na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka yana nuna cewa kamuwa da cuta na iya faruwa kafin bayyanar cututtuka.
Rahotanni kaɗan na asymptomatic lab-da aka tabbatar sun wanzu, amma an gano wasu ƙasashe masu asymptomatic yayin binciken gano lamba.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta bayyana cewa duk da cewa ba a san yadda cutar ke yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa na awanni zuwa kwanaki a kan farfajiya.
Musamman, an gano kwayar cutar ta gano har zuwa kwanaki uku a kan filastik (polypropylene) da bakin karfe 304, na kwana daya a kan kwali, da kuma har zuwa awanni hudu a kan tagulla.
Waɗannan, duk da haka, sun bambanta dangane da zafi da zafin jiki.
Babu wata hujja da ta nuna cewa dabbobi na iya daukar kwayar cutar ga mutane, amma hukumomin Burtaniya sun ba da shawarar cewa a wanke hannu bayan taɓa dabbobi, kamar bayan taɓa wasu farfajiyoyi da waɗanda ke da cutar suka taɓa.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 sun faru dangane da coronaviruses a cikin yanayi. A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke lalata garkuwar ta.
Ana zaton kwayar cutar ta zo ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa coronavirus yana da nasaba da kwayoyin halitta tare da Betacoronavirus, a cikin Sarbecovirus subgenus (B-domain) tare da zaren biyu da aka samo daga bat.
Kwayar cutar ta kasance daidai da kashi 96% a matakin cikakken kwayar halitta tare da samfurin sauran coronavirus na bat (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci kawai na amino acid a wasu sassan tsarin kwayoyin halittar mutum tsakanin kwayar cutar daga lard da kwayar cutar daga mutum.
Bambancin kwayoyin halittar mutum har zuwa yanzu ya gano cewa a mafi yawan kashi 92% na kwayoyin halitta sun kasance tsakanin coronavirus na shingles da SARS-CoV-2, wanda bai isa ya tabbatar da shingles a matsayin matsakaiciyar matsakaici ba.
Ana iya gano kamuwa da cutar ta hanyar cutar ta hanyar alamun cututtuka, kodayake a ƙarshe ana tabbatar da shi ta hanyar sake fasalin maganin polymerase chain reaction (rRT-PCR) na ɓoyewar kamuwa da cutar ko CT imaging.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya ba da shawarar cewa CT ya fi ƙarfin PCR, kodayake ba shi da ƙwarewa, tare da yawancin siffofin hoton da ke kan gaba tare da cutar huhu da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "bai kamata a yi amfani da CT don tantancewa ko azaman gwajin farko don gano COVID-19 ba".
WHO ta wallafa wasu takaddun shaida na gwajin RNA don SARS-CoV-1, tare da na farko da aka fitar a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin sake fasalin tsarin polymerase chain reaction (rRT-PCR).
Ana iya yin wannan gwajin a kan numfashi ko jini.
Sakamakon gwajin yana samuwa a cikin sa'o'i da dama zuwa kwanaki.
Yawancin lokaci ana yin gwajin ne da swabs na nasopharyngeal amma ana iya amfani da swabs na pharynx. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serology, wanda ke gano ƙwayoyin cuta.
Har zuwa 6 ga Afrilu 2020, babu ɗayan waɗannan gwaje-gwajen da aka tabbatar da cewa sun isa sosai don amincewa da amfani da su sosai.
A Amurka gwajin ƙwayar cuta wanda Cellex ya haɓaka an yarda da shi don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu izini kawai.
Abubuwan da ke nunawa a kan radiograph da CT na cututtuka masu alamomi sun hada da asymmetrical fastening na ƙasa da kuma rashin pleural effusion.
Ƙungiyar Radiology ta Italiya tana tattara bayanan yanar gizo na yanar gizo don neman hotunan hotuna don tabbatar da shari'ar.
Sakamakon haɗuwa da wasu cututtuka kamar adenovirus, hoto ba tare da tabbacin PCR ba yana da iyakantaccen ƙwarewa wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa yayin da hoton ba shi da ƙwarewa ga kamuwa da cuta, hanyar tana da sauri kuma ta fi dacewa, yana ba da shawarar yin la'akari da hanyar azaman kayan aikin tacewa a yankunan annobar.
An haɓaka cibiyar sadarwar juyayi mai amfani da hankali don gano ciwon hoto na kwayar cutar tare da duka radiograph da CT.
Dabarun hana yaduwar cututtuka sun hada da kiyaye tsabtar jiki gaba daya, wanke hannu, kauce wa taba idanu, hanci, ko baki da hannayen da ba a wanke ba, da tari ko hancin da ke kan kayan shafa sannan a jefa su kai tsaye cikin kwandon shara.
An shawarci waɗanda ke da yiwuwar kamuwa da cutar da su sanya abin rufe fuska a wuraren jama'a.
Hakanan an ba da shawarar matakan tsare kai na jiki don hana yaduwar cutar. Gwamnatoci da yawa sun hana ko kuma sun ba da shawarar kauce wa duk balaguron da ba su da mahimmanci zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Duk da haka, cutar ta kai ga yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su yi amfani da ƙa'idodin kariya, matakan kariya na tuntuɓar, da kuma kariya ta ido.
Amfani da bayanan wurin da gwamnati ke yi daga wayoyin salula don wannan dalili ya haifar da damuwa game da sirri, tare da Amnesty International da wasu kungiyoyi sama da 100 da suka fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar don amfani da son rai, kuma har zuwa 7 ga Afrilu 2020, sama da dozin ƙungiyoyin masana suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don shiga kusanci da mai amfani da wayar salula.
Masu amfani suna karɓar saƙo idan sun kasance kusa da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta yana yawo game da yadda za a hana kamuwa da cuta; misali, shafa hanci da kuma yin magana da kayan zaki ba shi da tasiri.
Babu riga-kafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa jama'a su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika ashirin, musamman bayan sun je bayan gida ko lokacin da hannayensu suka zama datti; kafin cin abinci; da kuma bayan sun hura hanci, tari, ko hancinsa.
Wannan shi ne saboda a waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, yana lalata kumfa mai karewa.
CDC ta ci gaba da ba da shawarar yin amfani da tsabtace hannu na giya tare da aƙalla kashi 60% na barasa ta hanyar abun ciki lokacin da sabulu da ruwa ba su da amfani.
WHO ta shawarci jama'a da su guji taba idanu, hanci, ko baki da hannayensu da ba a wanke ba.
Za'a iya gurɓata farfajiyar da wasu magunguna (a cikin minti daya na fallasa disinfectant don farfajiyar bakin karfe), gami da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran mafita, kamar benzalkonium chloride da gluconate na chryoxydine, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da cutar COVID a cikin wurare kamar ofisoshi ko cibiyoyin kulawa na yau da kullun, duk wuraren kamar ofisoshi, dakunan wanka, wuraren jama'a, kayan aikin lantarki da aka raba kamar su allunan, allon taɓawa, mabuɗan maɓalli, na'urorin sarrafawa ta nesa da injunan ATM da marasa lafiya ke amfani da su, ya kamata a tsabtace su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da hannayensu ko kuma kayan shafa yayin tari ko hancin, kuma su zubar da duk wani kayan shafawa nan da nan.
Ana ba da shawarar rufe fuska don waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin da nisan tafiyar da digo na numfashi da ke yaduwa yayin magana, hancinsa, da tari.
Hukumar Lafiya ta Duniya ta fitar da umarni kan lokacin da kuma yadda za a sanya abin rufe fuska.
A cewar Stephen Griffin, masanin kwayar cuta a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage yawan mutanen da ke taba fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da kula da tsabtace hannu ba".An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda zai iya kamuwa da cutar.
WHO ta ba da shawarar sanya abin rufe fuska ta hanyar masu lafiya kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutanen da ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Wasu ƙasashe sun fara ƙarfafa amfani da abin rufe fuska daga membobin al'umma.
A cikin Amurka, CDC ta ba da shawarar sanya abin rufe fuska na likitanci wanda ba na masana'anta ba.
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin amfani da jigilar jama'a ko kasancewa a cikin wuri mai cunkoso.
Jami'an kiwon lafiya na Thailand sun karfafawa mutane gwiwa su sanya abin rufe fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska lokacin da yake zuwa wuraren jama'a don kare kansa da wasu.
Gwamnatin Austriya ta ba da umarnin cewa duk wanda ya shiga kantin sayar da kaya dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna yankin da su sanya abin rufe fuska a wuraren da jama'a ke.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas na tsakanin birane da su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska a waje, yayin da ta kuma ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya sayen abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Kulawa ta zamantakewa (wanda aka fi sani da tsare jiki) yana tare da matakan kula da kamuwa da cuta da nufin rage saurin yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da keɓewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko manyan kantuna.
Mutane na iya aiwatar da hanyoyin nisantar zamantakewa ta hanyar kasancewa a gida, iyakance tafiya, guje wa wuraren da mutane ke taruwa, amfani da gaisuwa ba tare da taɓawa ba, da kuma ware kansu daga wasu.
Yawancin gwamnatoci yanzu suna tilasta ko ba da shawarar keɓewar jama'a a yankunan da cutar ta shafa.
Matsakaicin girman taron da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawarar an rage shi da sauri daga mutane 250 (idan ba a san cutar COVID-19 a yankin ba) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a da mutane fiye da biyu. Tsofaffi da waɗanda ke da matsalolin kiwon lafiya na ɓoye kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin garkuwar jiki sun sami haɗarin kamuwa da cututtuka da matsaloli masu tsanani kuma CDC ta shawarce su da su zauna a gida gwargwadon iko a wuraren da ke fama da cutar. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "sashin zamantakewar" da "sashin jiki", don bayyana cewa makasudin shine rage taɓawa ta jiki yayin da ake kula da alaƙar zamantakewa, ko dai ta hanyar yanar gizo ko ta nesa.
Amfani da kalmar "tsanantawar zamantakewa" ya haifar da ma'anar cewa ya kamata jama'a suyi rayuwa cikin cikakken keɓewa ta zamantakewa, maimakon ƙarfafa su su yi hulɗa da wasu ta hanyar madadin. Wasu ɓangarorin sun fitar da jagororin kiwon lafiyar jima'i don amfani da su yayin annobar.
Wannan ya haɗa da shawarar yin jima'i da wanda kuke zama tare da shi, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓewa a gida ga waɗanda aka gano suna da COVID-19 da waɗanda ake zargi sun kamu da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓewar kai da ta dace. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓewa ga duk mutanen da ke zaune a yankunan da cutar ta shafa.
An bayar da umarnin keɓe kai mafi tsauri ga waɗanda ke cikin rukunin haɗari.
Wadanda ke iya kasancewa cikin haɗuwa da wani da ke da COVID-19 da waɗanda suka yi balaguro zuwa ƙasashe ko yankuna da ke da yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin da za a iya samun kamuwa da cutar.
Dabaru don sarrafa annobar sune toshewa ko kuma kawar da su, da rage su.
Ana gudanar da rigakafi a farkon lokacin annobar kuma ana nufin ganowa da keɓe waɗanda ke da cutar da kuma gabatar da wasu matakan kula da kamuwa da cuta da allurar rigakafi don dakatar da cutar daga yaduwa ga sauran jama'a.
Lokacin da ba zai yiwu a dakatar da yaduwar cutar ba, sai a koma mataki na ragewa: ana daukar matakan rage saurin yaduwar cutar da rage tasirin ta ga tsarin kiwon lafiya da al'umma.
Ƙididdigar matakan da ke ragewa da ragewa za a iya gudanar da su a lokaci guda.
Matsin lamba yana buƙatar ƙarin matakan tsauraran matakai don dawo da cutar ta hanyar rage yawan haifuwa zuwa ƙasa da 1. Wani ɓangare na sarrafa yaduwar cututtukan cututtukan cututtuka shine ƙoƙarin rage ƙimar cutar, wanda aka sani da daidaitawa da cutar.
Wannan yana rage haɗarin ayyukan kiwon lafiya da yawa kuma yana ba da ƙarin lokaci don allurar rigakafi da hanyoyin magani.
Abubuwan da ba magunguna ba waɗanda za su iya magance yaduwar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓe kai; matakan al'umma da aka yi niyya kan tsare jiki kamar rufe makarantu da soke taron taro; shigar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan maganganun; haka kuma matakan muhalli kamar tsabtace farfajiya.
Sauran kasashen kuma sun dauki matakai da dama da nufin dakile yaduwar cutar.
Koriya ta Kudu ta gabatar da tantancewa da kewaye da gida, tare da ba da gargaɗi game da motsi na mutane masu kamuwa da cutar.
Singapore na ba da tallafin kuɗi ga waɗanda ke da cutar da ke keɓe kansu kuma suna ɗora manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska da kuma yin la'akari da shinge na kayan aikin likitanci.Game da Girma da Amurka, kwaikwayon ya nuna cewa raguwa (ragewa amma ba dakatar da yaduwar cutar ba) da matsi (dakatar da ci gaban cutar) suna da babban ƙalubale.
Manufofin ragewa mafi kyau na iya rage yawan buƙatun kiwon lafiya zuwa kashi biyu cikin uku da mutuwar rabin, amma har yanzu yana haifar da dubunnan dubban mutuwar da tsarin kiwon lafiya ya zama mai nauyi.
Matakan na iya zama na zaɓi amma dole ne a ci gaba da su muddin kwayar cutar tana yawo a cikin jama'ar ɗan adam (ko har sai an sami allurar rigakafi, idan ta zo da farko), saboda yaduwar za ta sake tashi nan da nan idan an sassauta matakan kariya.
Matsayi mai tsawo don hana cutar ya haifar da farashi na zamantakewa da tattalin arziki.
Babu wani maganin rigakafi da aka amince da shi musamman don COVID-19, amma ana ci gaba da haɓaka shi, gami da gwada magungunan da ake da su.
Shan maganin mura da aka ba ku a kan kanti, shan ruwa da hutawa zai taimaka wajen rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, ruwan intravenous da tallafin numfashi.
Yin amfani da kwayoyin steroid zai iya sa sakamakon ya yi muni.
Wasu mahaɗan da aka amince da su a baya don maganin wasu cututtukan ƙwayoyin cuta ana yin la'akari da su don amfani da su don magance COVID-19.
WHO ta kuma ce wasu "magungunan gargajiya da na gida" na iya ba da taimako ga alamun da SARS-CoV-19 ke haifarwa.
Ƙara ƙarfin aiki da daidaita kiwon lafiya don bukatun marasa lafiya na COVID-19 an bayyana ta WHO a matsayin matakan amsawa na cutar.
ECDC da ofishin WHO na yankin Turai sun fitar da jagorori ga asibitoci da manyan ayyukan kiwon lafiya don motsa albarkatu a matakai daban-daban, gami da mai da hankali kan ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓuɓɓuka idan ya cancanta, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta gaggawa ta hanyar horar da ma'aikata da haɓaka adadin masu numfashi da gadaje da ake da su.
Akwai dabaru da yawa game da inda farkon yanayin (wanda ake kira marasa lafiya marasa lafiya) ya fito.
An gano farkon cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Wannan lamarin ya fi dacewa da Kasuwar Kasuwancin Abinci ta Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'idar ita ce kwayar cutar ta samo asali ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma, a wasu kalmomin, yana da asalin dabbobi.
A ranar 30 ga Disamba, wasu likitoci a asibitin Wuhan Central sun sanar da abokan aikinsu game da "coronavirus kamar SARS".
Wadannan likitoci takwas, ciki har da Li Wenliang, 'yan sanda sun gargadi su saboda yada jita-jita, kuma wani, Ai Fen, shugabanninsa sun tsawata masa saboda tayar da wannan lamarin.
Hukumar Lafiya ta Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton isassun cututtukan cutar sankarar bargo da ba a sani ba ga hukumomin kiwon lafiya a Wuhan don haifar da bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, adadin masu cutar yana ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, kwayar cutar ta bazu zuwa sauran yankunan China, wanda ya taimaka wa hijirar Sabuwar Shekarar Sin da Wuhan ya zama babbar cibiyar sufuri da kuma tashar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da daya a Shenzhen.
Bayanai na hukuma sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu, 2020.Zuwa 26 ga Maris, Amurka ta zarce China da Italiya tare da yawan adadin mutanen da aka tabbatar a duniya.Zuwa 9 ga Afrilu, 2020, an samu rahotanni sama da miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Sakamakon annobar a Turai, ƙasashe da yawa a cikin Yankin Schengen sun takaita motsi da sarrafa kan iyakoki.
Amsar ƙasa ta haɗa da matakan hanawa kamar keɓewa (wanda aka sani da umarnin zama a gida, umarnin mafaka, ko umarnin gaggawa) da umarnin kulle-kulle.Ya zuwa 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'in gaggawa a Amurka, sama da mutane miliyan 50 suna cikin gaggawa a Philippines, kusan mutane miliyan 59 suna cikin gaggawa a Afirka ta Kudu da mutane biliyan 1.3 suna cikin gaggawa a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani yanayi na gaggawa, wanda ya karu zuwa mutane biliyan 2.6 kwanaki biyu bayan haka - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon cutar COVID-19 da aka tabbatar a ranar 1 ga Disamba 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon cutar ta kasance a ranar 17 ga Nuwamba.
Likita Zhang Jixiang ya lura da tarin cututtukan ciwon huhu da ba a san dalilinsa ba a ranar 26 ga Disamba, sannan asibitin ya sanar da CDC Wuhan Jianghan a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko ga samfurin mai haƙuri a ranar 27 ga Disamba 2019 ya nuna kasancewar coronavirus kamar SARS.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
A lokacin da aka sanar da wannan sanarwar, likitoci a Wuhan sun sami gargadi daga 'yan sanda saboda "fada jita-jita" game da annobar.
Hukumar Lafiya ta Kasa ta kasar Sin a farko ta yi ikirarin cewa babu "tabbacin tabbatacce" game da yaduwar mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na juyin juya hali wanda babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin mutane" don dakile yaduwar cutar.
A cikin abin da aka kira "mafi girma a cikin tarihin ɗan adam", an sanar da keɓewar keɓewa a ranar 23 ga Janairu wanda ya dakatar da tafiya zuwa ciki da waje Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, yana shafar mutane aƙalla miliyan 57.
An haramta amfani da motocin jama'a a cikin gari.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Huoshenshan Hospital, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti bayan haka, Asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta kuma sauya wasu wurare 14 a Wuhan kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi.A ranar 26 ga Janairu, gwamnati ta fara matakan da za su biyo baya don dakile barkewar COVID-19, gami da fitar da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu a fadin kasar sun rufe.
Yankunan Hong Kong da Macau sun fara wasu matakai, musamman dangane da makarantu da jami'o'i.
An fara aiwatar da ayyukan nesa a wasu yankuna na kasar Sin.
An kafa dokar hana zirga-zirga a cikin da kuma wajen Hubei.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a duk faɗin China na ɗan lokaci.
An aiwatar da kula da motsi na jama'a a birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu nau'ikan takunkumin waje.Bayan kamuwa da cutar ya shiga cikin duniya a watan Maris, gwamnatin China ta ɗauki tsauraran matakai don hana cutar "shigowa" daga wasu ƙasashe.
Misali, Beijing ta sanya dokar killace mutane na kwanaki 14 ga duk matafiya na kasa da kasa da ke shiga birnin. A ranar 23 ga Maris, babban yankin China yana da shari'ar yaduwar cikin gida guda daya a cikin kwanaki 5, a wannan yanayin matafiyin ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an toshe shari'ar yaduwar cutar cikin gida kuma an sarrafa yaduwar ta ta kasar Sin.
An sassauta takunkumin tafiye-tafiye a ranar guda a Hubei, ban da Wuhan, watanni biyu bayan dokar ta baci ta fara aiki.
Wadanda suke son shiga kasar Sin dole ne su nemi biza a ofishin jakadancin kasar Sin ko ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, tare da samar da wani tsari na karfafa kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki da ta fara da yin mintuna uku na shuru a karfe 10:00 na ranar 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tarayya ta nemi iyalai su nuna girmamawa ta yanar gizo kamar yadda suke bin tsarin tsare jiki don hana barkewar cutar COVID-19 sake faruwa.
An tabbatar da cewa COVID-19 ya yadu zuwa Koriya ta Kudu a ranar 20 ga Janairun 2020 daga China.
Hukumar kiwon lafiya ta kasa ta ba da rahoton karuwar lamuran da aka tabbatar a ranar 20 ga Fabrairu, wanda galibi ke da alaƙa da taron da aka yi a Daegu na sabon ƙungiyar addini da aka sani da Cocin Yesu Shincheonji.
Masu bin Shincheonji da suka ziyarci Daegu daga Wuhan ne ake zargi da haddasa cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin cocin 9,336, mutane 1,261 ko kusan 13% sun ba da rahoton alamun.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka tabbatar da cewa wasu sojoji uku sun kamu da cutar.
Har ila yau, an yi tasiri ga jadawalin jiragen sama kuma saboda haka an canza jadawalin.Koriya ta Kudu ta gabatar da abin da ake ganin shine mafi yawan shirye-shiryen da aka tsara a duniya don tantance yawan jama'a don gano cutar, da kuma ware duk wani mutum da ya kamu da cutar da kuma bin sawu da killace duk wanda ya taɓa saduwa da su.
Hanyoyin tantancewa sun haɗa da ba da rahoton kai tsaye na alamun bayyanar cututtuka ta hanyar sabbin masu zuwa ƙasashen waje ta hanyar aikace-aikacen hannu, gwajin cutar da aka yi a baya tare da sakamakon da ke samuwa a washegari, da haɓaka ƙarfin gwaji wanda ke ba da damar gwada mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin mai nasara wajen sarrafa annobar duk da cewa ba a kebe dukkan biranen ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman ko dai a kori Moon daga aiki saboda abin da suka zargi da rashin kulawar gwamnati game da annobar, ko kuma su yaba da yadda ta amsa.
A ranar 23 ga Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu cutar a cikin mako huɗu.
A ranar 29 ga Maris an bayar da rahoton cewa daga ranar 1 ga Afrilu duk sabbin masu shigowa kasashen waje za a killace su na makonni biyu.
Kamar yadda kafofin watsa labarai suka ruwaito a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimako don gwajin kwayar cutar daga ƙasashe daban-daban 121.
Iran ta ba da rahoton kamuwa da cutar SARS-CoV-2 ta farko a ranar 19 ga Fabrairu a Qom, wanda ya ga, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan rana.
Matakan kariya na farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'adu, wasanni, da sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta kashe Riyal tiriliyan biyar wajen yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma mutane ne kawai za a killace su.
An sanar da shirin takaita zirga-zirgar jiragen sama tsakanin biranen a watan Maris, duk da cewa cunkoson zirga-zirgar jiragen sama tsakanin biranen kafin bikin Sabuwar Shekarar Farisa ya ci gaba.
Abincin Shia a Qom ya kasance a buɗe ga baƙi har zuwa 16 ga Maris 2020.
Duk da ikirarin cewa an rufe adadin cutar a Iran, fiye da kasashe goma sun sake gano masu cutar a Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa cutar ta fi muni fiye da 388 da gwamnatin Iran ta bayar da rahoton har zuwa ranar.
An rufe majalisar dokokin Iran, inda aka ce 23 daga cikin mambobi 290 sun yi gwajin cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki 'yan gwagwarmayar kare hakkin bil adama da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, da kuma sakin duk fursunonin da suka cancanta a wani lokaci.
Ya ce akwai hadarin da ya fi yawa ga cutar ta yadu a cikin cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, waɗanda kuma ba su da isasshen kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana, mafi yawan adadin da aka rubuta a kasar tun barkewar cutar.
Akalla 'yan siyasa 12 da jami'an gwamnati ko tsoffin ma'aikata sun mutu sakamakon cutar har zuwa 17 ga Maris.
Har zuwa 23 ga Maris, Iran tana samun sabbin mutane 50 a kowace awa da kuma mutuwar mutum guda a kowace minti goma sakamakon cutar coronavirus.
A cewar jami'an WHO, akwai yiwuwar akwai mutane sau biyar a Iran fiye da yadda aka ruwaito.
Ya kuma ba da shawarar cewa takunkumin da Amurka ta kakaba wa Iran na iya shafar ikon da kasar ke da shi na kudi don magance cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya dage kan bukatar sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu matafiya biyu 'yan China suka gwada tabbatacce ga SARS-CoV-2 a Rome.
Yanayin ya fara karuwa cikin sauri, wanda ya bukaci gwamnatin Italiya da ta dakatar da dukkan zirga-zirgar jiragen sama zuwa da dawowa daga China tare da ayyana dokar ta baci.
An gano wasu gungun marasa lafiya na COVID-19 ba tare da wata alaƙa ba, farawa da tabbatar da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabuwar dokar doka don dakile annobar, gami da keɓe mutane sama da 50,000 daga birane daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A cikin yankin da cutar ta bulla, ba za a ba da izinin shiga da fita ba.
An riga an ba da umarnin dakatar da ayyukan aiki da kuma wasannin motsa jiki a yankin. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar lokacin da Italiya ta kai adadin mutuwar 100.
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, ya kamata a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantunan magani.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin ƙasa da ta fi yawan mutuwar da ke da nasaba da cutar coronavirus a duniya bayan da ta ba da rahoton mutuwar 3,405 daga annobar.
A ranar 22 ga Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama na soja guda tara tare da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke a Italiya, tare da yawancin waɗannan a yankin Lombardy.
Wani rahoton CNN ya nuna cewa haɗuwa da yawan tsofaffin mutane a Italiya da rashin iyawar gwada duk waɗanda ke da kwayar cutar har zuwa yau na iya ba da gudummawa ga yawan mutuwar.
Amsar da Burtaniya ta bayar ga kwayar cutar ta fara bayyana a matsayin daya daga cikin ƙasashe masu fama da cutar mafi nutsuwa, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta sanya kowane irin tsare-tsare na zamantakewa ko matakan killace jama'arta ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin da ake ganin ta yi da gaske a cikin martani ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawara don kauce wa duk tafiye-tafiye marasa mahimmanci da hulɗar zamantakewa, yana ba da shawarar mutane su yi aiki daga gida idan za su iya kuma su guji wurare kamar mashaya, gidajen abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da dakin motsa jiki dole ne su rufe da wuri-wuri, kuma sun yi alkawarin biyan ma'aikata albashi har zuwa kashi 80% na albashi har zuwa iyakar £2,500 a wata don kauce wa rashin aikin yi a cikin rikicin.
Ba kamar matakan da suka gabata ba, 'yan sanda sun tilasta dokar ta hanyar aika da takunkumi da kuma tarwatsa taron jama'a.
Yawancin kasuwancin da aka umarce su da su rufe, tare da banda ga kasuwancin da aka ɗauka "muhimmanci", gami da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma bita.
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar COVID-19 ta farko a jihar Pacific Northwest ta Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin masu kula da cutar coronavirus na fadar White House a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumin shiga ga matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka ta Amurka, babbar cibiyar kiwon lafiyar jama'a ta sanar da cewa sun samar da nasu gwajin.
Duk da haka, Amurka ta yi jinkirin fara gwaji, wanda ke kare ainihin adadin cutar a wannan lokacin.
Gwajin ya sha wahala saboda kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnati ga kayan gwajin da ba na gwamnati ba (aikin ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma tsauraran ƙa'idodi don waɗanda suka cancanci yin gwajin har zuwa farkon Maris (ana buƙatar shawarar likita bayan haka).
Har zuwa ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
Har zuwa ranar 13 ga Maris, The Atlantic ta ba da rahoton cewa an gudanar da gwaje-gwaje ƙasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ba da rahoton: "Mutane da yawa da ke da alamun cututtuka da umarnin likitoci sun jira na awanni ko kwanaki don gwaji".Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, matakin da wasu jihohi suka bi ba da daɗewa ba.
Makarantu a yankin Seattle sun soke azuzuwan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar.
A ranar ne Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Bayarwa don Shirye-shiryen Cutar Korona da Amsawa, wanda ya samar da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin gwamnati don amsa cutar.
Kamfanoni sun sanya takunkumin hana ma'aikata tafiya, soke taro, da kuma karfafa ma'aikata su yi aiki daga gida.
An soke abubuwan da suka faru da kuma wasannin motsa jiki. A ranar 11 ga Maris, Trump ya ba da sanarwar hana tafiye-tafiye ga yawancin Turai ban da Burtaniya, na kwanaki 30, farawa daga 13 ga Maris.
Kashegari, ya fadada wannan haramcin don hada da United Kingdom da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya sanya kudaden tarayya don amsawa ga rikicin.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun rufe ko rage sa'o'i a duk faɗin Amurka don ƙoƙarin rage yaduwar kwayar cutar.
Har zuwa 17 ga Maris, an tabbatar da barkewar cutar a duk jihohi 50 da gundumar Columbia.
A ranar 25 ga Maris, gwamnan ya ce zaman gidan yari yana da tasiri, lokacin da adadin adadin masu kamuwa da cutar ya fara raguwa daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da mutane 32,308 a Birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da ƙarin adadin masu kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya.
Kamar yadda rahotannin kafofin watsa labarai suka nuna a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin tsare kai har zuwa 30 ga Afrilu.
A wannan rana, USNS Comfort, wani asibitin asibiti mai ɗakunan kwana 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutum 884 sakamakon cutar coronavirus a cikin sa'o'i 24.
A jihar New York, an samu mutane sama da 100,000 a ranar 3 ga Afrilu. An soki Fadar White House saboda rage girman barazanar da kuma sarrafa saƙon ta hanyar umarci jami'an kiwon lafiya da masana kimiyya su daidaita maganganun jama'a da kuma wallafa bayanai game da cutar tare da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya amincewar da aka yi wa gwamnatin Trump game da rikicin ya kasance a cikin layi.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci, gami da kayayyakin kiwon lafiya masu mahimmanci, daga China.
An yi amfani da nazarin tsarin tafiye-tafiyen iska don yin taswira da hasashen yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Transportungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi yawan masu yawon buɗe ido daga Wuhan.
An kuma ba da rahoton cewa Dubai, Sydney, da Melbourne sanannun wurare ne ga waɗanda ke tafiya daga Wuhan.
An ba da rahoton cewa Bali ita ce mafi ƙarancin cikin shahararrun biranen 20 na biranen da ake zuwa dangane da wadatar, yayin da biranen Ostiraliya ke da mafi ƙarancin.Australia ta fitar da Tsarin Amincewa da Gaggawa don Novel Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa akwai abubuwa da yawa da ba a sani ba game da COVID-19, kuma cewa Ostiraliya za ta ba da fifiko ga kula da kan iyakoki da sadarwa a cikin martani ga cutar.
A ranar 21 ga Maris, an ayyana gaggawa ta lafiyar ɗan adam a Ostiraliya.
Dangane da aiwatar da keɓewar sufuri na jama'a a Wuhan da Hubei, wasu ƙasashe sun shirya fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta jirgin sama da ƙasar ta hayar, tare da izinin hukumomin China.
Kasashen Kanada, Amurka, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand na daga cikin kasashen da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasar ta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da' yan Poland hudu, dan kasar Sin daya, da kuma dan kasar Indiya daya.
An saukar da 'yan kasar Poland, China, da Indiya a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
Ana killace 'yan Brazil da suka je Wuhan a sansanin soji da ke kusa da Brasilia.
A ranar, an tura 'yan Kanada 215 (mutane 176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun tura mutane 277 a ranakun 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka canza shi zuwa cibiyar killacewa, inda suka zauna na kwanaki 14.
Jirgin sama na New Zealand ya isa Aukland a ranar 5 ga Fabrairu; fasinjojinsa (gami da wasu daga Ostiraliya da Pacific) an killace su a sansanin sojan ruwa a Whangaparoa, arewacin Aukland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta tura Amurkawa zuwa jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama dauke da 'yan Kanada 129 da aka kwashe daga Diamond Princess ya sauka a Trento, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta yi hayar ya dawo da' yan Afirka ta Kudu 112.
An gudanar da gwajin lafiyar kafin fitarwa, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin ba su da lafiya.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin jin kai wanda, a matsayin kariya, duk an sanya su cikin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen isar da agaji zuwa yankunan da cutar ta addabi kasar Sin, tare da kungiyoyi masu hadin gwiwa a yankin Chicago da suka samu nasarar isar da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.Kungiyar agajin jin kai ta Direct Relief, tare da hadin gwiwar FedEx, ta aika da abin rufe fuska 200,000 tare da sauran kayan kariya na sirri, gami da safar hannu da riguna, ta hanyar jigilar gaggawa ta sama zuwa Asibitin Union na Wuhan a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kokarin magance su tare don kare "al'ummomin da ke cikin haɗari a Afirka da Kudancin Asiya".
Interaction ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta aika da tallafin da ya kai dala miliyan 2.26 ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da sama da tan 13 na kayayyakin kiwon lafiya zuwa Wuhan, Malaysia ta ba da sanarwar ba da gudummawar safar hannu na likita miliyan 18 ga China, Jamus ta ba da gudummawar kayayyakin kiwon lafiya da suka haɗa da kayan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na taimakon likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a matsayin tallafin kuɗi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da taimakon likita da ƙwararru don taimakawa Italiya sarrafa annobar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da kayan kariya 60,000 zuwa Addis Ababa, Habasha don tarayyar Afirka ta rarraba.
Daga nan sai ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwaji na kasar Sin.
Alal misali, Spain ta dawo da kayan gwaji na coronavirus na kasar Sin 58,000 tare da daidaito na kashi 30%, yayin da Netherlands ta dawo da abin rufe fuska na kasar Sin 600,000 da suka lalace.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, da ake zargin sun fito ne daga China, amma a zahiri daga Colombia.
A gefe guda kuma, an karɓi taimakon China a sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan tallafi na gaggawa ga ƙasashe masu tasowa.
Hukumar lafiya ta duniya ta yaba wa kokarin da gwamnatin kasar Sin ke yi na kula da cutar.
WHO ta lura da bambance-bambance tsakanin barkewar cutar SARS ta 2002-2004, lokacin da aka zargi gwamnatin China da yin sirri har ta shafi ayyukan rigakafi da sarrafawa, da kuma rikicin da ke faruwa wanda ya ga gwamnatin tsakiya "ta ba da sabuntawa akai-akai don kauce wa fargaba kafin hutun Sabuwar Shekarar Sin".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da gwamnatin tsakiya ta yanke na aiwatar da takunkumin zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya bayyana cewa duk da cewa "ba lallai ba ne shawarar da WHO ta yi", amma kuma "muhimmiyar alama ce ta sadaukar da kai don shawo kan annobar a inda ta fi mayar da hankali" kuma ta kira ta "ba a taɓa yin irinta ba a tarihin lafiyar jama'a".A ranar 30 ga Janairu, biyo bayan tabbatar da yaduwar mutum ga mutum a wajen China da kuma karuwar adadin masu cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin Babban Lamarin Kiwon Lafiyar Jama'a na Duniya (PHEIC), PHEIC na shida tun lokacin da aka fara aiwatar da matakin a lokacin annobar cutar ta alade a 2009.
Darakta Janar na WHO Tedros Adhanom ya ce PHEIC sakamakon "hadarin yaduwar duniya ne musamman ga ƙasashe masu ƙarancin kuɗi da matsakaita ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani game da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a ɗauki matakan da za su hana balaguron ƙasa da ƙasa da cinikayya" kuma "WHO ba ta ba da shawarar ƙuntata kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummomin duniya da su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen da aka tsara a cikin ƙasashe masu ƙarancin kuɗi, suna mai da hankali kan muhimmancin tallafawa ƙasashen da "ba su da tsarin da za su iya gano mutanen da ke da cutar, idan ta bayyana".
Tedros ya ci gaba da yin sanarwa yana mai cewa "mu ne mafiya karfi a cikin sarkarmu mafi rauni" kuma ya yi kira ga al'ummar duniya da su "shiga hannun jari a yau ko kuma su biya daga baya".
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da ba da "ikon tsarin Majalisar Dinkin Duniya gaba ɗaya don amsawa".
Sakamakon haka an kunna wata ƙungiyar Kula da Rikicin Majalisar Dinkin Duniya, wanda zai ba da damar daidaita dukkanin martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan amsar kiwon lafiya yayin da sauran hukumomin za su iya kawo ƙwarewar su don magance tasirin tasirin zamantakewa, tattalin arziki da ci gaba na cutar".
A ranar 14 ga watan Fabrairu, an kunna wani rukunin hadin gwiwar China da WHO ke jagoranta don samar da kwararru na kasa da kasa da WHO a filin kasar Sin don taimakawa wajen gudanar da harkokin cikin gida da kuma tantance "matsanancin cutar da kuma yaduwar cutar" ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin kasa da kuma gudanar da ziyarar gani da ido don tantance "sakamakon ayyukan mayar da martani a yankuna da kauyuka, gami da birane da yankunan karkara".A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya ta kamata ta yi karin kokari don shirya don yiwuwar barkewar cutar coronavirus" ta hanyar cewa duk da cewa har yanzu ba a fara kiran ta cutar ba, kasashen su kasance "a cikin shirin".
A cikin martani ga barkewar cutar a Iran, WHO ta tura Tawagar Haɗin gwiwa don tantance yanayin.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga ƙimar barazanar coronavirus a duniya daga "babba" zuwa "mafi girma", matakin mafi girma na faɗakarwa da kimanta haɗari.
Mike Ryan, darektan zartarwa na shirin gaggawa na lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa "Wannan bita ne na gaskiya ga kowace gwamnati a duniya: farka.
Kwayar cutar na iya zuwa kuma ya kamata ku kasance cikin shiri, "yana mai jaddada cewa matakan da suka dace na iya taimakawa duniya kauce wa" mafi munin yanayin. "
Ryan ya ci gaba da cewa bayanan na yanzu ba sa ba da damar jami'an kiwon lafiya su ayyana cutar a duniya, kamar yadda sanarwar ke nufin "muna yarda da cewa duk mutanen da ke duniya za su iya kamuwa da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cewa annobar coronavirus ta zama annoba.
Darakta-Janar ya ce WHO "tana matukar damuwa da yadda ake samun kamuwa da cuta da kuma tsananin cutar, da kuma yadda ake samun rashin aiki". WHO ta fuskanci mummunan zargi saboda abin da ake ganin rashin kulawar annobar, gami da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma rarraba kwayar cutar a matsayin annobar.
Wannan ƙin yarda ya haɗa da takarda don Darakta Janar na WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu har zuwa 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada haƙƙin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin ya karbi taimakon da zai ceci rayuka kuma gwamnati na da wannan hakkin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba dalili bane na nuna bambanci ga wasu kungiyoyi.
Masana sun jaddada cewa dukkan mutane suna da hakkin samun lafiya, gami da nakasassu, membobin kungiyoyi 'yan tsiraru, tsofaffi, marasa matsuguni, marasa gida, wadanda ke rayuwa cikin mawuyacin yanayi, fursunoni, da 'yan gudun hijira da sauran kungiyoyin da ke bukatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwa ta tattalin arziki da ci gaba ta kaddamar da wani dandali don samar da cikakken bayani kan lokaci game da ra'ayoyin manufofi a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa tattauna tasirin gaggawa da ƙuntatawa na balaguro, cibiyar dijital ta haɗa da Masu Kula da Manufofin Kasa, kuma tana da nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta sha suka daga Amurka, Ministan Ofishin Ministan Burtaniya Michael Gove da dan Shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro sakamakon yadda ta gudanar da annobar, wacce ta fara a lardin Hubei, China.
An kori wasu jami'ai a lardin daga jam'iyyar kwaminis ta kasar Sin (CPC) saboda yadda aka gudanar da killace mutane a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin dadin yadda kungiyoyin siyasa ke amsawa game da yaduwar cutar a lardin.
Wasu masu sharhi sun yi imanin cewa wannan yunkurin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da yaduwar cutar coronavirus.
Wasu jami'an kasar Sin, Janar Zhao Lijian sun musanta rahoton farko da ya nuna cewa annobar coronavirus ta samo asali ne daga Wuhan, suna mai yarda da ka'idar makirci cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Amurka a karkashin Donald Trump ta kira coronavirus "kwayar cutar China" ko "kwayar cutar Wuhan" tana mai cewa "ƙasar Sin ta samar da kwayar cutar da yanzu ta zama annobar duniya", wanda wasu masu sukar suka soki a baya a matsayin wariyar launin fata da kuma "ƙoƙarin karkatar da hankali daga gazawar gwamnatinta wajen dakile cutar".
Jaridar Daily Beast ta samu wata tashar gwamnatin Amurka da ke nuna hanyoyin sadarwa masu ban tsoro tare da asalin asalinsa a cikin majalisar tsaron kasa, tare da dabarun da aka kira "Dukkanin game da China ne.
An gaya mana mu yi kokarin tabbatar da cewa an bayyana wannan sakon ta kowane hali, gami da taron manema labarai da kuma nunawa a talabijin. "Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na tura tallafi ga kasashen da ke fama da cutar wani bangare ne na kokarin farfaganda don shafar duniya.
Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmayar samun tasiri ta hanyar juya belin da kuma 'siyasa mai karimci'.
Borrell ya kuma ce "China tana ta kokarin tura sakon cewa, sabanin Amurka, ita abokiyar zama ce mai dogaro da dogaro".
China ta kuma bukaci Amurka da ta janye takunkumin da ta kakaba wa Syria, Venezuela da Iran, yayin da ta bayar da rahoton cewa ta tura tallafi ga kasashen biyu na karshe.
An dakatar da tallafin masks 100,000 daga Jack Ma zuwa Cuba ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da tallafin da ake baiwa wasu kasashe zuwa kasashensu.
Kuma an samu rahoton rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin numfashi da ke kan hanyarsu ta zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce "Kasar Sin ce kadai ke ba da amsar ta bangarorin biyu.
Wannan ba kyakkyawan alama ba ne game da hadin kan Turai".
A ranar 22 ga Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umarci sojojin Rasha da su aika da sojojin likitoci, motocin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta kawo "manyan majiyoyin siyasa" da ba a bayyana sunansu ba suna cewa kashi 80 cikin dari na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da yin kuskuren "ƙwarewar siyasa da diflomasiyya".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jiragen sama masu jigilar kayayyakin kiwon lafiya zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce "yayin da yake ba da taimako ga abokansa a Amurka, [Putin] ya yi la'akari da cewa lokacin da masana'antun kayan aikin likita na Amurka suka sami ci gaba, su ma za su iya ba da amsa idan ya cancanta".
Aikin soja na NATO "Defender 2020" wanda aka shirya a Jamus, Poland da ƙasashen Balkan, mafi girman atisayen yaƙin NATO tun ƙarshen Cold War, za a gudanar da shi a ƙarami.
Sakatare Janar na Kamfen na Yaki da Makaman Nukiliya Kate Hudson ya soki horon Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana barazanar rayukan ba kawai sojojin Amurka da sauran kasashen Turai da ke halarta ba har ma da mutanen ƙasashen da suke aiki".Gwamnatin Iran ta yi fama da cutar, tare da kusan 'yan majalisa biyu da wasu manyan siyasa goma sha biyar ko kuma tsoffin mutane.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika a bude ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fama da yaki da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta sanya wa Iran.
Masu nazarin siyasa sun yi tsammanin hakan zai yi tasiri ga damar da Donald Trump zai samu na sake zaɓar shugaban kasa a zaben 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewa da rashin fahimta" bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a killace shi na makonni biyu a wuraren da gwamnati ta tsara.
Jama'ar Koriya ta Kudu da farko ba su da tabbas game da martanin Shugaba Moon Jae-in ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon daga aiki saboda abin da ake ganin rashin kulawar gwamnati game da annobar, ko kuma suna yabon yadda ta amsa.
Wasu masu sharhi sun nuna damuwa cewa wannan matakin zai ba gwamnati damar karfafa karfin ikonta.
A Hungary, majalisarta ta kada kuri'ar ba firaminista Viktor Orbán damar yin mulki ta hanyar doka har abada, dakatar da majalisa da zabuka da hukunta wadanda ake ganin sun yada labaran karya game da kwayar cutar da kuma yadda gwamnati ta magance rikicin.
An zargi annobar coronavirus da wasu rashin wadataccen kayayyaki, sakamakon amfani da kayan aiki don yaƙar cutar da ke ƙaruwa a duk duniya, sayayyar firgici, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargaɗi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar buƙatun masu amfani da kuma katsewar masu samarwa.
Wasu yankuna kuma sun ga fargabar sayayya wanda ya haifar da shimfidawa daga kayan masarufi kamar abinci, kayan wanka, da ruwan kwalba, wanda ke haifar da karancin wadata.
Masana'antar fasaha musamman ta yi gargadin jinkirin isar da kayayyakin lantarki.
A cewar babban daraktan WHO Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Wannan buƙatar ta haifar da hauhawar farashin har zuwa sau ashirin na farashin yau da kullun kuma hakan ya haifar da jinkirin samar da kayan aikin likita na watanni huɗu zuwa shida.
Hakanan yana haifar da karancin kayan kariya na mutum a duk duniya, tare da WHO da ke gargadin cewa wannan na iya zama haɗari ga lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou don siyar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da karancin abinci mai gina jiki a wasu manyan kasuwanni kuma gwamnatin Ostiraliya ta hana shi a baya. Duk da yawan cutar COVID-19 a Arewacin Italiya da lardin Wuhan, da kuma ci gaba da buƙatar kayayyakin abinci, yankuna biyu sun tsira daga mummunan karancin abinci.
Matakan da China da Italiya suka dauka don magance tarin kayayyaki da sayar da kayayyaki masu mahimmanci sun yi nasara, suna kauce wa mummunan karancin abinci da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya tare da samar da kayan gona mai mahimmanci ba ya ganin raguwa mai yawa, amma farashin na iya ƙaruwa a cewar wakilan masana'antar.
Rashin abinci na ɗan lokaci ne, har ma a Wuhan, yayin da jami'an gwamnatin China ke sakin aladu don tabbatar da wadataccen abinci ga yawan jama'a.
Irin wannan dokar ta wanzu a Italiya da ke buƙatar masana'antun abinci su ajiye kayan abinci don irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: a cewar rahotannin kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020 sakamakon matakan da gwamnati ta dauka don dakile yaduwar kwayar cutar, kuma tallace-tallace na kiri ya ragu da kashi 20.5%.
Ganin cewa babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an ga cutar ta kawo barazanar kawo cikas ga tattalin arzikin duniya.
Agathe Demarais daga Sashin Nazarin Tattalin Arziki ya yi hasashen cewa kasuwar za ta ci gaba da hawa da sauka har sai an sami cikakken hoto game da sakamakon da ake iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa durkushewar tattalin arziki sakamakon annobar a kan ci gaban duniya na iya wuce yanayin barkewar cutar SARS a 2002-2004.
Wani bincike da masana suka yi a jami'ar Washington da ke St. Louis ya nuna cewa za a samu tasirin da ya kai dala biliyan 300 a kan kayayyakin da ake samarwa a duniya wanda zai iya wucewa na tsawon shekaru biyu.
An ba da rahoton cewa kungiyar kasashen dake fitar da man fetur (OPEC) na cikin "rikice-rikice" bayan faduwar farashin mai sakamakon karancin bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu sakamakon karuwar adadin masu kamuwa da COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da yaduwar cutar coronavirus, wasu alamun kasuwancin Amurka da suka hada da NASDAQ-100, S&P 500 Index, Dow Jones Industrial Average sun ba da rahoton faɗuwarsu mafi muni tun 2008, tare da Dow ya faɗi maki 1,191, mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi a 2007-08.
Dukkanin alamun uku sun ƙare makon da raguwa sama da 10%.
A ranar 28 ga Fabrairu, Scop GmbH Assessment ta tabbatar da ƙarfin darajar darajar darajar China, amma ta riƙe Ra'ayi mara kyau.
Hannun jari sun fadi saboda tsoron coronavirus, mafi girman faduwar da aka samu a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a yi koma bayan tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakin gaggawa na babban bankin da na jihar wanda ya zo a kan kari.
Babban bankin ya amsa da sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Yawon shakatawa shine ɓangaren da ya fi fama da ƙuntatawa na balaguro, rufe wuraren jama'a da abubuwan jan hankali, da shawarwarin gwamnati game da balaguro a duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama sun soke jirage saboda karancin buƙata, gami da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanonin jiragen sama na yanki a cikin Flybe na Burtaniya suka yi biris.
Tasirin da ke kan masana'antar jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
An rufe wasu tashoshin jirgin kasa da tashar jirgin ruwa.
Cutar ta faru ne a lokacin Chunyun, lokacin tafiye-tafiye mai yawa wanda ke da alaƙa da hutun Sabuwar Shekarar Sinawa.
Wasu abubuwan da suka shafi jama'a an soke su ta hanyar gwamnatocin jihohi da na lardi, gami da bikin Sabuwar Shekarar shekara, tare da kamfanoni masu zaman kansu kuma suna rufe shagunan su da abubuwan jan hankali kamar Disneyland Hong Kong da Disneyland Shanghai.
Yawancin abubuwan da suka faru na Sabuwar Shekarar Lunar da abubuwan jan hankali na yawon bude ido an rufe su don kauce wa taron jama'a, gami da Forbidden City a Beijing da bukukuwa a cikin haikalin gargajiya.
A larduna 24, daga cikin larduna 31, da kananan hukumomi da yankuna, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa ranar 10 ga watan Fabrairu, suna umarci dukkan wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Wannan yanki yana wakiltar kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta kara matakan mayar da martani kan kamuwa da cutar zuwa matakin da ya fi girma kuma ta ayyana dokar ta baci, rufe makarantu har zuwa watan Maris da kuma soke bikin Sabuwar Shekara.
Ziyarci kantin sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40 cikin dari.
Kasuwancin da ke Arewacin Amurka da Gabas ta Tsakiya sun fadi da kashi 50 zuwa 60 cikin dari.
Wannan kuma ya haifar da raguwar kashi 33-43% a cikin zirga-zirgar tafiya zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu kula da cibiyoyin cin kasuwa a duk duniya suna aiwatar da ƙarin matakai, misali inganta tsafta, sanya masu duba zafin jiki don bincika zafin jiki na baƙi, da soke abubuwan da suka faru.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta kai kololuwa a Wuhan, mutane kusan miliyan 5 a China sun rasa ayyukansu.
Yawancin kusan ma'aikata 'yan gudun hijira miliyan 300 daga yankunan karkara na kasar Sin sun makale a gida a yankunan karkara ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus na iya kawar da ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar wani kimantawa da Bankin Tsaro na Tarayya na St. Louis ya yi.
A tsakiyar watan Maris, ma'aikata Faransa miliyan 4 sun nemi fa'idodin rashin aikin yi na ɗan lokaci kuma ma'aikata Biritaniya miliyan 1 sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan rabin a Jamus sun tura ma'aikatansu zuwa tsarin ma'aikata na ɗan gajeren lokaci wanda gwamnati ke tallafawa wanda aka sani da Kurzarbeit.
An aiwatar da tsarin biyan diyya na gajeren lokaci a Faransa da Burtaniya.
Masana'antar wasan kwaikwayo da al'adun gargajiya sun sami mummunan tasiri ta hanyar cutar, yana shafar ayyukan ƙungiyoyi da kuma mutane - duka masu aiki da kai da masu zaman kansu - a duk duniya.
Kungiyoyin al'adu da al'adu suna ƙoƙari su haɓaka manufofin su (galibi ana samun kuɗin jama'a) don samar da damar samun kayan al'adu ga al'umma, kiyaye lafiyar ma'aikatansu da al'umma, da tallafawa masu fasaha a duk lokacin da zasu iya.
Har zuwa Maris 2022, a duk duniya kuma a matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu sun rufe nune-nunen, an soke shirya abubuwan da aka shirya da kuma wasan kwaikwayon kuma an jinkirta su har abada.
A cikin martani, akwai matakai masu ƙarfi don samar da madadin sabis ta hanyar dandamali na dijital. Wani sabon faɗuwa da ya raguwa daga annobar shine soke ayyukan addini, manyan abubuwan da suka shafi wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide da wake-wake, taron bitar fasaha, da wasan kwaikwayo na zamani.
An kuma yi wa masana'antar fim barazana. Vatican ta sanar da cewa an soke bikin Juma'ar Albarka a Rome, wanda ke faruwa a makon karshe na Lent na lokacin tuba na Kirista.
Yawancin bishops sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun gudanar da ayyukan coci ta hanyar rediyo, yawo kai tsaye ta yanar gizo ko talabijin yayin da wasu ke ba da ibada ta hanyar wucewa.
Tare da Roman Katolika Bishop na Roma rufe majami'u da majami'u da kuma St. Peter's Square ya zama ba tare da Krista ba, sauran addinai sun soke ayyukan kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, temples da warehouses.
Ministan lafiya na Iran ya sanar da soke sallar Juma'a a yankunan da annobar ta shafa kuma an rufe makabarta, yayin da Saudiyya ta hana masu bautar kasashen waje da mazauna cikinta shiga wuraren ibada a Makka da Madina.
Cutar ta haifar da rikice-rikice masu yawa a cikin kalandar wasanni a duk duniya tun bayan Yaƙin Duniya na Biyu.
Yawancin manyan wasannin wasanni an soke su ko an jinkirta su, gami da gasar zakarun Turai ta 201920, Premier League ta 201920, UEFA Euro 2020, kakar NBA ta 201920 da kakar NHL ta 201920.
Cutar ta shafi shirye-shirye don Wasannin Olympics na bazara na 2020, wanda aka fara shirin fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar a ranar 24 ga Maris cewa za a "sake tsara taron zuwa kwanan wata bayan 2020 amma ba bayan bazara na 2021 ba".
Wannan ya sa yawancin 'yan wasan caca suka koma kan layi, tare da yawancin shafukan caca na kan layi suna ba da rahoton ƙaruwa mai yawa a cikin sabon adadin rajistar su.
Yawancin manyan gidajen wasan kwaikwayo kamar Broadway sun dakatar da wasan kwaikwayon.
Wasu masu fasaha sun binciko hanyoyin da za su ci gaba da samarwa da raba ayyukan ta hanyar intanet a matsayin madadin ga wasan kwaikwayon rayuwa na gargajiya, kamar su wasan kwaikwayo na raye-raye ko ƙirƙirar "bikin" na yanar gizo don masu fasaha su gabatar, rarraba da kuma gabatar da ayyukansu.
A kan layi, yawancin abubuwan da ke cikin yanar gizo game da coronavirus sun bazu yayin da mutane da yawa ke juyawa zuwa raha da nishaɗi a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, nuna kyamar baki da wariyar launin fata ga mutanen da ke da asalin kasar Sin da Gabashin Asiya, da kuma mutanen da ke da zafi a Turai, Amurka da sauran ƙasashe.
An lura da abubuwan tsoro, shakku, da rashin tausayi a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya-Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in ke cikin China) sun yi rikodin halin wariyar launin fata da aka nuna a kungiyoyi daban-daban a duniya suna cewa Sinawa sun cancanci kamuwa da cutar ko kuma karɓar abin da ake zargi da adalci.
Wasu kasashen Afirka ma sun ga karuwar halin nuna adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci bisa ga yankunan da suka fito.
Akwai tallafi ga China, a ciki da wajen layi, da kuma ga waɗanda ke cikin yankunan da cutar ta fi shafa.
Bayan barkewar cutar zuwa sabuwar kasar, mutanen da ke Italiya, kasar farko a Turai da ta fara fuskantar mummunar annobar COVID-19, suma na iya zama masu fama da rashin tabbas da kuma nuna kyamar baki.
A Japan, alamar #ChineseDontComeToJapan ta bazu a shafin Twitter.
Sinawa da sauran mutanen Asiya a Burtaniya da Amurka sun ba da rahoton yawan nuna wariya, da kuma tashin hankali.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton coronavirus a matsayin "Covid na kasar Sin", kalmar da masu sukar suka dauka a matsayin wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan bas din da ke dauke da 'yan Ukraine da kuma bakin haure daga Wuhan zuwa Novi Sanzhary.
Dalibai daga Arewa maso gabashin Indiya, waɗanda ke da iyaka da China, da kuma karatu a manyan biranen Indiya sun ba da rahoton samun rikice-rikice da suka shafi cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal Dilip Ghosh ya ce 'yan kasar Sin sun lalata muhalli kuma "wannan shine dalilin da ya sa Allah ya rama musu".
Bayan haka, ofishin jakadancin kasar Sin a Kolkata ya yi tir da wannan bayanin, yana mai cewa "ba daidai ba ne". A kasar Sin, cutar ta shafi ƙiyayya da wariyar launin fata da ke tattare da mutanen da ba Sinawa ba, tare da bayyana baƙi a matsayin "sharar baƙi" da kuma niyya don "halakawa".
Yawancin jaridu masu talla da aka biya sun fitar da shi don wasu ko duk labaran su na coronavirus.
Yawancin masu wallafa kimiyya suna samar da takardun kimiyya game da annoba da ke samuwa a cikin bude hanya.
Wasu masana kimiyya sun zaɓi raba sakamakon su nan da nan akan sabar bugawa kamar bioRxiv.
Cutar cututtuka mai tasowa  Cutar cututtuka tare da cutar da ke tasowa, yawanci sabon abu a cikin yanayin annobar ko yanayin watsawa
Duniya da cututtuka  Babban hoto na duniya da yaduwar cututtuka
Jerin cututtuka da cututtuka - Jerin yawan mutuwar cututtuka
Cinikin namun daji da cututtukan dabbobi - Hadarin kiwon lafiya da ke tattare da cinikin namun daji na waje
Gwajin dakin gwaje-gwaje don cutar coronavirus na numfashi ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa sun haɗa da hanyoyin gano kasancewar ƙwayoyin cuta da hanyoyin gano ƙwayoyin cuta da aka samar don amsawa ga kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne kawai don gano RNA na kwayar SARS-CoV-2.
Ana amfani da gwajin don tabbatar da sabuwar cuta ko kuma cutar mai aiki.
Ana iya amfani da ganowar antibody (serology) don duka ganewar asali da lura da yawan jama'a.
Gwajin rigakafi yana nuna yawan marasa lafiyar da suka kamu da cutar, gami da waɗanda alamun cutar ba su da sauƙi don bayar da rahoto ko waɗanda ba su da alamun cutar.
Yawan mutuwar cututtuka da kuma yawan rigakafi a cikin al'umma za a iya ƙaddara daga sakamakon wannan gwajin.
Sakamakon iyakancewar gwaji, har zuwa Maris 2020 babu wata ƙasa da ke da cikakkun bayanai game da yaduwar cutar a cikin yawan jama'arta.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma akwai bambance-bambance da yawa a yawan gwaje-gwajen da aka yi a ƙasashe.
Wannan bambancin zai iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama babban ƙari a wasu ƙasashe.
Ta amfani da ainihin lokacin sake fasalin kwayar halitta ta polymerase chain reaction (rRT-PCR) ana iya yin gwajin akan samfurin numfashi da aka samu ta hanyoyi daban-daban, gami da swabs na nasopharyngeal da samfurin sputum.
Ana samun hukuncin a cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi da swabs na pharynx yana da tabbaci ne kawai a farkon makon cutar.
Daga nan kwayar cutar za ta iya ɓace a cikin makogwaro yayin da take ci gaba da ninkawa a cikin huhu.
Ga wadanda suka kamu da cutar da aka gwada a cikin na biyu, a madadin haka ana iya ɗaukar samfurin daga cikin iska ta hanyar amfani da catheter na inhalation ko kuma ana iya amfani da kayan da ke haifar da tari (sputum).
An haɓaka ɗayan gwajin PCR na farko a Charité a Berlin a cikin Janairun 2020 ta amfani da ainihin lokacin jujjuyawar jujjuyawar polyemerase (rRT-PCR), kuma ya zama tushen kayan aiki 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Ƙasar Ingila ta kuma haɓaka gwajin ta 23 ga Janairu 2020. Kamfanin Kogenbiotech na Koriya ta Kudu ya haɓaka PCR-tushen, gwajin gwaji na SARS-CoV-2 na asibiti (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
Ya gano kwayar "E" da dukkan beta coronaviruses ke rabawa, da kuma kwayar RdRp da ta dace da SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka karɓi amincewar amfani da gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiyar Kasa ta China don kayan gano SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba Kwamitin Gano RT-PCR na 2019-Novel Coronavirus (2019-nCoV) na Lokaci na Gaskiya ga dakunan gwaje-gwajen kiwon lafiya ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin kayan gwajin ya haifar da sakamakon rashin tabbas saboda lalacewar reagent, da gwajin ƙyallen kwalba a CDC a Atlanta; wannan ya haifar da matsakaicin ƙananan samfurori 100 a kowace rana da aka sarrafa cikin nasara a cikin watan Fabrairun 2020;
Gwaje-gwaje masu amfani da abubuwa biyu ba za a iya tabbatar da amincin su ba har zuwa 28 ga Fabrairun 2020, kuma kafin hakan ba za a ba da izinin fara gwaje-gwaje na jihohi da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin Amincewar Amfani da Gaggawa.
Ya zuwa 5 ga Maris 2020 LabCorp ta sanar da kasancewar gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics kuma ta yi amfani da gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu iyakance adadin da aka sanar; dole ne a tattara samfuran da sarrafa su bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology ta VECTOR ta ƙasa ce ta haɓaka da samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020 ne aka yi rajistar gwajin ta Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin adadi mai yawa, tare da ba da damar injin guda ɗaya don yin gwaje-gwaje kusan 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin Abbott m2000; FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ɗin ya sami EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
Hukumar ta amince da gwajin da ke amfani da fasahar kara girman isothermal nucleic acid maimakon PCR.
Tun da wannan gwajin ba ya buƙatar jerin zafin jiki mai yawa, wannan hanya zai iya ba da sakamako mai kyau a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a cikin Amurka kuma Abbott yana sa ran hanzarta samarwa don aika gwaje-gwaje 50,000 a rana. Gwaje-gwaje waɗanda ke amfani da ƙwayoyin cuta na monoclonal waɗanda ke ɗaure musamman ga proteonucleocapsid (N protein) na sabon coronavirus ana haɓaka su a Taiwan, tare da fatan gwajin zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar yadda gwajin saurin mura yake.
A cikin Maris 2020 wani bita na rubuce-rubuce ya kammala cewa "hoto na kirji yana da ƙarancin ƙimar bincike a farkon matakin, yayin da gano CT [komputa mai kwakwalwa] na iya kasancewa tun kafin bayyanar cututtuka ta fara".
Hanyoyin CT na musamman sun hada da ƙarancin gilashin ƙasa mai yawa tare da watsawa, asymmetrical da posterior.
Dominance na subpleura, buɗewa da haɗuwa suna faruwa yayin da cutar ta ci gaba.
Wani binciken da ya kwatanta PCR da CT a Wuhan a asalin cutar ta yanzu ya ba da shawarar cewa CT ya fi PCR hankali sosai, kodayake ba shi da ƙwarewa, tare da yawancin fasalin hoton da ke aiki tare da cutar huhu da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "bai kamata a yi amfani da CT don tantancewa ko azaman gwajin farko don gano COVID-19 ba".
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da shi don gano kamuwa da cuta a cikin mutane da ke farawa kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma a cikin sa ido na yawan jama'a.
Tsarin atomatik mai zurfi a yawancin dakunan gwaje-gwaje na asibiti zai iya aiwatar da wannan kimantawa amma kasancewar sa zai dogara ne akan yawan samarwa ga kowane tsarin.
Don CLT ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurin samfurin don bin tsarin rigakafi.
Don PoCT samfurin jini guda ɗaya ana samunsa ta hanyar allura a cikin fata.
Ba kamar hanyar PCR ba ana buƙatar matakan horo kafin kimantawa.A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda ke ba da sanarwar ga hukumar kamar yadda ake buƙata kuma saboda haka yanzu suna iya rarraba gwajin rigakafin su.
Har zuwa 7 ga Afrilu 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa.A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano ƙwayoyin IgG da IgA ga ƙwayoyin cuta a cikin samfurin jini.
Gwajin gwajin yana iya ɗaukar ɗaruruwan samfurori a cikin awanni kaɗan kuma saboda haka ya fi sauri fiye da kimantawa na PCR na yau da kullun don RNA na kwayar cuta.
Ana iya gano ƙwayoyin cuta a cikin kwanaki 14 bayan kamuwa da cuta. A farkon watan Afrilu, Burtaniya ta gano cewa babu kayan gwajin ƙwayoyin cuta da aka saya da suka dace don amfani.
Hong Kong ta kafa wani tsari wanda ke ganin marasa lafiya da ake zargi za su iya zama a gida, "sashen gaggawa zai ba da bututun samfurin ga marasa lafiya", suna yi wa bututun tsami, su dawo da shi kuma su sami sakamakon gwajin ba da daɗewa ba.
Cibiyar ta taimaka wa Koriya ta Kudu ta gudanar da wasu gwaje-gwaje mafi sauri, mafi inganci fiye da sauran ƙasashe.A Jamus, Associationungiyar Kwararru ta Kwararru ta Kwararru ta Kula da Lafiya ta Dokokin Lafiya ta ce a ranar 2 ga Maris, cewa suna da ƙarfin gwaje-gwaje 12,000 a rana a cikin yanayin asibiti kuma an gwada 10,700 a cikin makon da ya gabata.
In da likita ya bukaci a yi masa gwajin, inshorar lafiya ce ke biyan kuɗin.
A cewar shugaban cibiyar Robert Koch, Jerrman tana da damar yin gwaji 160,000 a mako.
A ranar 19 ga watan Maris, an ba da gwajin tuki a manyan birane.
Har zuwa 26 ga Maris 2020 ba a san yawan gwaje-gwajen da aka gudanar a Jamus ba, saboda sakamakon tabbatacce ne kawai aka ruwaito.
Binciken farko na dakin gwaje-gwaje ya nuna cewa har zuwa makon kalandar 12/2020 aƙalla samfura 483,295 aka gwada ciki har da makon 12/2020 kuma samfura 33,491 (6.9%) sun gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a Asibitin Technion da Rambam sun haɓaka da gwada hanyar gwada samfuran daga marasa lafiya 64 a lokaci guda, ta hanyar tattara samfuran kuma kawai ci gaba da gwaji idan samfurin da aka haɗu ya tabbata.
Tare da ginin da wanda ya kafa BGI Wan Jian ya sa ido kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa shari'o'in a Hubei za su kasance da kashi 47% mafi girma kuma farashin da ya dace don gudanar da keɓewa zai ninka idan ƙarfin gwajin bai kai burin ba.
An bi labaran Wuhan da sauri ta hanyar labaran Hou Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk faɗin China.
Har zuwa 4 ga Maris 2020 jimlar yau da kullun na yau da kullun shine gwaje-gwaje 50,000 a rana. An saki wani buɗe tushen, ƙirar multiplex wanda Origami Assays ya samar wanda zai iya gwada samfura 1122 na marasa lafiya don COVID19 ta amfani da ƙididdiga 93 kawai.
Har zuwa watan Maris, karancin da kuma karancin kayan aiki sun haifar da cunkoso ga gwaji mai yawa a cikin EU da Burtaniya da Amurka.
Wannan ya sa wasu marubuta suyi bincike kan tsarin shirya samfurin wanda ya shafi dumama samfurin a 98 C (208 F) na tsawon mintuna 5 don fitar da kwayoyin RNA don ƙarin gwaji.A ranar 31 ga Maris an ba da sanarwar cewa UAE tana gwada yawancin jama'arta don Coronavirus a kowane mutum fiye da kowace ƙasa, kuma tana kan hanyar da ta dace don haɓaka matakan gwaji don isa ga yawancin jama'a.
Wannan shi ne ta hanyar hada-hadar iyawar tuki, da kuma sayen dakin gwaje-gwaje mai yawan aiki daga Group 42 da BGI (wanda ya dogara da dakin gwaje-gwaje na gaggawa "Hou-Yan" a kasar Sin)
An gina shi cikin kwanaki 14, wannan dakin gwaje-gwaje na iya gudanar da dubban gwaje-gwaje na RT-PCR a rana kuma shine na farko a duniya a wannan sikelin da za a gudanar a wajen China.
An samar da wasu gwaje-gwaje daban-daban da ke nuna sassan kwayoyin halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da tsarin Jamus na samar da kayan aiki wanda aka tura zuwa ƙasashe masu karamin kuɗi ba tare da albarkatun da za su ci gaba da kayan aikin kansu ba.
An buga hanyar Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta kasance ba har zuwa 28 ga Janairu, yana jinkirta gwajin da ke akwai a cikin Amurka. China da Amurka suna da matsala game da amincin kayan gwajin a farkon fitowarsu, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙatu da shawarwari don gwaji ta masana kiwon lafiya.
A gefe guda, masana sun ce shirye-shiryen Koriya ta Kudu na yin gwaji yana taimakawa wajen rage yaduwar cutar coronavirus.
Yawan gwaje-gwajen, mafi yawansu a cikin dakunan gwaje-gwaje masu zaman kansu, waɗanda gwamnatin Koriya ta Kudu ta gina a cikin 'yan shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin mafi kyawun hanyar rage saurin cutar ta COVID-19. Babban buƙatun gwaji saboda yaduwar kwayar cutar ya haifar da jinkirin ɗaruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da kayan kwalliya da magungunan sarrafa sinadarai ya zama iyakantacce.
A watan Maris na shekarar 2020 kasar Sin ta bayar da rahoton matsalolin da ke tattare da daidaito a cikin kayan gwajin su.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "rauni"; Gwamnati daga baya ta fitar da takunkumin hukuma wanda ya hana gwajin masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya zama sakamakon rashin tattara samfurin ko amfani da kayan aiki yadda ya kamata.
Ma'aikatar ta Spain ta ce za ta sake dawo da kayan aikin da ke dawo da sakamakon da ba daidai ba, kuma za ta maye gurbinsu da wasu kayan aikin gwaji daban-daban da Shenzhen Bioeasy ta samar.80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da ba daidai ba.
Firayim Minista Matovic ya ba da shawarar cewa a jefar da kit ɗin zuwa Danube.Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya gaya wa gwajin da Turkiyya ta saya daga China yana da "matakin kuskure mai yawa" kuma ba ta "amfani da shi".
Gwajin, wanda aka bi tare da keɓe waɗanda suka gwada tabbatacce da kuma gano waɗanda suka taɓa yin hulɗa da mutumin da ke da cutar SARS-CoV-2 a, ya ba da sakamako mai kyau.
Masu bincike da ke aiki a garin Vo na Italiya, wurin mutuwar COVID-19 ta farko a Italiya, sun gudanar da zagaye biyu na gwaji a kan mutane kusan 3,400, kusan kwanaki goma a jere.
Kusan rabin mutanen da suka gwada tabbatacce ba su da alamun cutar, kuma duk waɗanda aka gano suna cikin keɓewa.
Tare da takunkumin hana tafiye-tafiye, ya kawar da sabuwar cutar gaba daya.
Tare da binciken tuntuɓar kai tsaye, ƙuntatawa na balaguro, gwaji, da keɓewa, annobar coronavirus ta 2020 a Singapore ta yi tafiya a hankali fiye da sauran ƙasashe masu tasowa, amma ba tare da tsauraran matakan hanawa ba kamar tilasta rufe gidajen abinci da shagunan sayar da kayayyaki.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara ga jama'arta da su zauna a gida a ranar 28 ga Maris, amma za a sake buɗe makarantu a kan kari bayan hutu a ranar 23 ga Maris.
Wasu ƙasashe ma sun yi aiki da cutar ta hanyar gano lamba mai ƙarfi, ƙuntatawa na balaguro, gwaji da keɓewa, amma tare da umarnin gaggawa mara ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani binciken kididdiga ya gano cewa ƙasashe da ke yin ƙarin gwaji, dangane da yawan mutuwar, suna da ƙananan mutuwar, wataƙila saboda waɗannan ƙasashe sun fi iya gano waɗanda ke da ƙananan alamomi ko babu alamomi.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji da dakunan gwaje-gwaje na ƙasa tare da iyakantaccen ƙwarewa game da COVID-19 aika da samfuran farko biyar masu inganci da samfuran COVID-19 guda goma marasa kyau zuwa ɗayan dakunan gwaje-gwaje 16 na WHO don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka da ɗaya a Ostiraliya.
A cikin jadawalin da ke ƙasa, shafi na "Positive as % of tests" yana da tasiri ga manufofin gwaji na ƙasa.
Kasashen da ke gwada mutane kawai da aka kwantar a asibiti za su sami mafi girman sakamako mai kyau a matsayin kashi na gwaji fiye da ƙasashen da ke gwada duk mutanen da ke cikin su, ko suna da alamun cutar ko a'a, sauran sun kasance iri ɗaya.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, aikin tsabtace hannu ne wanda ke nufin kawar da datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Wanke hannaye da sabulu akai-akai a wasu "lokaci masu mahimmanci" na rana yana hana yaduwar cututtuka da yawa, misali gudawa da zawo, waɗanda ke yaduwa ta hanyar hanyar bayan gida zuwa baki.
Mutum na iya kamuwa da cututtukan numfashi kamar mura ko mura, misali, idan ba su wanke hannayensu ba kafin su taɓa idanu, hanci, ko baki (watau, mucous membranes).
Lokaci biyar masu mahimmanci a rana waɗanda ke ganin wanke hannu da sabulu suna da mahimmanci sun haɗa da: kafin da bayan zubar da ruwa mai yawa, bayan wanke bayan yara ko canza diapers, kafin ciyar da yara, kafin cin abinci da kafin da bayan shirya abinci ko sarrafa nama mai raw, kifi ko kaji.
Idan sabulu da ruwa ba su da yawa, za a iya wanke hannaye da toka.
Kafin, lokacin, da kuma bayan an shirya abinci.
Kafin da kuma bayan kula da marasa lafiya.
Bayan ka canja diaper ko kuma ka share yaran da suka yi amfani da bayan gida.
Bayan shan iska, tari ko fitsari.
Bayan taɓa dabba, abincin dabba, ko ɓarnar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi al'adun likita.
Wanke hannu kafin amfani da magani ko kula da likita na iya hana ko rage yaduwar cuta.
Babban manufar aikin wanke hannu shine tsabtace hannaye daga ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da haɗari ko cuta.
Wannan yana da mahimmanci musamman ga mutanen da ke sarrafa abinci ko aiki a fannin kiwon lafiya, amma kuma muhimmiyar aiki ne ga jama'a gaba ɗaya.
Wanke hannu yana da fa'idodi da yawa ga lafiyar jiki, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan cututtukan gudawa; rage kamuwa da cututtukan numfashi;
kuma rage yawan mutuwar jarirai a gida.
Binciken da aka yi a 2013 ya nuna cewa ingantaccen aikin wanke hannu zai haifar da karamin ci gaba a cikin girman yara a cikin shekaru biyar.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da alaƙa da cututtukan numfashi da gudawa ta hanyar gabatar da sauye-sauyen halayya masu sauƙi, misali wanke hannaye da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar mutane kusan kashi hamsin cikin ɗari.
Hanyoyin da ke gudanar da wanke hannu na iya rage cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
48% ragewar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututut
Ciwon huhu, babban ARI, shine sanadin mutuwa mafi yawa a cikin yara 'yan kasa da shekaru biyar, yana kashe kusan yara miliyan 1.8 a kowace shekara.
Ciwon ƙura da ciwon huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, al'adar wanke hannu da sabulu kafin cin abinci da bayan amfani da bayan gida na iya ceton rayuka fiye da duk wani allurar rigakafi ko magani, rage mutuwar gudawa da kusan rabi da kuma mutuwar cututtukan numfashi mai tsanani da kusan kashi ɗaya cikin huɗu.
Ana yawan hada wanke hannu da sauran ayyukan tsabtace jiki a matsayin wani ɓangare na shirin ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu zai iya karewa daga impetigo wanda aka watsa ta hanyar saduwa ta jiki.
Ƙananan sakamako mai illa na wanke hannuwan hannu da yawa shine wanke hannayen hannu da karfi zai iya haifar da lalacewar fata ta hanyar bushewa a fata.
Wani bincike daga Denmark a shekarar 2012 ya gano cewa yawan wanke hannuwa na iya haifar da ƙaiƙayi, yanayin fata mai ƙyalli da aka sani da eczema na hannu ko dermatitis na hannu, wanda ya zama ruwan dare gama gari tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta cuta mai cike da damuwa (OCD).
Akwai lokuta masu mahimmanci guda biyar a cikin yini wanda wanke hannu da sabulu yana da mahimmanci don rage watsa cututtukan ƙazanta zuwa baki: bayan amfani da bayan gida (yin fitsari, ɓoyewa), bayan tsabtace bayan yara (canza diapers), kafin ciyar da yara, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa nama mai raw, kifi ko tsuntsu.
Sauran lokutan da ya kamata a yi amfani da wanke hannu yadda ya kamata don hana yaduwar cututtuka sun haɗa da kafin da bayan kula da rauni ko rauni; bayan yin fitsari, tari, ko ɓoye hanci; bayan taɓa ƙurar dabba ko sarrafa dabba; da kuma bayan riƙe shara.
Yawan wanke hannu da sabulu yana da ƙanƙanci a yawancin ƙasashe.
A shekarar 2015, binciken wanke hannu a kasashe 54 ya gano cewa a matsakaita kashi 38.7% na gidaje suna da al'adar wanke hannu da sabulu. A shekarar 2014, binciken ya nuna Saudi Arabia tana da mafi girman kashi 97 cikin dari; Amurka tana kusa da tsakiyar kashi 77 cikin dari; da China a mafi karancin kashi 23 cikin dari.
Shirin Kula da Kiwon Lafiya na Mahimmanci wanda Ma'aikatar Ilimi ta aiwatar a Philippines misali ne na manyan ayyuka don ƙarfafa lafiyar yara da iliminsu.
Gwagwarmaya sau biyu a shekara, tare da wanke hannayenku kowace rana da sabulu, da kuma goge haƙoranku kowace rana tare da florida shine ainihin shirin na kasa.
An yi nasarar aiwatar da shi a Indonesia.
Ana iya inganta kawar da ƙwayoyin cuta daga fata ta ƙara sabulu ko kayan wanki a cikin ruwa.
Babban aikin sabulu da kayan wanki shine rage shinge a cikin maganin, da kuma kara yawan solubility.
Ruwa kadai ba shi da inganci wajen wanke fata domin kitse da furotin, da suke sashe ne na ƙasa, ba sa narkewa cikin ruwa.
Amma, idan aka samu ruwa mai kyau, zai taimaka wajen wankewa.
Saboda yanayin sake amfani da shi, sabulu mai ƙwanƙwasa yana iya adana ƙwayoyin cuta da aka samu daga amfani da shi.
Ƙananan nazarin da aka yi game da ƙwayar cuta daga sabulu mai ƙazanta ya gano cewa ba zai yiwu a yi ba saboda an kawar da kwayoyin cuta lokacin da aka wanke su da kumfa.
Cibiyar CDC ta ce "sabulu mai ruwa wanda aka fitar ba tare da amfani da hannu ba ya fi kyau".
Sabulu mai maganin cututtukan ƙwayoyin cuta yana da babban talla ga jama'a masu mahimmanci game da lafiyarsu.
Babu wata hujja da ta nuna cewa amfani da maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta yana da kyau ga kwayoyin da ke jure maganin rigakafi.
Duk da haka, sabulu na antibacterial yana dauke da wakili na yau da kullum kamar triclosan, wanda ke da jerin sunayen da suka dace da kwayoyin halitta.
Don haka, ko da yake sabulu na antibacterial ba ya zaɓar nau'in ƙwayoyin cuta masu jurewa, yana iya zama ba shi da tasiri kamar yadda aka tallata shi.
Baya ga surfactants da wakilan kare fata, waɗannan ƙwararrun ƙirar na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, antimicrobial-aiki benzoic acid da ƙarin mai ƙoshin fata (aloe vera, bitamin, bulbs, tsire-tsire na shuka).
Ruwa ba zafi ba ne don wanke hannuwanku ba kuma ba zafi ba ne don kashe kwayoyin cuta.
Kwayoyin cuta suna ninkawa da sauri a zafin jiki (37 °C).
Duk da haka, ruwan dumi mai sabulu ya fi tasiri fiye da ruwan sanyi mai sabulu don kawar da man fetur na halitta wanda ke da datti da kwayoyin cuta.
Sabanin abin da mutane da yawa ke tsammani, binciken kimiyya ya nuna cewa amfani da ruwan dumi ba shi da wani tasiri na rage ƙwayoyin cuta a hannayen.
Mai tsabtace hannu ko mai tsabtace hannu shine mai tsabtace hannu wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990s da farkon ɓangaren karni na 21, rubbing da barasa na kayan tsabtace hannu na ruwa (wanda aka fi sani da rubbing na barasa, rubbing na antiseptic, ko tsabtace hannu) ya fara zama sananne.
Yawancin su suna dogara ne akan isopropyl ko ethanol barasa wanda aka tsara tare da wakili mai kauri kamar Carbomer (polymer na acrylic acid) a cikin gel, ko humicant kamar glycerin zuwa ruwa, ko kumfa don saukaka amfani da rage tasirin bushewar barasa.
Bugu da ƙari, ƙara hydrogen peroxide mai narkewa zai ƙara haɓaka aikin antimicrobial.
Rubbing barasa yana kashe kwayoyin cuta, kwayoyin cuta masu jurewa (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza da hepatitis) da fungi.
Ruwan wankewa na giya wanda ya ƙunshi kashi 70% na barasa yana kashe kashi 99.97% (ragewa 3.5 log, daidai da raguwa 35 decibels) na ƙwayoyin cuta a hannaye 30 seconds bayan amfani da kashi 99.99% (ragewa 4 zuwa 5 log) na ƙwayoyin cuta a hannaye minti 1 bayan amfani.
Sanitizers na hannu masu amfani da giya kusan ba su da tasiri ga nau'in kwayar cutar norovirus (ko Norwalk), mafi yawan sanadin cututtukan cututtukan gastroenteritis.
Ana shafa gaban da bayan hannayen biyu da tsakanin dukkan yatsunsu na kimanin dakika 30 har sai ruwan, kumfa ko gel ya bushe.
Dole ne a wanke yatsunsu sosai, ta hanyar shafa su a kan dabino biyu. Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka sun ba da shawarar wanke hannaye fiye da shafawa da tsabtace hannu, musamman idan hannaye suna da datti.
Ana amfani da wannan wakili da yawa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta.
Amfani da tsabtace hannu na giya akai-akai na iya haifar da bushewar fata sai dai idan an ƙara emollients da/ko moisturizers a cikin tsari.
Za a iya rage ko kawar da tasirin barasa ta hanyar ƙara glycerin da / ko wasu emollients zuwa tsari.
A cikin gwajin asibiti, tsabtace hannu na giya wanda ya ƙunshi emollients ya haifar da raguwa mai yawa a cikin damuwa da bushewa a kan fata fiye da sabulu ko kayan tsabtace cututtuka.
Allergic contact dermatitis, contact urticaria syndrome ko kuma rashin jin daɗin shan barasa ko ƙarin abu a cikin rubbing hannu mai shan giya ba safai ba.
Yawanci yana da kyau don rage cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Duk da cewa ba ruwa ba ne, amma yana da tasiri sosai, ba ya wanke hannuwanku daga kwayoyin halitta.
Wannan shine dalilin da ya sa tsabtace hannu ba shi da tasiri kamar sabulu da ruwa don hana yaduwar cututtuka da yawa, saboda har yanzu akwai cututtukan cututtuka a hannu.
Ingancin tsabtace hannu mara amfani da giya ya dogara sosai da kayan aikinta da tsari, kuma a tarihi sun kasance marasa nasara fiye da barasa da rubbing barasa.
A kwanan nan, an nuna cewa abubuwan da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial bayan amfani, ba kamar barasa ba wanda aka nuna cewa yana da tasiri bayan amfani da yawa, mai yiwuwa saboda rashin dacewar fata a hankali.
Yawancin mutane masu karamin karfi ba za su iya samun sabulu ba, maimakon haka suna amfani da toka ko ƙasa.
Ƙura ko ƙasa na iya zama mafi tasiri fiye da amfani da ruwa kawai amma yana iya zama ƙasa da sabulu.
Akwai damuwa idan ƙasa ko toka sun gurɓata da ƙwayoyin cuta waɗanda zasu iya haɓaka maimakon rage yaduwar cuta.
Ash kuma yana da kayan aikin kashe kwayoyin cuta kamar sabulu saboda yana samar da maganin alkaline idan ya zo cikin ruwa.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan sabulu bai samu ba.
Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar hanyoyin wanke hannu da kyau don hana yaduwar cuta sun haɗa da waɗannan matakan:
Hannun rigar ruwa mai zafi ko sanyi.
Ana ba da shawarar ruwan da ke gudana saboda wanka mai tsayawa na iya zama mai ƙazanta, a lokaci guda zafin ruwan ba ze da tasiri.
Wanke hannayenka yayin shafa su da sabulu mai yawa, gami da bayan hannunka, tsakanin yatsunsu, da ƙarƙashin ƙusoshinka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan suna amfani da sabulu fiye da ruwa kawai.
Aƙalla na ɗan lokaci.
Ƙarfafawa yana haifar da motsi, wanda ke taimakawa wajen kawar da kwayoyin daga fata, kuma ƙarawa da yawa yana kawar da kwayoyin.
Ka wanke shi da ruwa mai gudãna.
Yin wanka a cikin wanka zai iya sake gurɓata hannayenku.
Ka bushe shi da tawul mai tsabta ko ka bar shi ya bushe.
Hannun da ke cikin ruwa da danshi suna da saukin sake zama datti. babban yatsu, wuyan hannu, tsakanin yatsunsu da ƙarƙashin ƙusoshin yatsunsu sune wuraren da ba a kula da su koyaushe.
Ƙwayoyin ƙwayoyin cuta suna iya kasancewa a cikin ƙusa da aka cire.
Ana ba da shawarar yin amfani da kayan shafawa don hana hannayen su bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Akwai zaɓuɓɓuka masu sauƙi don sauƙaƙe wanke hannu idan babu ruwan famfo da/ko sabulu, watau zuba ruwa daga kwanon rufi ko kwanon rufi tare da ramuka masu dacewa da/ko amfani da toka idan ya cancanta a ƙasashe masu tasowa. Idan wadatar ruwa ta iyakance (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai mafita mai amfani da ruwa kamar "bututun tip" da sauran zaɓuɓɓuka masu arha.
Bututun bututu fasaha ce mai sauƙi wacce ke amfani da jag wanda aka rataye da igiya, da kuma lever da ƙafafun ke sarrafawa don zuba ruwa kaɗan a hannu da sabulu.
Wani muhimmin ɓangare na aikin tsabtace hannu shine bushe hannu mai inganci, amma akwai muhawara game da wane nau'i ne mafi inganci na bushewa a cikin gidan wanka na jama'a.
Yawancin bincike sun nuna cewa takarda mai tsabtace hannu yana da tsabta fiye da na'urar busar hannu ta lantarki da ke cikin yawancin dakunan wanka.
A shekara ta 2008, wani bincike da Jami'ar Westminster, London ta yi, kuma masana'antar takarda ta tallafawa, wato taron Turai na Tissue, ya kwatanta yadda tsabta take idan aka yi amfani da takarda takarda, busar hannu mai dumi da kuma busar hannu mai iska mai zamani.
Bayan wankewa da bushe hannaye da busar iska mai dumi, adadin kwayoyin cuta a ƙasan yatsunsu ya karu da kashi 194% kuma a cikin dabino da kashi 254%.
Drying tare da na'urar busar iska ta haifar da karuwar adadin kwayoyin cuta a ƙananan yatsunsu a matsakaita na 42% kuma a kan dabino na 15%.
Bayan wankewa da bushe hannuwanku da tawul ɗin takarda, adadin ƙwayoyin cuta a ƙasan ƙarshen ƙarshen an rage su da kashi 76% kuma a kan hannayen hannu da kashi 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don sanin ko yiwuwar gurɓatawar gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbata
Jirgin iska mai bushewa, wanda ke fitar da iska daga cikin na'urar a saurin saurin 180 m/s (650 km/h; 400 mph), yana iya fitar da ƙwayoyin cuta daga hannayen da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar busar hannu mai iska mai zafi yana yada ƙwayoyin cuta har zuwa mita 0.25 daga na'urar busar.
Takardar takarda ba ta nuna yaduwar kwayoyin cuta ba. A shekara ta 2005, wani binciken da TÜV Produkt und Umwelt ya yi ya kimanta hanyoyin bushewa na hannu daban-daban.
An sami waɗannan canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannu:
Akwai masana'antun masu bushewa da yawa, kuma sun kwatanta su da takarda takarda don bushewa.
Wanke hannuwanka da tawul din tsabtace hannu ya zama wani zaɓi na musamman yayin tafiya lokacin da sabulu da ruwa ba su samuwa.
Masu wanke hannu da barasa dole ne su ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu don magani ya daɗe da zama wajibi lokacin da likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a cikin 1846) wajen hana cututtuka a cikin yanayin asibiti.
Akwai na'urar lantarki da ke gargadi ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa amfani da shi na iya rage yawan kamuwa da cuta.
Wanke hannuwanku a cikin likita na aƙalla dakika 15, ta amfani da sabulu da ruwa da yawa ko gel don tausawa da shafa kowane ɓangaren hannu.
Hannun da aka shafa tare da yatsun da aka saka a cikin kuskure.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goga mai gashi don kawar da shi.
Tun da ƙwayoyin cuta na iya kasancewa cikin ruwa a hannayenmu, muna bukatar mu wanke su sosai kuma mu shafa su da tsabtace tawul.
Bayan bushe hannayenku, ana buƙatar amfani da tawul ɗin takarda don rufe ruwa (kuma buɗe ƙofar idan ya cancanta).
Wannan yana hana hannayenku sake zama datti idan kun taɓa farfajiya.
Wanke hannu a cikin yanayin kiwon lafiya yana nufin kawar da ƙwayoyin cuta ("kwayoyin cuta") da hana su yadawa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu a kai a kai yana kan matakin da ba za a iya karɓa ba a yawancin wuraren kiwon lafiya, tare da yawancin likitoci da ma'aikatan jinya da ke mantawa da wanke hannayensu kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan kamuwa da cututtukan jini da ke da alaƙa da catheter da kashi 66 cikin ɗari.
Ana kuma samun shawarwari game da tsabtace hannu ta hanyar wannan ƙungiyar a shafin yanar gizon don ra'ayoyin jama'a.
An yi nazarin nazarin da ya dace da Whitby et al.
Na'urorin kasuwanci na iya aunawa da tabbatar da tsabtace hannu, idan ana buƙatar nuna bin ƙa'idodin ƙa'idodi.
Hukumar Lafiya ta Duniya tana da "Lokaci Biyar" na wanke hannu:
bayan an fallasa shi zuwa jini/ruwan jiki
kafin aikin aseptic, da kuma
Bayan kula da marasa lafiya. Ƙarin sinadarai masu maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Irin wannan kisa na iya zama mai so kafin yin tiyata ko a cikin yanayin da kwayoyin cuta masu jurewa sun yadu sosai. Don 'wanke' hannun mutum don tiyata, ana buƙatar bututu wanda za'a iya kunnawa da kashewa ba tare da taɓa hannayen ba, wasu chlorhexidine ko iodine washes, tawul mai tsabta don bushe hannayen bayan wankewa, da kuma goga mai tsabta don shafawa da sauran kayan aikin tsabta don tsabtace ƙarƙashin ƙusa.
Duk kayan ado dole ne a cire.
Wannan hanya tana buƙatar wanke hannayenku da ƙafar hannu zuwa gwiwoyi, yawanci 2-6 minti.
Ba a buƙatar tsawon lokacin shafawa (minti 10).
Lokacin wankewa, dole ne a hana ruwa a cikin ƙananan hannu daga komawa hannun.
Bayan an gama wanke hannuwan, an bushe hannayen da zane mai tsabta kuma an sa rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da marasa lafiya.
Don sarrafa cututtukan staph a asibiti, an gano cewa mafi girman fa'idar wanke hannu ya zo daga farkon 20% na wankewa, kuma an sami ƙarin fa'idodi kaɗan lokacin da yawan wanke hannu ya ƙaru sama da 35%.
Wankewa da sabulu na yau da kullun yana haifar da fiye da sau uku na yawan cututtukan cututtukan da aka watsa zuwa abinci fiye da wankewa da sabulu na antibacterial. Kwatanta shafa hannuwan da maganin barasa tare da wanke hannuwan da sabulu na antibacterial na tsawon sakan 30, kowannensu ya nuna cewa shafa hannuwan da barasa yana rage gurɓatar ƙwayoyin cuta da kashi 26% fiye da sabulu na antibacterial.
Amma sabulu da ruwa sun fi tasiri fiye da shafa hannu da barasa don rage kwayar cutar mura A H1N1 da kuma spores na Klostridium difficile daga hannaye.
Akwai bukatar karin bincike kan irin maganin da zai fi dacewa a wurare daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu an yarda da su azaman kayan aiki mai tsada da mahimmanci don cimma kyakkyawan lafiya, har ma da ingantaccen abinci.
Koyaya, rashin wadatar ruwa, sabulu ko kayan wanke hannu a gida, a makarantu da wuraren aiki ya sanya ƙalubalen cimma halin wanke hannu a duniya.
Misali, a yawancin yankunan karkara na Afirka, bututun wanke hannu kusa da kowane gidan wanka na jama'a da na masu zaman kansu ba safai ba, duk da cewa akwai wadatattun hanyoyin da za a gina tashoshin wanke hannu.
Koyaya, ƙananan yawan wanke hannu na iya zama saboda ƙarancin sabulu ko ruwa.
Talla da kuma ba da shawara don wanke hannu da sabulu na iya tasiri ga yanke shawara na siyasa, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da haifar da canjin halayyar al'umma na dogon lokaci.
Don wannan ya yi aiki yadda ya kamata, dole ne a yi sa ido da kuma kimantawa.
Binciken da aka yi na nazarin bincike 70 ya gano cewa hanyoyin da ke cikin al'umma suna da tasiri wajen inganta wanke hannu a cikin LMIC, yayin da kamfen tallan zamantakewar ba su da tasiri sosai.
Lokacin da aka cimma daidaitattun ka'idoji, makarantar zata iya motsawa daga daya zuwa ƙarshe taurari uku,
Samar da tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin inganta wanke hannu da ake yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke kokarin canza dabi'u.
Wasu nazarin sun yi la'akari da tasirin farashin wanke hannu gaba ɗaya a cikin ƙasashe masu tasowa dangane da DALY.
Amma wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi tsada fiye da sauran hanyoyin ruwa da tsaftacewa.
Muhimmancin wanke hannu ga lafiyar ɗan adam  musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye da suka haifi jariri ko sojoji da suka ji rauni a asibiti  an fara gane su ne a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Forence Nightingale, "wanda ya kafa aikin jinya na zamani" na Ingila.
A lokacin mutane da yawa sun yi imani cewa cutar ta samo asali ne daga ƙazamin wari da ake kira miasmas.
A cikin shekarun 1980, cututtukan da ke tattare da abinci da cututtukan kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su kara inganta tsabtace hannu a matsayin wata hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Cutar mura ta alade a cikin 2009 da cutar COVID-19 a cikin 2020 sun haifar da haɓaka wayar da kan jama'a a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kanku daga irin wannan cutar mai yaduwa.
Alal misali, ana saka hotunan "daidai wanke hannu" kusa da wankin wanke hannu a bayan gida da kuma bayan gida a ofisoshin gwamnati da kuma filayen jirgin sama a Jamus.
Kalmomin "wanke hannun mutum daga" wani abu, yana nufin bayyana rashin yarda mutum ya dauki alhakin wannan abu ko kuma ya shiga cikin wannan.
Ya samo asali ne daga ayar Littafi Mai-Tsarki a cikin Matta lokacin da Pontius Bilatus ya wanke hannunsa daga yanke shawarar gicciye Yesu Kiristi, amma ya zama magana tare da amfani da yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na wanke ta da wani abu mai ban mamaki, wanda ke wakiltar jin laifinta game da laifin da ta aikata kuma wanda ta rinjayi mijinta ya aikata.
An gano cewa mutane, bayan tunawa ko sake tunani game da rashin da'a, suna iya wanke hannayensu sau da yawa fiye da sauran mutane kuma suna daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba su damar wanke hannayensu bayan irin wannan tunani ba su da wataƙila su shiga cikin wasu ayyukan "wanke" na biyan kuɗi, kamar yin aikin sa kai.
Addini ya tsara wanke hannu don dalilai na tsabta da alama. Wanke hannu a alamance, ta amfani da ruwa ba tare da sabulu don wanke hannu ba, wani ɓangare ne na al'adar wanke hannu da aka samu a addinai da yawa ciki har da addinan Baha'i, Hindu, Tivila da netilat yadayim a addinin Yahudanci, Lavabo a addinin Kirista da Wudhu a addinin Musulunci. Addini kuma ya tsara wanke hannaye masu tsabta musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun umurci mutum ya wanke hannayensa bayan ya shiga bayan gida.
Addinan Hindu, Buddha, Sikh, Yahudanci da Musulunci ma sun bukaci wanke hannu kafin da kuma bayan cin abinci.
Kula da haɗarin COVID-19 a wuraren aiki
Kula da haɗarin wurin aiki don COVID-19 shine aikace-aikacen hanyoyin kiwon lafiya da aminci na aiki don kula da haɗari don hana cutar coronavirus ta 2019 (COVID-19).
Kula da haɗarin aiki daidai ya dogara da wurin aiki da aikin aiki, bisa la'akari da kimanta haɗarin ga tushen haɗari, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya fuskantar kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Kiwon Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki, wanda a ciki mahimman matakan rigakafin kamuwa da cuta sun haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi, da kiyaye tsaftace-tsare na yau da kullun da kuma kashe ƙwayoyin cuta a wuraren aiki.
Ayyukan da ke da haɗarin haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar hulɗa da mutane da ba a sani ba ko ake zargi da COVID-19, amma ana iya kamuwa da su saboda yaduwar al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali sun haɗa da iska ta amfani da matattarar iska mai inganci, masu hana hancin, da kuma samun kayan kariya na mutum idan sun haɗu da mutanen da ke da cutar COVID-19.
OSHA ta ɗauki ma'aikatan kiwon lafiya da gidajen gawa da ke fuskantar mutanen da aka sani ko ake zargi da COVID-19 a matsayin masu haɗarin haɗari, wanda ke ƙaruwa zuwa haɗarin haɗari mai girma idan ma'aikaci ya yi aikin samar da aerosol a kan, ko tattara ko sarrafa samfuran daga mutanen da aka sani ko ake zargi da kamuwa da COVID-19.
Kula da haɗari masu dacewa ga waɗannan ma'aikata sun haɗa da kulawar injiniya kamar ɗakunan iska tare da matsin lamba mara kyau da kayan aikin kariya na mutum wanda ya dace da aikin aiki.
Cutar COVID-19 na iya haifar da wasu tasiri a wuraren aiki.
Ma'aikata za su iya yin rashin aiki saboda rashin lafiya, kula da wasu ko tsoron haɗari.
Hanyoyin kasuwanci na iya canzawa, duka dangane da kayan da aka nema, da kuma yadda ake samun waɗannan kayan (kamar siyayya a waje da lokacin aiki ko ta hanyar sabis na isarwa ko tuki).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ke shafar ƙasa kai tsaye na iya zama cikin matsala. Shirye-shiryen kamuwa da cuta da shirye-shiryen amsawa za a iya amfani da su azaman jagorar matakan kariya.
Shirin yana magance matakan haɗari dangane da wurare daban-daban na aiki da ayyukan aiki ciki har da tushen haɗari, abubuwan haɗari da ke tasowa daga gida da kuma yanayin al'umma, da kuma abubuwan haɗari na kowane ma'aikaci kamar tsufa ko yanayin rashin lafiya.
Ya kuma bayyana matakan da ake buƙata don magance waɗannan haɗarin, da kuma shirin gaggawa don yanayin da cutar za ta iya haifar.
Shirye-shiryen shirye-shirye da kuma amsawa ga cututtukan cututtuka na iya zama batun shawarwarin shirin ƙasa ko na ƙasa.
Manufofin mayar da martani ga annobar sun haɗa da rage yaduwar cutar a tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan cututtuka, ci gaba da gudanar da kasuwanci, da rage tasirin tasirin tasirin wasu abubuwa a cikin sarkar samar da su.
Cutar ta yi yawa a cikin al'ummomin da kasuwancin ke aiki kuma hakan ya shafi yadda ake amsawa.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a cikin lafiyar aiki da lafiya don rarraba kula da haɗari bisa ga tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, iko mafi inganci shine sarrafa injiniya, sannan sarrafa gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin haɗari ba tare da dogaro da halayyar ma'aikata ba, kuma yana iya zama mafi kyawun mafita don aiwatarwa.
Gudanar da gudanarwa shine canji a cikin manufofin aiki ko hanyoyin da ke buƙatar aikin ma'aikaci ko mai aiki.
Kayan kare kai (PPE) ana ganin basu da tasiri sosai kamar na injiniya da kula da gudanarwa amma suna iya taimakawa hana wasu fallasa.
Duk nau'ikan PPE dole ne a zaɓa bisa haɗarin ma'aikaci, a haɗa su daidai gwargwadon dacewa (watau masu numfashi), a sa su daidai a kan daidaito, a bincika su koyaushe, a kiyaye su kuma a maye gurbinsu, idan ya cancanta, kuma a cire su da kyau, a tsabtace su kuma a adana su ko a zubar da su don hana gurɓata.
A cewar Hukumar Kula da Lafiya da Kiwon Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da iyakancewar aikin aiki tare da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta na asali da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannaye akai-akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi ciki har da rufewa lokacin tari da hancinsa, samar da tawul da kwandon shara, shirya don aiki ta waya ko sauye-sauye idan ya cancanta, ba ƙarfafa ma'aikata su yi amfani da kayan aikin wasu ko kayan aiki, da kiyaye tsaftacewa da tsabtace aikin yau da kullun.
Ganowa da kuma ware mutane masu saurin kamuwa da cutar yana da matukar muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi su zauna a gida har sai sun sami sauƙi daga zazzabi, alamun zazzabi ko wasu alamun aƙalla awanni 24 ba tare da shan maganin rage zazzabi ko maganin canza wasu alamun ba, da kuma manufofin rashin lafiya masu sassauƙa, suna ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma ma'aikata sun san wannan manufar.
A cewar OSHA, ayyukan haɗarin haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar hulɗa sau da yawa ko kusanci a cikin ƙafa shida (1.8 m) daga mutanen da ba a san su ba ko kuma ake zargin suna da cutar COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma da ke faruwa a kusa da wurin kasuwancin, ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa zuwa wurin da ke da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke da hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a da wasu manyan wuraren sayar da kayayyaki. Kulawa na injiniya don waɗannan rukunin da kuma rukunin haɗarin haɗari sun haɗa da shigar da matattarar iska mai inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar masu kariya ta filastik da sanya tagogin direba don sabis na abokin ciniki. Kulawa na gudanarwa don waɗannan rukunin da rukunin haɗarin haɗari sun haɗa da ƙarfafa rukunin ma'aikata marasa lafiya su zauna a gida, maye gurbin taron fuska da fuska da sadarwar kama-da-wane, ƙirƙirar juzu'i na lokaci-lokaci, dakatar da balaguron da ba su da mahimmanci tare da annobar COVID-19 mai gudana, haɓaka tsarin sadarwa na gaggawa gami da ma'aikata dandalin tattaunawa don amsa damuwa, samar da ma'aikata tare da ilimi da horo na yau da kullun game da abubuwan haɗarin COVID-19 da halayyar sutura, horar da ma'aikata masu amfani da tufafi da kayan kariya game da yadda za su yi amfani da su, da ƙarfafa kula da yanayin sirri, ƙila ta hanyar samar da takamaiman aiki na yau da kullun, sanya takunkumin rufe fuska ko wasu hanyoyin kariya ga abokan ciniki, ko masu aiki da ke buƙatar samun damar yin aiki, rufe fuska, fuska da fuska, da sauran matakan da suka shafi COVID-19 da wasu hanyoyin haɗari.
Ma'aikata a cikin wannan rukunin haɗari ba sa buƙatar yin amfani da kayan numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mutumin da ke rashin lafiya daga wasu a nesa da ƙafa 6, sanya ma'aikaci don kula da mutumin da ke rashin lafiya, da ba da abin rufe fuska ga mutumin da ke rashin lafiya ko kuma tambayar mutumin da ke rashin lafiya ya rufe baki da hanci da zane lokacin da yake tari ko hancinsa.
Ma'aikatan jirgin za su sa safar hannu na likita na yau da kullun yayin kula da matafiya marasa lafiya ko taɓa ruwa na jiki ko abubuwan da ke iya gurɓata, kuma wataƙila ƙarin kayan kariya idan matafiya marasa lafiya suna da zazzabi, tari mai ɗorewa ko wahalar numfashi.
Gloves da sauran kayan sawa da ake zubar dasu dole ne a zubar dasu a cikin jakar biohazard, kuma dole ne a tsabtace da kuma tsabtace wuraren da aka gurbata bayan haka.
A mafi kyau, ya kamata a yi bin diddigin likita a cikin ɗakunan mutane masu keɓewa.Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutumin da ya kamu da cutar ya kasance a cikin ginin makarantar ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙananan zuwa matsakaiciyar yaduwar al'umma, ana iya aiwatar da dabarun nisantar zamantakewa kamar soke ziyarar filin, taro da sauran manyan tarurruka kamar ilimin motsa jiki da azuzuwan mawaƙa ko cin abinci a cafeteria, ƙara sarari tsakanin tebur, lokutan isowa da dawowa, iyakance baƙi marasa mahimmanci, da amfani da wuraren ofisoshin kiwon lafiya daban don yara masu alamun mura.
Lokacin da akwai babban kamuwa da cuta a cikin al'ummomin gida, ban da dabarun nisantar da jama'a, ana iya yin la'akari da tsawaita dakatar da makaranta.
Jami'an tilasta bin doka da dole ne su yi hulɗa da mutanen da aka tabbatar ko ake zargi da COVID-19 ana ba da shawarar su bi ƙa'idodin kamar na masu aikin likita na gaggawa gami da kayan kariya na sirri.
Idan kusanci ya faru yayin kamawa, ma'aikata su tsabtace da kuma cire belinsu da kayan aikin su kafin sake amfani da su tare da feshi ko tsabtace gida, kuma su bi ƙa'idodin aiki na yau da kullun don rufewa da zubar da PPE da aka yi amfani da su da kuma sanyawa da wanke tufafi.
OSHA ta ɗauki ma'aikatan kiwon lafiya da gidajen gawa suna cikin babban ko babban haɗarin haɗari.
Ayyukan haɗari masu haɗari sun haɗa da isar da kiwon lafiya, tallafi, dakunan gwaje-gwaje da ma'aikatan jigilar kayayyaki waɗanda ke da haɗari ga sanannun ko masu cutar COVID-19.
Yana da haɗarin haɗari sosai idan ma'aikata suka yi aikin samar da aerosol a kan, ko tattara ko sarrafa samfurori daga sanannun ko masu cutar COVID-19.
Hanyoyin samar da kayan aiki sun hada da intubation, hanyoyin da ake amfani da su don yin tari, bronchoscopy, wasu hanyoyin da za a yi da kuma binciken hakori, ko kuma tattara samfurori.
Ayyukan gidan gawawwakin haɗarin haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da aka sani ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; yana da haɗarin haɗari sosai idan sun yi autopsies. Ƙarin sarrafa injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don mutanen da aka sani ko ake zargin suna da cutar COVID-19, gami da lokacin da aka yi aikin samar da aerosol.
Aikin iska tare da matsin lamba mai mahimmanci zai iya zama dacewa a wasu wuraren kiwon lafiya da gidajen gawa.
Ya kamata a kula da samfurin tare da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya da za a shigar da su a keɓe su zuwa wuraren jira daban-daban dangane da ko sun kasance masu cutar COVID-19 da ake zargi. Baya ga PPE, OSHA ta ba da shawarar masu yin aiki a nisan ƙafa 6 daga marasa lafiya da aka sani, ko ake zargi, da cutar SARS-CoV-2, da waɗanda ke yin aikin samar da aerosol.
A cikin Amurka, N95 mai tace fuska mai numfashi wanda aka amince da NIOSH ko mafi kyau dole ne a yi amfani dashi a cikin mahallin cikakken tsari da rubutaccen shirin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo da gwajin likita.
Sauran nau'ikan na'urorin numfashi na iya ba da kariya mafi girma da haɓaka jin daɗin ma'aikata. WHO ba ta ba da shawarar suturar rufewa ba saboda COVID-19 cuta ce ta numfashi wacce ba ta yaduwa ta ruwa na jiki.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga ma'aikatan da ke kula da shiga da fita.
Ga waɗanda ke karɓar samfurin numfashi daga, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da hanyoyin samar da aerosol ba, WHO ta ba da shawarar rufe fuska, fuska, ko idanu, rigunan kariya da safar hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko respirator FFP2.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatun PPE ta hanyar telehealth, shinge na zahiri kamar taga mai haske, ta hanyar ba da damar waɗanda ke cikin kulawa ta kai tsaye don shiga ɗakin marasa lafiya na COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman ayyuka, ci gaba da amfani da kayan numfashi iri ɗaya ba tare da cire su ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, da kuma hana amfani da abin rufe fuska ga mutane marasa alamun cutar.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
A ina: Dukan ma'aikatan Wikimedia Foundation
TAMBAYA: [Covid-19] Rage nauyi da shirya don nan gaba
Ranar da aka ƙaddara: 14 ga Maris, 2020, 00:24 UTC
Ba a kiyaye haƙƙin mallaka ba
Mun sami kanmu cikin yanayi na musamman wannan watan.
Cutar COVID-19 wani abu ne da ya nuna yadda muke da alaƙa a duniya da kuma alhakin da muke da shi ga juna.
Ba mu taɓa fuskantar irin wannan ƙalubalen ba, amma mun san cewa mafi kyawun amsarmu ta dogara ne da irin tausayi, haɗin kai da kuma gina al'umma a tsakiyar wannan ƙungiyar.
Abokantaka da kuma kulawar da muka gani a tsakanin abokan aikinmu ta hanyar imel, tarho da kuma tattaunawa ta kai tsaye, tabbaci ne mai ban mamaki na mutane masu ban mamaki da muka yi sa'a da za mu yi aiki tare.
Ina godiya da kuma alfahari da kasancewa abokin aikinku.
A makon da ya gabata, wasu mutane sun gaya mini yadda suke godiya ga aikin da muke yi.
Wannan ya tunatar da ni yadda ma'anar duniya ta kasance a yau lokacin da aka ambaci Wikipedia, da kuma yadda ta zama alama mai ƙarfi saboda wannan mahimmin kayan aiki ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ya sa duk wannan ya yiwu, ko kuna kiyaye shafin yanar gizonku ko biyan abokan aikinku ko kuma kiyaye al'ummarmu lafiya.
Duniya na bukatar bayanan da Wikipedia ke bayarwa, musamman a wannan lokaci.
Wannan lokaci ne wanda ba kawai abin da muke yi ba amma yadda muke yi, zai haifar da tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da kuke takawa, za mu yi wasu canje-canje masu mahimmanci ga yadda muke aiki tare, daga mako mai zuwa.
Yadda za mu daidaita ayyukanmu da jadawalinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A cikin tattaunawar, mun yi la'akari da abin da muke tsammanin zai zama amsa mai dacewa da abin da muke fuskanta da kuma hanya mafi kyau don tabbatar da cewa wannan ƙungiyar ta ci gaba a wannan lokacin.
Tare, muna son kawar da damuwa da tallafawa aikinmu na dogon lokaci.
Idan kana bukatar ka rage gudu kadan, ba matsala.
Ga dukkan ma'aikata, masu kwangila da ma'aikatan kwangila:
Aƙalla, aikinmu na yau da kullun zai kasance kusan awanni 4 a rana ko 20 a mako har sai an sanar da mu.
Ba mu sanar da hutu - idan za ka iya aiki a kan al'ada hours, da manufa iya amfani da ku.
Duk da haka, duniya ta yau ba ta da tabbas. Ko kuna kula da ƙaunatattunku, sayen kayan abinci ko ganin likita, lafiyarku ita ce fifiko.
Ba za mu rubuta your lokaci.
Idan kana da rashin lafiya, kada ka yi aiki.
Ba a gaya masa ba, amma mun gaya masa.
Babu bukatar ranar rashin lafiya ko PTO - kawai ka sanar da manajanka kuma ka taimaka wa ƙungiyarka ta sake duba kalandarku da jadawalin don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano ku da cutar COVID-19, ku sanar da Bryan a cikin T&C Ops don T&C su iya taimaka muku da tallafi da tabbatar da cewa an kula da yanayinku yadda ya kamata daga gudanarwa).
Waɗanda ake biyan su a kan sa'a za a biya su a kan kari.
Mun sanar da kuma tabbatar da mu sadaukar da girmama mu dan kwangila alkawari da ma'aikatanmu ma'aikatan da aka biya da sa'a.
Kowa zai sami albashi bisa ga yawan sa'o'in da ya yi a al'ada.
Wannan ya haɗa da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana so ka yi aiki, muna goyon bayan ku.
Mutane da yawa suna amfani da aikinsu don su kawar da damuwarsu daga duniyar da ke kewaye da su.
Abin da muke yi zai iya sa mu farin ciki, musamman a irin wannan lokaci.
Bugu da ƙari, wannan game da kula da kanka.
Abin da kawai muke roƙonku ku yi magana da manajanku don mu san abin da za mu yi tsammani kuma mu daidaita shi yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole mu ci gaba da tafiya.
SRE, HR Ops, Trust & Security, da kuma Rukunin Tallafin Kuɗi (da sauransu) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu da kuma mayar da hankalinmu kan tallafawa abin da ke da mahimmanci ga aikinmu.
Muna da ayyuka da yawa da za mu yi, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Saurin tafiya yanzu ba zai cutar da mu ba.
Ba mu da niyyar yin "biyu sau biyu don kama abin da aka bari" da zarar annobar ta wuce.
Ba za a bukaci ku yi aiki na tsawon lokaci ba don ku cika wa'adin da ba zai yiwu ba.
Mun san cewa yanayi ya sauya, kuma za mu yi kokarin kafa sabon manufa da kuma lokaci idan ya cancanta.
Me ya faru da APP?
Don daidaitawa da ainihin gaskiyarmu da tsammanin lokutan aikinmu na yau da kullun, muna son daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Muna fatan bayar da shawarar tsawaita shirin 2019-2020 wanda zai ba da ƙarin lokaci don kasafin kuɗi don ba ma'aikata damar ba da fifiko ga aiki mai mahimmanci, kula da kansu da kula da ƙaunatattun su yayin taimaka wa waɗanda suke buƙatar ko so su yi aiki tare da rage lokacin aiki na makonni masu zuwa.
Tsarin lokaci mai tsawo yana rage yawan aiki da damuwa na shirin yau da kullun a cikin ƙungiya.
Za mu gabatar da shawarwarinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilanmu da tawagarmu game da matakan da za mu bi idan muka samu tabbaci.
Na gode wa APP tawagar a kan your jagoranci a cikin wannan.
Matsayin ofishi, fallasa da tsaftacewa
A makon da ya gabata, an sanar da mu cewa ɗaya daga cikin abokan aikinmu na SF na iya kamuwa da cutar COVID-19.
Amma don taka tsantsan, mun ɗauki ƙungiyar tsabtace rigakafi don kawar da ƙwayoyin cuta a duk wuraren da muke a ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar asibiti don kashe kowace hanya da kuma kofar shiga da kuma tsarin hawa da ke zuwa bene.
Ginin ya ɗauki ladabi na musamman na aikin kulawa don amfani da samfuran da ke tallafawa amincin mazaunan.
Mun ji dadi cewa ofishin zai zama da samuwa a lokacin da muka yanke shawarar komawa.
Ofishinmu na D.C. yana cikin WeWork, wanda ke raba ƙa'idodin COVID-19 tare da mu da kuma duk ma'aikatanmu da ke D.C.
A makon da ya gabata ne ofishinmu na D.C. ya koma shirye-shiryen nesa daidai da jagororin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aiki na da ke New York suka sani, mun kuma tattauna batun sayen wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta ta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aiki na nesa na dogon lokaci mun san cewa zai iya zama daidaitawa kuma muna so mu ba ku wasu shawarwari:
Ka rage lokacin taron zuwa awa ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi la'akari da yadda za ka raba shi zuwa kwanaki da yawa.
Ka tsara taron da kyau, ka tsara jadawalin taron kuma ka aika da littattafan da za ka karanta a gaba.
Ka ƙirƙiri bidiyo ta hanyar tsoho, ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da kuma haɗin kai tsaye.
Da wani shugaban da zai kula da kowane taro, wani don saka idanu kan tattaunawa don tambayoyi da kuma bin diddigin jerin masu magana, kuma wani don taimakawa wajen yin rubutu (ko yin rubutu tare).
Aika da imel zuwa goyon bayan fasaha idan kana bukatar wani m headphone.
Yi amfani da kuɗin da kake biya don abinci mai sauƙi.
Shiga cikin Slack ta hanyar #remoties don tattaunawa da abokan aikinka game da ayyukan da aka ba ku
Kungiyar ayyukan HR tana duba jagororin yanar gizo na ergonomics don tallafawa ci gaban ayyukan da aka rarraba a duk faɗin Gidauniyar.
A cikin 'yan makonnin nan mun nemi duk masu karɓar tallafin al'umma da su soke duk wani taron jama'a da Wikimedia ke tallafawa, kamar editaton har sai WHO ta sanar da ƙarshen annobar.
Mun sanar da su cewa mun fahimci buƙatarmu don sokewa da sauran ƙuntatawa na iya zama wani abu da ba zai yiwu ba wajen kammala ayyukan tallafin da suka amince da su kuma ba za a ɗauki mataki ba saboda jinkiri ko sauya waɗannan manufofin.
A cikin makonni masu zuwa za mu ci gaba da ƙarin jagororin kan Wikimania da sauran taron al'ummomin yanki da na al'ada.
Jima'i na gama gari daga cikin al'ummomin duniya gaba ɗaya ya zama kamar baƙin ciki ne game da katsewa amma yana jin kwanciyar hankali game da tsabta da ikon mai da hankali ga al'ummarsu, Wikimedia da sauransu.
Komawa gaba, CRT yana ƙoƙari don haɓaka shafi game da Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyoyin sadarwarmu da su.
Ci gaba da tuntuɓarmu kan batutuwan da suka shafi COVID-19
Za mu aika da gayyatar zuwa kalandarku don Alhamis mai zuwa, a 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku da kuma ɗan lokaci don tuntuɓar juna.
Muna cikin wannan tare kuma muna nan don taimakawa duk yadda za mu iya.
A yanzu haka, za ka iya ci gaba da nemo bayanai daga wannan imel ɗin, da kuma duk wasu muhimman bayanai game da COVID-19 a kan Wiki na Office.
CRT zai tabbatar da cewa duk waɗannan shafuka suna da sabuntawa kuma duk bayanan suna cikin wuri ɗaya.
Muna kuma kokarin tabbatar da sadarwa ta yau da kullun tare da ma'aikatanmu a cikin ƙasashen da abin ya shafa sosai a wannan lokacin.
Idan kana da wasu tambayoyi game da tafiya, wani taron, wani babban aiki, ko ƙalubalen ɗaukar hoto, ko duk wani taimako da kake buƙata, kada ka yi jinkirin sanar da kuma aiki tare da CRT.
Muna nan don taimakawa wajen samar da tallafi da kuma zama masu sadarwa idan an buƙata.
Idan kuna da wasu batutuwa masu sirri ko masu mahimmanci, don Allah aika imel zuwa Bryan Judan - Darakta na Ayyukan HR na Duniya.
Babu wani daga cikin waɗannan canje-canjen da za a iya ɗauka a matsayin watsi da aikinmu da alhakinmu.
Duk da haka, duk wannan shine fahimtar cewa a wannan lokacin, aikinmu da alhakinmu na iya buƙatar daidaitawa ta hanyar da ba ta taɓa faruwa ba.
Waɗannan su ne matakan da muka yi imanin cewa wajibi ne don tallafawa juna don mu ci gaba da aiki, samar da motsinmu tare da goyon bayan da suke buƙata, da kuma sabis na duniya da za su iya tsammani.
Ayyukanmu na yau da kullun za su kasance a can suna jiran lokacinmu.
Yanzu lokaci yayi da za mu tallafawa juna da kuma samar da sarari don muhimman ayyukan da za su zo a cikin makonni masu zuwa kuma wataƙila watanni masu zuwa.
Muna bukatar ku duka ku tabbatar da hakan, kuma muna bukatar ku duka ku kula da kanku da iyalanku domin ku kasance cikin shiri mafi kyau idan lokacin bukata ya zo.
Yanzu, don Allah -- ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S) da sauran waɗanda ke cikin Teamungiyar Shugabanci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Angiotensin-converting enzyme 2 (ACE2) shine enzyme wanda ke haɗuwa a kan farfajiyar waje (ƙwayoyin sel) na ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana magance aikin enzyme mai canzawa na angiotensin (ACE) wanda ke da alaƙa da rage yawan angiotensin-II da haɓaka Ang ((1-7) yana mai da shi magani mai yiwuwa don magance cututtukan zuciya.
An kira nau'in mutum na enzyme a matsayin hACE2.
Angiotensin-converting enzyme 2 shine zinc wanda ke dauke da metaloenzyme wanda yake a saman endothelium da sauran sel.
Furotin ACE2 ya ƙunshi yankin M2 peptidase N-terminal da kuma yankin mai ɗaukar amino acid na renal colectrin C-terminal.
ACE2 shine nau'in membrane mai nau'in nau'i na 1, tare da yankin enzymatic wanda aka nuna a kan ƙwayoyin halitta a cikin huhu da sauran kyallen takarda.
Ƙarƙashin ƙwayoyin ACE2 yana haɗuwa da yankin transmembrane ta wani enzyme da ake kira sheddase, kuma an saki furotin da aka narkar da shi zuwa jini kuma daga bisani ya fita cikin fitsari.
ACE2 yana cikin yawancin gabobin: ACE2 yana da tagwaye a cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Ana kuma gano bayanin mRNA ACE2 a cikin ƙwayar ƙwayar cuta, striatum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine ya zama mai daidaitawa ga ACE.
ACE yana haɗa hormone na angiotensin I zuwa cikin narrowing na angiotensin II.
ACE2 a akasin wannan yana haɗuwa da amino acid phenylalanine carboxyl-terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa angiotensin vasodilator (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya haɗawa da wasu peptides da suka haɗa da [des-Arg9]- bradikinin, apelin, neurotensin, dinorphine A da ghrelin.
ACE2 kuma yana daidaita rarraba membrane na SLC6A19 mai ɗaukar amino acid mai tsaka tsaki kuma an nuna shi a cikin cutar Hartnup.
A matsayin furotin mai yaduwa, ACE2 yana aiki a matsayin babban cibiyar shiga cikin sel don wasu coronaviruses ciki har da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, ɗaurewar sunadarai na S1 mai mahimmanci ga SARS-CoV da SARS-CoV2 a cikin yankin enzymatic a kan ACE2 a saman ƙwayoyin halitta yana haifar da endocytosis da fassarar kwayar cutar da enzymes zuwa cikin endosomes dake tsakanin kwayoyin.
Tsarin shigarwa kuma yana buƙatar haɓakar S-protein ta hanyar TMPRSS2 mai amfani da ƙwayar cuta, mai hanawa wanda ke ƙarƙashin bincike a halin yanzu a matsayin mai warkewa.
Koyaya, ƙungiyoyi da ƙungiyoyi masu ƙwarewa da ƙungiyoyi masu tsarawa suna ba da shawarar ci gaba da daidaitaccen ACE inhibitor da ARB far.
Binciken da aka yi na yau da kullun da kuma nazarin meta da aka buga a ranar 11 ga Yuli 2012 ya gano cewa "amfani da ACE inhibitors yana da alaƙa da raguwar raguwar 34% a cikin haɗarin cutar huhu idan aka kwatanta da sarrafawa".
Bugu da ƙari, "hadarin ciwon huhu ya ragu ga marasa lafiya da ke shan ACE inhibitors waɗanda ke da haɗarin ciwon huhu, musamman waɗanda ke fama da bugun jini da rashin ƙarfi.
Hakanan an danganta amfani da ACE inhibitors tare da raguwa a cikin mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Sake haɗuwa da ACE2 na mutum (rhACE2) ana ɗaukarsa a matsayin sabon magani don raunin huhu mai tsanani, kuma yana nuna yana haɓaka haemodynamics na huhu da kuma rage iskar oxygen a cikin 'yan alade tare da cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Rabin rabin rayuwa na rhACE2 a cikin mutane shine awanni 10 kuma farkon aikin shine mintuna 30 ban da lokacin aiki na awanni 24.
Wasu binciken sun ba da shawarar cewa rhACE2 na iya zama magani mai yiwuwa ga waɗanda ba su da haƙuri ga masu hana tsarin renin angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke kewaye da ingantaccen angiotensin II.
Aikace-aikacen b'COVID-19 aikace-aikacen software ne na wayar hannu wanda aka tsara don taimakawa bin hanyar tuntuɓar mutum a cikin martani ga cutar coronavirus ta 2019-20, wanda shine tsarin gano mutanen ("abokan hulɗa") waɗanda zasu iya kasancewa tare da mutum mai kamuwa da cuta.
Mutane da yawa aikace-aikace da aka ɓullo da ko samarwa da gwamnatin jami'an goyon bayan a wasu yankuna da kuma jurisdictions.
An samar da wasu tsarin don gina aikace-aikacen bin diddigin lamba.
An haifar da damuwa game da sirri, musamman game da tsarin da ke dogara da bin diddigin yanayin aikace-aikacen masu amfani.
Sauran hanyoyin da ba su da damuwa sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci ga mai amfani a kan sauran wayoyin salula.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar cewa za su haɗa aikin don tallafawa aikace-aikacen tushen Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da haɗin gwiwar Alipay, ta ƙaddamar da wata manhaja da ke ba 'yan ƙasa damar bincika ko sun taɓa yin hulɗa da waɗanda ke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 a kasar Sin. A Singapore, ana amfani da wata manhaja da ake kira TraceTogether.
An haɓaka aikace-aikacen ta hanyar ƙungiyar IT ta gida, an ƙaddamar da shi azaman tushen buɗewa kuma za a ba da shi ga gwamnati.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka haɓaka aikace-aikacen.
Har zuwa 14 ga Afrilu 2020, aikace-aikacen yana jiran amincewa ta Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin lamba yana cikin matakan ci gaba, kuma zai kasance a shirye don ƙaddamarwa a cikin 'yan makonni.
Australia da New Zealand suna la'akari da aikace-aikacen da ke kan aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen ƙuntatawa na ƙasa don marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, waɗanda aka tsara don tabbatar da cewa ba su bar gida ba.
Ross Anderson, farfesa a fannin tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin aikace-aikacen aikace-aikace, ciki har da kuskuren kuskure da kuma yiwuwar rashin tasiri idan aiwatar da aikace-aikacen ya iyakance ga ƙananan yawan jama'a.
Dangane da damuwa game da yaduwar aikace-aikacen "coronavirus" masu rikitarwa ko haɗari, Apple ya sanya iyaka ga nau'ikan ƙungiyoyi waɗanda za su iya ƙara aikace-aikacen da suka shafi coronavirus a cikin App Store, suna iyakance su ga "masu iko" ko kuma manyan ƙungiyoyi kawai.
Google da Amazon sun sanya irin wannan takunkumin.
Masu fafutukar kare sirrin sun nuna damuwarsu game da tasirin sa ido kan amfani da aikace-aikacen coronavirus, musamman game da ko za a dakatar da tsarin sa ido da aka kirkira don magance cutar coronavirus da zarar barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a kawo karshen irin wannan sa ido.
Kungiyar ta bayyana sharudda takwas ga ayyukan gwamnati:
Dole ne a yi amfani da "daidai da doka, idan ya cancanta kuma ya dace";
Za a iya samun ƙarin kulawa da kulawa tare da sassan da aka saka;
amfani da bayanai ya kamata ya kasance iyakance ga manufar COVID-19;
Ana buƙatar a tabbatar da tsaro da kuma rashin sani na bayanai da aka tabbatar da cewa an tabbatar da su;
Dole ne a hana kulawar dijital daga ƙara tsanantawa da nuna bambanci da ɓoyewa;
Duk wani musayar bayanai tare da wasu kamfanoni dole ne a bayyana su a cikin doka;
Za a kare su daga cin zarafi da kuma hakkin 'yan kasa na mayar da martani kan cin zarafi;
Za a buƙaci a sami ma'ana ta hanyar duk "masu ruwa da tsaki", gami da masana kiwon lafiya da kungiyoyi masu zaman kansu.
Shawarwarin shirin Google/Apple suna nufin magance matsalar sa ido ta yau da kullun ta hanyar cire hanyoyin sa ido daga tsarin aiki na na'urorin su da zarar ba a buƙatar su.
Wasu ƙasashe suna amfani da bin sawun wurin da ke kan hanyar sadarwa maimakon aikace-aikace, kawar da buƙatun duka biyu don saukar da aikace-aikacen da ikon kauce wa sa ido.
A Isra'ila, an yarda da bin sawun yanar gizo.
Hanyoyin sadarwa masu amfani da hanyar sadarwa waɗanda ke da damar yin amfani da bayanan wuri na asali suna da babbar matsala game da sirrin sirri.
Koyaya, ba duk tsarin da ke da sabar cibiyar sadarwa bane dole ne su sami damar yin amfani da bayanan wurin zama na sirri; an riga an ƙirƙiri wasu tsarin kiyaye sirrin sirri waɗanda ke amfani da sabar cibiyar sadarwa kawai don sadarwa tare da juna (duba sashe na ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da aka yi amfani da shi don yin amfani da hanyar sadarwa.
Maimakon amfani da aikace-aikacen da aka keɓance, tsarin yana tattara bayanan sa ido daga tushe daban-daban ciki har da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma haɗuwa da waɗannan duka yana haifar da sanarwa ta hanyar saƙon rubutu ga mutanen da ke iya kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu yuwuwar tuntuɓar, gwamnati ta kuma ba da bayanan wurin ga jama'a, wani abu da aka ba da izini saboda manyan canje-canje a cikin dokokin sirrin bayanai bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar wasu aikace-aikace da shafukan yanar gizo.
Har zuwa 6 ga Afrilu 2020, ba a ba da cikakken bayani ba.
Kula da alaƙa da kiyaye sirrin sirri ra'ayi ne da aka tsara tare da mahimman littattafan nazarin jiki tun daga 2013.
Duk da haka, PEPP-PT aiki ne na daidaituwa wanda ya ƙunshi matsakaiciyar hanya da tsakiya, kuma ba yarjejeniya guda ɗaya ba.
A cikin wannan yarjejeniya, bayanan da aka gano da kansu ba su taɓa barin na'urar ba, kuma duk haɗuwa tana faruwa akan na'urar.
Kungiyar Sirrin MIT Media Lab tana haɓaka SafePaths, dandamali don amfani da fasahohin tsare sirri lokacin tattarawa da amfani da wuri ko bayanan haɗin gwiwa don bin hanyar COVID-19.
Wannan ya dogara ne akan bincike daga takardar farin takarda "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" da aka buga a watan Maris na 2020. Wani irin wannan yunƙuri shine dandamali na SafeTrace ta Enigma MPC, wani kamfani mai haɓaka fasahar sirri wanda kuma aka kafa asali a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki mai aminci don bawa masu amfani damar raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da yin sulhu kan sirrin bayanai ba.
A ranar 5 ga Afrilu, 2020, an kafa ƙungiyar TCN Coalition ta duniya ta ƙungiyoyi da yawa waɗanda suka haɗu kan mahimman hanyoyin da manyan ladabi masu yawa, tare da manufar rage rarrabuwa, da kuma ba da damar aiki a duniya ta hanyar aikace-aikacen sa ido da faɗakarwa, muhimman fannoni don cimma amfani da yawa.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aikace-aikacen gwamnati na hukuma ke amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun sanar da wani shiri don bin hanyoyin sadarwa wanda suke da'awar zai kiyaye sirrin su, bisa ga haɗin haɗin Bluetooth Low Power da kuma sirrin sirri.
Sun kuma buga takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana nufin ƙaddamarwa a matakai uku:
An kaddamar da kayan aiki don baiwa gwamnati damar samar da manhajar gano cutar korona da kuma tsare sirrin mutane
hada wannan aikin kai tsaye cikin iOS da Android shirin Google da Apple don magance matsalolin aiwatarwa da sa ido na yau da kullun ta hanyar fara rarraba tsarin ta hanyar sabunta tsarin aiki, sannan kuma fitar da su ta wannan hanyar da zarar barazanar ta wuce.
Sake sanya magunguna (wanda kuma aka sani da canza manufar magani, sake fasalin, sake sanyawa ko sake fasalin magani) shine canza manufar magani wanda aka amince dashi don magance cututtuka daban-daban ko yanayin kiwon lafiya daga dalilin da yasa aka haɓaka shi da farko.
Wannan bincike ne na kimiyya da ake ci gaba da yi don samar da magani mai inganci da lafiya ga COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma maganin plasma mai warkewa. SARS-CoV-2 yana da kusan furotin 66 masu magani, kowannensu yana da wurare masu ɗaure ligand da yawa.
Nazarin wannan rukunin haɗin yana ba da kyakkyawan shiri don haɓaka maganin rigakafi mai tasiri ga furotin na COVID-19.
Daga cikin yawancin sunadarai masu mahimmanci na SARS-CoV-2 sune mafi mahimmanci sune proteases kamar papain, RNA-dogara polymerase, helicase, S-protein da ADP ribophosphate.
Hussein A A, et al sun yi nazarin wasu mahaɗan ɗan takara waɗanda aka inganta su kuma aka bincika su don kamanceceniya ta tsarin tare da magungunan da aka amince da su don hanzarta haɓaka magungunan anti-SARS-CoV-2 masu ƙarfi a cikin binciken sa na farko don ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na antimalarial wanda kuma ake amfani dashi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance cikin magunguna huɗu da ake nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa gwajin jihar New York akan chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin Amincewar Amfani da Gaggawa (USA).
Ba a amince da maganin ta hanyar gwajin gwaji na FDA ba kuma an ba da izinin ƙarƙashin EUA ne kawai a matsayin gwaji na gwaji don amfanin gaggawa a cikin marasa lafiya da aka kwantar da su asibiti amma ba za su iya karɓar magani a cikin binciken asibiti ba.
CDC ta ce "amfani, sashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da SARS-CoV-2" ba a riga an kafa shi ba.
Likitoci sun ce suna amfani da maganin ne sa'ad da "ba su da wani zaɓi".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna gudanar da ƙaramin bincike kan amfani da chloroquine tare da haɗuwa da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a jami'ar Duke da jami'ar Oxford.
Makarantar Likitancin NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da maganin hana yaduwar hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir "a bayyane yake yana da tasiri".
Marasa lafiya 35 a Shenzhen sun gwada mummunan a matsakaici na kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kasance kwanaki 11 ga marasa lafiya 45 da basu karɓa ba.
A wani bincike da aka yi a Wuhan, an yi amfani da kashi 240 na marasa lafiya da cutar huhu, rabin su sun sha favipiravir, rabin kuma suka sha umifenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke tallafawa maganin har yanzu ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adanawa kuma ta yi amfani da sojojin don jigilar magunguna zuwa asibitocin jami'a, waɗanda za su yi amfani da magungunan don kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya sauya ra'ayi game da gwamnatin Trump game da sayan magunguna.
Zai iya zama ba shi da lafiya ga mata masu ciki ko waɗanda ke ƙoƙarin yin ciki.
Wani binciken lopinavir/ritonavir (Kaletra), haɗin maganin rigakafin lopinavir da ritonavir, ya bayyana cewa "babu wani fa'ida da za a lura".
An tsara magungunan ne don rage kwayar cutar HIV maimakon kwafa ta hanyar ɗaure ta da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza magungunan don gano mahaɗan da za su ɗaure ga SARS-CoV-2 protease. Akwai suka a cikin ƙungiyar kimiyya game da tura albarkatu don canza manufar magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta kirkiro da kuma bunkasa shi a matsayin magani ga cutar Ebola da kamuwa da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafi a cikin vitro akan yawancin phylum, pneumo, paramyxo- da coronaviruses.
Wata matsala da maganin rigakafi shine nuna juriya ta hanyar maye gurbi wanda zai iya haifar da cutar da kuma cutar da ta fi tsanani.
Wasu nazarin farko na gwaji sun ba da shawarar remdesivir na iya samun babban katangar haɓakar haɓakar haɓakar. Akwai wasu gwaji na asibiti da ake gudanarwa ciki har da biyu da Asibitin Jami'ar Cleveland ke gudanarwa; ɗaya ga mutane masu rashin lafiya mai sauƙi da ɗayan don waɗanda ke da cutar mafi tsanani.
Akwai gwaji uku na asibiti da ake gudanarwa don bitamin C na intravenous ga waɗanda aka kwantar da su a asibiti kuma suna da rashin lafiya mai tsanani tare da COVID-19, biyu masu sarrafawa (China, Kanada) da ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwaji don maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gwajin asibiti don Teijin's Alvesco (ciclesonide), corticosteroid mai shan iska don asma, don kula da marasa lafiya masu alamun cutar da cutar coronavirus.
Wani nau'i na enzyme mai canza angiotensin 2, ana gudanar da gwaji na Phase II akan marasa lafiya 200 da aka zaba daga asibitoci da masu fama da cutar a Denmark, Jamus da Austria don tantance tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar colchicine wajen rage rikicewar kumburi da ciwon huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken da ake kira COLCORONA, ya ɗauki manya 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko kuma ba su da hanyar hana haihuwa mai tasiri ba su cancanci.
Ana gwada wasu magungunan hana jini a Italiya.
Ana amfani da heparin mai ƙananan ƙwayar halitta don kula da marasa lafiya, yana motsa Hukumar Kula da Magunguna ta Italiya don buga jagororin akan amfanin sa.
An sanar da wani bincike mai yawa kan marasa lafiya 300 da ke binciken amfani da sodium enoxaparin a allurai na rigakafi da na warkewa a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan binciken da aka yi kan maganin rigakafin cutar da aka amince da shi don cutar kamar MERS, SARS da West Nile virus.
Ribavirin: ribavirin an ba da shawarar don maganin COVID-19 a ƙarƙashin jagororin 7 na China
Umifenovir: Umifenovir an ba da shawarar don maganin COVID-19 a ƙarƙashin jagororin 7 na China
An gano wasu magungunan rigakafi a matsayin masu canza manufa don maganin COVID-19:
Tocilizumab (Anti-IL-6 Receptor): An amince da shi daga China.
Har ila yau, gwaji a Italiya da China, kuma duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce ta cutar coronavirus ta 2019 (COVID-2019).
Ko da yake babu allurar rigakafi da ta kammala gwajin asibiti, akwai gwaji da yawa a ci gaba don haɓaka allurar rigakafi.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta kasance a cikin ƙasa da watanni 18.
A watan Afrilu, an fara gwajin rigakafin kashi biyar.
An gano COVID-19 a watan Disamba na 2019.
Babban annobar a duk duniya a cikin 2020, ta ba da damar saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da kwayar halitta da aka buga don haɓaka yiwuwar allurar rigakafi akan SARS-CoV-2.
An bayyana a watan Afrilu, mahimmancin shirin CEPI don haɓaka allurar rigakafi, ƙarfin masana'antu, aiwatar da sikelin da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa akwai dandamali daban-daban na fasaha 10 a ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafi mai tasiri akan COVID-19.
Manyan dandamali da ke nufin ci gaba zuwa binciken tsaro na Phase I sun haɗa da:
nucleic acid (DNA da RNA) (Mai haɓaka Phase 1 da mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (Mai haɓaka Phase I da mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto adenovirus nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, adadin alluran rigakafi 115 suna cikin matakan farko na ci gaba, tare da tabbatar da 78 a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da sauran 37 da aka sanar, amma tare da karancin bayanan jama'a (wanda ake ganin yana cikin shiri ko kuma ana tsara shi).
Gwajin Phase I-II yana aiwatar da gwajin farko na aminci da rigakafi , yawanci bazuwar, sarrafawa da wuribo da wurare da yawa, yayin da yake ƙayyade tasirin tasiri mafi kyau.
Gwajin Mataki na III yawanci ya ƙunshi ƙarin masu shiga ciki har da rukunin sarrafawa da gwajin ingancin allurar rigakafi don hana cutar, yayin da ake lura da mummunan sakamako a mafi kyawun allurai.
Daga cikin alluran rigakafi 79 da ke cikin ci gaba (wanda aka bayyana a farkon Afrilu 2020), 74 har yanzu ba a cikin kimantawar ɗan adam ba (har yanzu a cikin binciken "preclinical").
A ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar halitta wanda zai canza kwayar cutar ta kwayar halitta don motsa amsar rigakafi.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da ci gaba da aikin rigakafin, da nufin fara gwajin mutum a 2021.
An sanar da aikin samar da allurar rigakafin a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ke jagoranta, ya sanar da cewa ya fara aiki kan samar da allurar rigakafi.
Janssen tana haɓaka allurar rigakafin baka tare da Vaxart wanda abokin aikinta ne na ilimin halittu.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, OncoGen Lab a Romania ya buga wata takarda game da ƙirar allurar rigakafi tare da irin wannan fasahar da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala nazarin allurar rigakafi kuma sun fara gwaji.
A ranar 27 ga Fabrairun 2020, wani kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin allurar rigakafi don ƙirƙirar allurar rigakafin peptide li-Key akan COVID-19.
Suna son samar da allurar rigakafin da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Sojojin Amurka da Cibiyar Kula da Magunguna a Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, duka a yammacin Maryland, sun ba da sanarwar cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi aiki tare da Novavax Inc.
a cikin samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gwajin gwaji da kuma gwaji na farko na gwaji ta Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki da nau'ikan 11 waɗanda duk da cewa suna kan saurin tafiya zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere-kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayoyin cutar coronavirus a ƙarƙashin wani ɓangare na asusun Cibiyar Nazarin Kiwon Lafiya ta Kanada.
An shirya gwajin gwajin mutum a watan Yuli ko Agusta 2020.
A farkon makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac "kuɗi mai yawa don samun damar yin allurar rigakafin Covid-19", kuma gwamnatin Jamus ta yi hamayya da hakan.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA tare.
Wani ɗan takarar allurar rigakafin da ke da tushen mRNA BNT162, yanzu haka yana cikin gwajin gwaji yayin da ake sa ran fara gwajin asibiti a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020 a Italiya, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya ya ba da sanarwar cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za su iya fara gwajin ɗan adam a ƙarshen kaka.
A ranar 19 ga Maris, 2020 a Faransa, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 ga ƙungiyar bincike kan allurar rigakafin COVID-19 wanda ya haɗa da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI a cikin ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi don wasu alluran rigakafi shida.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin RNA mai ƙarfin kansa don COVID-19.
An samar da wannan rigakafin ne cikin kwanaki 14 bayan karbar umarni daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da tallafin C$275 miliyan don ayyukan bincike kan matakan rigakafin likita game da COVID-19, gami da yawancin 'yan takarar allurar rigakafi a kamfanonin Kanada da jami'o'i kamar Medicago da yunivarsitin Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da sadaukar da dala miliyan 192 na C$192 don samar da allurar rigakafin COVID-19, tare da shirin kafa "bankin allurar rigakafi" na ƙasa da sabbin alluran rigakafi da za a iya amfani da su idan wani annobar coronavirus ta sake barkewa.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoto game da gwajin PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, suna mai cewa "MNA ta ba da allurar rigakafin SARS-CoV-2 S1 wanda ke haifar da ƙarfin antigen-specific antibody response [a cikin beraye] wanda aka nuna ya fara makonni 2 bayan allurar rigakafi".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar ƙwararrun alluran rigakafin DNA a matsayin yiwuwar fuka-fukan hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don kwafin kwayoyin cuta na mutum don samar da ƙwayoyin cuta marasa lahani, waɗanda za su iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta da ke yaƙi da kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun tattara albarkatu don samun damar yin amfani da na'urori masu sarrafa kwamfuta daga IBM, haɗe da albarkatun girgije daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira tasirin rashin amfani.
Wannan yana nufin cewa suna iya samun fa'idodi ban da cututtukan da suka hana.
Wani gwaji da aka yi a Ostiraliya ya yi niyyar shigar da ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar allurar rigakafin da ke cikin ci gaba ba ta da lafiya ko tasiri.
Binciken farko don kimanta ingancin allurar rigakafi ta amfani da ƙirar dabbobi na musamman na COVID-19 kamar ƙwayoyin cuta masu maye gurbin ACE2, sauran dabbobin gwaji da kuma na dabbobi masu kama da dabbobi, sun nuna buƙatar matakan kiyaye lafiyar matakin 3 don sarrafa ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitaccen tsarin aminci.
An gwada alluran rigakafin SARS da MERS a cikin samfuran dabbobi ba na ɗan adam ba.
A shekarar 2020, babu wani maganin warkewa ko kariya ga SARS da aka tabbatar yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa alluran rigakafi da sababbin magunguna don magance SARS sune fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Yayin da MERS ke yaduwa, ana tsammanin binciken SARS na yanzu zai iya zama samfuri mai amfani don haɓaka allurar rigakafi da magunguna don kamuwa da MERS-CoV.
A watan Maris na 2020, akwai allurar rigakafin MERS (wanda aka kafa ta DNA) wanda ya kammala gwajin gwaji na mutum na farko, kuma wasu uku suna kan hanya, duk alluran rigakafin kwayar cutar kwayar cuta ne, masu ɗaukar kwayar adenoviral biyu (ChAdOx1-MERS, BVRS-GamVac), da mai ɗaukar kwayar MVA ɗaya (MVA-MERS-S).
Bayanai a shafukan sada zumunta sun inganta ka'idar makirci da ke cewa an san kwayar cutar da ke bayan COVID-19 kuma akwai riga-kafi.
Takaddun shaida da aka ambata ta hanyar kafofin watsa labarun daban-daban suna nufin takaddun shaida na yanzu don juzu'in kwayoyin halitta da allurar rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar b'Coronavirus 2019 (COVID-19) cuta ce mai saurin yaduwa ta hanyar coronavirus mai saurin kamuwa da cutar numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Alamomin yau da kullun sun haɗa da zazzabi, tari da numfashi.
Sauran alamun cututtuka na iya haɗawa da gajiya, ciwon tsoka, zazzabi, ciwon makogwaro, rashin wari da ciwon ciki.
Lokaci daga lokacin da aka fallasa har zuwa lokacin da aka fara amfani da shi yana da kwanaki biyar amma zai iya farawa tsakanin kwana biyu zuwa goma sha huɗu.
Yayin da yawancin lokuta ke haifar da alamun rashin lafiya, wasu suna ci gaba zuwa cutar huhu da rashin aiki da kwayoyin halitta.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu rahotannin sama da mutane miliyan 2.24 a cikin kasashe da yankuna 210, wanda ya haifar da mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar musamman tsakanin mutane ta hanyar kusanci, galibi ta hanyar ƙananan digo da aka samar ta tari, hancin baki ko magana.
Yayin da ake fitar da wadannan digo a lokacin numfashi, yawanci suna fadawa kasa ko saman maimakon zama masu kamuwa da cuta na dogon lokaci.
Mutane na iya kamuwa da cutar ta hanyar taɓa gurbataccen farfajiyar sannan su taɓa idanunsu, hanci ko bakinsu.
Kwayar cutar na iya rayuwa a saman ƙasa har tsawon sa'o'i 72.
Mafi yawan kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya faruwa kafin bayyanar cututtuka da kuma a cikin yanayin cutar.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda ake zargi da ɗaukar kwayar cutar da masu kula da su.
Shawarwarin da aka bayar game da amfani da abin rufe fuska ga jama'a sun bambanta, tare da wasu hukumomi suna ba da shawarar kada su yi amfani da su, wasu suna ba da shawarar amfani da su wasu kuma suna ba da umarnin amfani da su.
A halin yanzu, babu allurar rigakafi ko maganin ƙwayoyin cuta na musamman don COVID-19.
An samu karuwar cutar a cikin yawancin ƙasashe a duk yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar na iya zama marasa alamun cutar ko kuma nuna alamun mura kamar zazzabi, tari, gajiya da numfashi.
Alamun damuwa sun haɗa da wahalar numfashi, ciwo ko ci gaba da damuwa a cikin kirji, rikicewa, wahalar tafiya da fuska ko leɓunan blueness; ana ba da shawarar neman likita nan da nan idan waɗannan alamun suka bayyana.
Ba a saba gani ba, za a iya lura da ciwon numfashi na sama kamar yin fitsari, ruwa a hanci ko ciwon makogwaro.
Alamun cututtukan gastrointestinal kamar tashin zuciya, amai da zawo ana lura dasu cikin kashi da yawa.
Wasu daga cikin shari'o'in da aka samu a China sun nuna cewa a farkon lokaci, kawai akwai ƙarancin bayanai da bugun zuciya.
A wasu, cutar na iya ci gaba zuwa ciwon huhu, gazawar gabobin jiki da mutuwa.
Wannan shi ake kira lokacin incubation.
Lokacin incubation na COVID-19 yawanci kwanaki biyar zuwa shida ne amma yana iya kasancewa tsakanin biyu zuwa 14 days.
97.5% na marasa lafiya da ke nuna alamun cutar za su yi hakan a cikin kwanaki 11.5 tun lokacin kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke kamuwa da cutar ba ne ke nuna alamun cutar.
Matsayin wannan mai ɗaukar hoto a cikin watsawa har yanzu ba a san shi sosai ba; duk da haka, bayanan farko sun nuna cewa yana iya taimakawa wajen yada cutar.
Adadin waɗanda suka kamu da cutar ba su nuna alamun da ba a sani ba a halin yanzu kuma ana nazarin su, tare da Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KDCC) ta ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar sun kasance marasa alamun cutar yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada cututtukan da ba su da alamun cutar a cikin adadin cututtukansu na yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ciki da kuma leɓen ruwa na iya ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana fitar da ƙarin ɗigon ruwa fiye da magana ta al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa tari da ba a rufe baki ba zai iya sa ruwa ya yi ta motsawa har mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta da asali, Masanin Kimiyya na Kasa ya ba da shawarar cewa yiwuwar canja wurin bioaerosol da kuma masu tattara iska a cikin wuraren da ke cikin ɗakin jama'a sun nuna samfurin tabbatacce ga RNA na kwayar.
Wasu hanyoyin kiwon lafiya kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓoyewar numfashi zuwa cikin iska kuma hakan yana haifar da yaduwar ciki.
Duk da cewa akwai damuwa cewa ana yada shi ta hanyar stool, ana ganin wannan haɗarin yana da ƙarancin gaske. Kwayar cutar tana da saurin yaduwa lokacin da mutum ba shi da alamun cutar; kodayake yaduwa yana yiwuwa kafin bayyanar cututtuka, haɗarin yana da ƙanƙanci.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da cewa gabaɗaya ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana kamuwa da mutane biyu zuwa uku gaba ɗaya.
Musamman, an gano kwayar cutar a matsayin mai ganowa na kwana ɗaya akan kwali, har zuwa kwana uku akan filastik (polypropylene) da bakin karfe (AISI 304), da har zuwa awanni huɗu akan 99% jan ƙarfe.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan wanki ma suna da tasiri idan aka yi amfani da su yadda ya kamata; kayan sabulu suna raunana murfin mai na kwayar cutar, suna kashe shi da kuma kawar da shi daga fata da sauran farfajiyoyi.
Sauran mafita kamar benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe ƙwayoyin cuta na tiyata) ba su da tasiri sosai.
A cikin biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mutum na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus mai saurin kamuwa da cutar numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2) wani sabon abu ne mai saurin kamuwa da cutar coronavirus mai saurin kamuwa da cutar numfashi, wanda aka fara warewa daga mutane uku da cutar huhu dangane da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon kwayar cutar SARS-CoV-2 da ke faruwa a cikin coronavirus suna da alaƙa da juna.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke ɓarke da kumfa mai kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Cutar huhu ita ce mafi yawan kwayoyin da COVID-19 ke shafa saboda kwayar cutar tana shiga cikin ƙwayoyin cuta ta hanyar kwayar halittar angiotensin-enzyme-converting enzyme (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolus na nau'in II a cikin huhu.
Kwayar cutar tana amfani da wani nau'in glycoprotein na musamman da ake kira "peplomer" don haɗawa da ACE2 kuma shiga cikin ƙwayoyin mai karɓar baƙi.
An gano raunin zuciya mai tsanani a cikin kashi 12% na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China kuma ya fi yawa a cikin masu fama da cutar.
Yawan cututtukan cututtukan zuciya suna da yawa, saboda halayen kumburi na tsarin jiki da cututtukan tsarin rigakafi yayin ci gaban cutar, amma mummunan rauni na myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Abubuwan karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami ƙaruwar cututtukan thrombosis (31%) da thromboembolism na jijiyoyin jini (25%) a cikin marasa lafiya na ICU tare da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da rashin kyakkyawan hangen nesa.
Kodayake SARS-COV-2 yana da tropism ga ƙwayoyin epithelial na bayyana ACE2 a cikin hanyoyin numfashi, marasa lafiya tare da COVID-19 mai tsanani suna da alamun alamun cutar hyperinflammatory.
Musamman, ƙwayoyin T da ke ɓoye GM-CSF na cututtukan cututtuka an nuna su don daidaitawa tare da yawan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin IL-6 da kuma mummunan cututtukan huhu a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton cutar lymphocytic a lokacin da aka yi masa autopsy.
WHO ta wallafa wasu ka'idojin gwaji don cutar.
Matsayin gwajin shine ainihin lokacin juyawa juyawa polymerase chain reaction (rPT-PCR).
Ana yin gwajin ne akan samfurin numfashi da aka samo tare da swabs na nasopharyngeal; duk da haka, ana iya amfani da swabs na hanci ko samfurin tari.
Ana iya samun hukuncin a cikin awanni biyu zuwa kwana biyu.
Ana iya amfani da gwajin jini amma wannan yana buƙatar samfurin jini biyu da aka ɗauka makonni biyu da suka wuce kuma yanke shawara yana da ƙimar gaggawa.
Masana kimiyya na kasar Sin sun iya ware wani kwayar cutar coronavirus da kuma buga jerin kwayoyin halitta don dakunan gwaje-gwaje a duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu 2020, gwajin antibody (mai yiwuwa yana gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) yana cikin ci gaba amma ba a yi amfani da shi sosai ba.
Kwarewar kasar Sin a gwajin ta nuna cewa ya kasance daidai da kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020 don amfani da shi a ƙarshen wannan watan. Jagoran bincike da Asibitin Zhongnan na Jami'ar Wuhan ya wallafa ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halayen asibiti da haɗarin annoba.
Rashin tabarau mai yawa na filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
Dominance na subpleura, yawancin ƙuƙwalwa (ƙaddamar da ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓangaren ɓang
Akwai wasu bayanai game da cutar ta COVID-19 da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Babban binciken ilimin halayyar mutum a lokacin autopsy shine:
Maganin: pleurisy, pericarditis, haɗuwa da huhu da ƙwayoyin huhu
Akwai nau'ikan cututtuka guda huɗu don cutar sankarar bargo:
ƙananan ciwon huhu: edema na huhu, pneumocytes, hyperplasia, manyan pneumocytes, ƙonewa na sararin samaniya tare da mamayewar lymphocytes da kuma samar da kwayoyin halitta masu yawa
mummunar ciwon huhu: lalacewar alveolus mai rarrafe (DAD) tare da fitar da alveolus mai rarrafe.
DAD shine sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
sake dawo da ciwon huhu: exudate tarawa a cikin alveolus rami da kuma interpulmonary fibrosis
Jini: yaduwar jini na jini (DIC), leukoerythroblastic ricis
Matakan kariya don rage yiwuwar kamuwa da cuta sun hada da zama a gida, kauce wa wuraren taruwa, wanke hannuwanku da sabulu da ruwa akai-akai kuma aƙalla na dakika 20, aiwatar da tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe baki da hanci da zane yayin tari ko hancin kuma yana ba da shawarar amfani da cikin kafada idan babu zane.
Ana ba da shawarar tsabtace hannaye bayan kowane tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, a wani ɓangare don iyakance motsi ta hanyar mutane marasa alamun cutar. Dabarun tsare-tsaren zamantakewar jama'a suna da nufin rage hulɗa da mutanen da ke da cutar tare da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, iyakance tafiya da soke manyan taron jama'a.
Ka'idodin kurkuku sun haɗa da cewa jama'a su kasance aƙalla ƙafa 6 (1.8 m) nesa da juna.
Babu wasu magunguna da aka gano suna da tasiri don hana COVID-19.Tun da ba a sa ran allurar rigakafi har zuwa farkon 2021, babban abin da ke cikin sarrafa COVID-19 shine ƙoƙarin rage ƙimar annobar, wanda aka sani da "lanƙwasa kwari".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa aƙalla na dakika 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun yi datti, kafin su ci abinci ko kuma bayan sun hura hanci, tari ko fitsari.
Har ila yau, an ba da shawarar yin amfani da tsabtace hannu na giya tare da aƙalla kashi 60% na giya amma kawai lokacin da ba a ba da sabulu da ruwa ba.
A cikin wannan tsari, aikin antimicrobial ya fito daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa kawar da ƙwayoyin cuta a cikin barasa; "ba shine mai aiki ba don antisepsis na hannu".
An kara glycerol a matsayin mai laushi.
Ana kula da mutane tare da kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen, da kuma tallafawa sauran gabobin da aka shafa.
CDC ta ba da shawarar cewa duk wanda ake zargi da dauke da cutar ya sanya abin rufe fuska mai sauki.
Ana amfani da iskar oxygenation na membrane (ECMO) don magance matsalar rashin ƙarfi na numfashi, amma fa'idodi har yanzu suna cikin la'akari.
Ana ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don haɓaka rigakafi.
Kulawa mai tallafi na iya zama da amfani ga waɗanda ke da alamun rashin lafiya a farkon kamuwa da cutar.
Masu kula da marasa lafiya da masu ilimin cututtukan huhu a Amurka suna tattara shawarwarin magani daga hukumomi daban-daban zuwa wata hanya ta kyauta, IBCC.
Har zuwa watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitoci sun ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Ya kamata a ɗauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a cikin saitunan kiwon lafiya lokacin aiwatar da hanyoyin da zasu iya haifar da aerosol, kamar intubation ko iska ta hannu.
Ga masu aikin kiwon lafiya da ke kula da waɗanda ke da cutar COVID-19, CDC ta ba da shawarar sanya mutumin a cikin Infection Infection Room (AIIR) a cikin gida ban da amfani da matakan kariya na yau da kullun, matakan kariya na tuntuɓar mutum da matakan kariya na gida.
Abubuwan da aka ba da shawarar sune: rigunan PPE, respirator ko abin rufe fuska, masu kariya na ido da safar hannu ta likita. Idan akwai, respirator (a maimakon abin rufe fuska) ya fi dacewa.
An amince da kayan numfashi na N95 ta hanyar masana'antar amma FDA ta riga ta ba da izinin amfani da abin rufe fuska a ƙarƙashin Amincewar Amfani da Gaggawa (EUA).
An tsara shi don karewa daga ƙwayoyin halitta kamar ƙura amma yana da tasiri akan takamaiman magungunan ƙwayoyin halitta ba a tabbatar da shi don amfani da labaran ba.
Lokacin da ba a samun abin rufe fuska, CDC ta ba da shawarar amfani da abin rufe fuska ko kuma a matsayin zaɓi na ƙarshe, abin rufe fuska na gida.
Yawancin masu cutar COVID-19 ba su da tsanani da za su buƙaci iska ta inji ko kuma ta madadin, amma wasu kashi suna buƙatar hakan.
Wani nau'in tallafi na numfashi ga mutane tare da COVID-19 dangane da gazawar numfashi ana nazarin shi sosai ga marasa lafiya a asibiti tare da wasu shaidu cewa ana iya guje wa intubation tare da canula mai zurfi ko matsin lamba mai kyau na iska biyu.
Ko waɗannan biyu suna ba da fa'idodi iri ɗaya ga mutanen da ke fama da rashin lafiya ba a sani ba.
Wasu likitoci sun zaɓi su kasance tare da iska mai mahimmanci idan akwai saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol fiye da na ƙwanƙwasawar hanci.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ƙarfin tsarin kiwon lafiya don kula da ƙaruwar yawan adadin masu cutar COVID-19 waɗanda ke da tsananin buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5% na waɗanda aka shigar da su cibiyar kulawa mai tsanani, kashi 2.3% sun bukaci taimakon injin numfashi na inji kuma kashi 1.4% sun mutu.
A China, aƙalla kashi 30% na marasa lafiya da ke asibiti da COVID-19 za a kai su ICU.
Samun iska ta inji ya zama da wahala yayin da cututtukan cututtukan numfashi (ARDS) ke ci gaba a cikin COVID-19 kuma samun iskar oxygen yana da wahala.
Masu ba da iska suna iya sarrafa matsin lamba kuma ana buƙatar PEEP mai ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin haɗarin cutar huhu da ke tattare da iska da kuma pneumothorax.
Mai yiwuwa ba za a iya samun sa a kan na'urar numfashi ba.
Bincike kan yiwuwar magani ya fara a watan Janairun 2020, kuma wasu magungunan rigakafi suna cikin gwaji na asibiti.
Remdesivir ya bayyana a matsayin mafi kyawun abin da za a iya tsammani.
Duk da yake sabbin magunguna na iya ɗaukar lokaci har zuwa 2021 don haɓakawa, wasu magungunan da ake gwadawa an riga an amince da su don wasu amfani suna cikin ƙarin gwaji.
Ana iya gwada magungunan rigakafi a kan mutane da ke fama da cututtuka masu tsanani.
WHO ta ba da shawarar masu sa kai su shiga cikin gwajin inganci da amincin magani mai yuwuwa. FDA ta ba da izini na ɗan lokaci don plasma mai gyarawa azaman magani na gwaji a cikin lokuta masu tsanani ko masu saurin barazanar rai.
Har yanzu ba a yi nazarin asibiti ba don tabbatar da cewa yana da lafiya da tasiri ga cututtuka.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar hannu don magance cutar.
Ana buƙatar masu amfani su shigar da sunayensu da ID.
Wannan app ɗin na iya gano 'masu kusa' ta amfani da bayanan sa ido kuma don haka haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan an gano wata barazana, app ɗin ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da nazarin manyan bayanai akan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da hankali na wucin gadi don bin diddigin mutanen da ke da cutar da mutanen da suka tuntuɓi a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ke fama da cutar coronavirus.
An dauki matakan tilasta keɓewa da kare waɗanda ke hulɗa da 'yan ƙasa masu kamuwa da cutar.
Hakanan a cikin Maris 2020, Deutsche Telekom ta raba bayanan wurin wayar gaba ɗaya tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincika da hana yaduwar cutar.
Rasha na amfani da fasahar gano fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce masu amfani da wayoyin salula sun sanar da shi cewa "kashi 40% na mutane suna ci gaba da motsawa".
Gwamnatin Jamus ta gudanar da taron hackathon na tsawon sa'o'i 48 a karshen mako tare da masu halarta sama da 42,000.
Shugabar Estonia Kersti Kaljulaid ta yi kira ga duniya da ta samar da hanyoyin magance cutar coronavirus.
Mutum na iya fuskantar matsin lamba daga keɓewa, ƙuntatawa na tafiya, sakamakon magani ko tsoron kamuwa da cutar kanta.
BBC ta nakalto Rory O'Connor yana cewa. "Ƙaruwar keɓewar zamantakewa, kadaici, damuwa game da kiwon lafiya, damuwa da koma bayan tattalin arziki sune cikakkiyar dubban haɗari ga lafiyar tunanin mutane da jin dadin su".
Cutar za ta haifar da sakamako mai laushi tare da ƙananan alamomi ko babu alamomi, kamar cututtukan numfashi na sama kamar mura.
Yawancin lokuta masu sauƙi sukan warke cikin makonni biyu, yayin da waɗanda ke da mummunan cuta ko rashin lafiya suna ɗaukar makonni uku zuwa shida don warkewa.
Mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanai daga wasu ƙwayoyin cuta iri ɗaya kamar SARS da MERS, amma bayanai don COVID-19 ba su da yawa.
A cikin yawancin waɗanda ke fama da cutar, COVID-19 na iya saurin haɓaka zuwa cututtukan cututtukan numfashi (ARDS) wanda ke haifar da rashin ƙarfi na numfashi, harin septic ko gazawar gabobin da yawa.
Matsaloli da ke tattare da COVID-19 sun haɗa da cutar sauro, ƙarancin jini da lalacewar zuciya, koda da hanta.
Rashin daidaituwa, musamman ƙaruwa a cikin lokacin prothrombin, an bayyana a cikin kashi 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, yayin da ba a lura da aikin koda ba a cikin kashi 4% na wannan rukunin.
Aƙalla kashi 20-30% na mutanen da ke kamuwa da COVID-19 suna nuna ƙaruwa a cikin enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da ƙarin kwanaki biyar don asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin shigar da su asibiti da mutuwa.
A cikin nazarin shari'ar farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa shine kwanaki 14, tare da cikakken ɗaukar kwanaki shida zuwa 41.
A wani binciken da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da mutuwar kashi 2.8% yayin da mata ke da mutuwar kashi 1.7%.
Binciken cututtukan cututtuka a kan samfurin huhu na mutuwa ya nuna lalacewar alveolus da aka yi da fibromisoid na ƙwayoyin salula a cikin huhu biyu.
An lura da canjin kwayar cutar a cikin ƙwayoyin cuta.
Hoton huhu ya nuna ciwon numfashi mai tsanani (ARDS).
A cikin mutuwar 11.8% da Hukumar Kiwon Lafiyar Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya tare da karuwar matakan troponin ko dakatar da zuciya.
Dangane da bayanan watan Maris daga Amurka, kashi 89% na waɗanda aka kwantar da su a asibiti tare da yanayin kiwon lafiya na yanzu, Samun albarkatun likita da yanayin tattalin arziki na yanki na iya yin tasiri ga yawan mutuwar.
Kimanin yawan mutuwar daga yanayin ya bambanta saboda bambancin yankunan su, amma kuma saboda wahalar da ke tattare da hanyoyin.
Ƙananan ƙididdigar ƙananan lokuta na iya haifar da ƙididdigar yawan mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance ne saboda cututtukan da suka gabata na iya nufin cewa yawan mutuwar yanzu ya wuce kima.
Masu shan sigari sun fi sau 1.4 fuskantar mummunan bayyanar cututtuka na COVID-19 kuma suna da aƙalla sau 2.4 mafi kusantar buƙatar kulawa ta musamman ko mutuwa fiye da waɗanda ba sa shan sigari. An nuna damuwa game da ci gaba na dogon lokaci na cutar.
Hukumomin asibitin Hong Kong sun gano raguwar kashi 20% zuwa 30% a cikin karfin huhu a cikin wasu marasa lafiya da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gabobin.
Hakanan yana iya haifar da ciwon bayan kulawa mai kyau bayan farfadowa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata ta samar da ingantacciyar rigakafi mai dorewa a cikin waɗanda suka warke daga cutar ba.
Ana ganin rigakafi mai yiwuwa ne, bisa ga halayyar sauran coronavirus, amma a cikin yanayin da aka warke daga COVID-19 an bi shi da gwajin tabbatacce don coronavirus a ranar da aka ruwaito.
Duk waɗannan lokuta ana tsammanin sun fi muni tare da kamuwa da cuta fiye da sake kamuwa da cuta.
Ana ganin kwayar cutar ta kasance ta halitta kuma ta samo asali ne daga dabbobi, ta hanyar kamuwa da cuta mai yawa.
Ba a san ainihin asalin cutar ba amma har zuwa Disamba 2019 kamuwa da cutar gaba ɗaya kusan ana haifar da shi ne ta hanyar watsawa daga mutum zuwa mutum.
Wani bincike kan mutane 41 da suka kamu da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya nuna cewa farkon bayyanar cututtuka ya fara ne a ranar 1 ga Disamba, 2019.
A cikin sanarwar da WHO ta bayar a ranar 8 ga Disamba, 2019, an bayyana farkon bayyanar cututtuka.
Ana amfani da wasu matakai don auna yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci kuma ana rinjayar su da yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓin magani, tsawon lokaci tun farkon kamuwa da cuta da kuma halayen jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cututtukan ICD-10 gaggawa U07.1 don mutuwar kamuwa da cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar kamuwa da cutar SARS-CoV-2 ba tare da tabbacin dakin gwaje-gwaje na COVID-19 da aka gano a asibiti ko kuma cututtukan cututtuka ba.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar zuwa shari'ar duniya ya kai kashi 6.9% (153,822/2,240,191) har zuwa 17 ga Afrilu 2020.
Ƙididdiga ya bambanta da yankuna. Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da ke kamuwa da cuta (wanda aka gano da wanda ba a gano ba) wanda ya mutu daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna bin takamaiman al'umma daga kamuwa da cuta zuwa warwarewar shari'ar.
Duk da yake ba kowa ba ne ke samun rigakafi, kasancewar rigakafi na iya ba da bayani game da yawan mutanen da ke kamuwa da cutar.
A tsakiyar cutar a Italiya, Castiglione d'Adda, wani karamin gari mai yawan mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ne ta hanyar bukukuwan Carnival, kuma yaduwar zuwa ga matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ake lasafta ta haka ba.
Bugu da ƙari, tsarin kiwon lafiyar Jamus bai yi muni ba tukuna.
A cikin Netherlands, aƙalla kashi 3% na iya samun ƙwayoyin cuta kamar yadda aka kiyasta daga mai ba da jini.
An tabbatar da mutuwar mutane 69 (0.004% na yawan) daga COVID-19.
Tasirin annobar da kuma yawan mutuwar ta bambanta tsakanin maza da mata.
Yawan mace-mace ya fi yawa ga maza a binciken da aka gudanar a China da Italiya.
Matsayin da ya fi dacewa ga maza shi ne a cikin shekarunsu na 50, inda rata tsakanin maza da mata ke raguwa zuwa shekaru 90.
A kasar Sin, yawan mace-mace ya kai kashi 2.8 cikin dari ga maza da kashi 1.7 cikin dari ga mata.
Babu cikakken bayani game da ainihin dalilin wannan bambancin tsakanin maza da mata amma wasu abubuwa na al'ada da halayya na iya zama sanadin.
Bambancin ilimin rigakafi ta hanyar jinsi, rashin shan taba a cikin mata da maza suna haifar da yanayin rashin lafiya kamar hawan jini a cikin matashi fiye da mata na iya taimakawa wajen mutuwar mace.
A Turai, kashi 57% na mutanen da suka kamu da cutar maza ne kuma kashi 72% na yawan mutanen da suka mutu sakamakon COVID-19 maza ne.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta biye da bayanan da suka shafi jima'i don kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne kuma suna da haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa an fara gano CO don corona, VI don ƙwayoyin cuta, D don cuta da 19 don lokacin annobar: 31 ga Disamba 2019.
An zaɓi sunan don kauce wa yin magana game da takamaiman wuri na ƙasa (misali China), nau'in dabba ko rukunin mutane, daidai da ƙa'idodin ƙasashen duniya don sanya suna da nufin kauce wa ƙyama.
Bugu da ƙari WHO tana amfani da "kwayar cutar COVID-19" da "kwayar cutar da ke da alhakin COVID-19) a cikin sadarwar jama'a.
Dukansu cututtuka da ƙwayoyin cuta ana kiransu "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an saba kiran kwayar cutar da cutar da "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da cutar numfashi mai saurin kamuwa da cutar 2019-nCoV a matsayin sunayen wucin gadi don ƙwayoyin cuta da cututtuka daidai da jagororin 2015 game da amfani da wuri don cututtuka da sunayen ƙwayoyin cuta.
An sanar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin daidaitattun sarkar samarwa, wasu masana'antun dijital suna fitar da kayan kiwon lafiya kamar su hanci da kuma sassan iska.
A wani misali, lokacin da asibitin Italiya ke buƙatar bawul ɗin numfashi na gaggawa, kuma masu samarwa ba za su iya isar da su a cikin lokacin da ake buƙata ba, wani ɗan aikin injiniya ya juya gida kuma ya samar da bawul 100 da ake buƙata a cikin dare.
Bayan farkon barkewar COVID-19, ra'ayoyin maƙarƙashiya, rashin fahimta da rashin gaskiya sun bayyana game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar kuma sun bazu kan layi cikin sauri.
Mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata alama ba ta kwayar cutar a alade, duck da kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Ana gudanar da bincike na duniya kan alluran rigakafi da magungunan COVID-19 ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara "Gwajin SOLIDARITY" don tantance tasirin maganin maganin rigakafin cutar guda huɗu na yanzu tare da mafi kyawun tasirin da ake tsammani.
Babu riga-kafi a yanzu amma hukumomi da yawa suna aiki kan samar da allurar rigakafi.
An yi amfani da ƙoƙarin da aka yi a baya akan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Akwai dabarun rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna da burin samar da allurar rigakafin cutar gaba ɗaya.
Amfani da kwayar cutar ko dai a kashe ta ko a kashe ta, yana nufin samun saurin amsawar rigakafi a jikin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, allurar rigakafi, tana nufin ƙirƙirar allurar rigakafi mai saurin kamuwa da wasu ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, binciken ya mai da hankali kan furotin mai suna S-peptide wanda ke taimakawa kwayar cutar ta shiga cikin masu karɓar enzyme ACE2.
Dabara ta uku ita ce allurar rigakafin nucleic acid (allurar rigakafin DNA ko RNA, sabuwar dabara don ƙirƙirar allurar rigakafi).
An gwada gwajin gwaji na kowane irin wannan dabarun don aminci da inganci.A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara da masu sa kai huɗu a Seattle.
Alluran rigakafi sun ƙunshi lambar halittar da ba ta da lahani da aka kwafe daga kwayar cutar da ke haifar da cutar. An ba da shawarar ƙaruwa da dogaro da ƙwayoyin cuta a matsayin wata babbar matsala ga ci gaban allurar rigakafin SARS-COV-2, amma wannan abu ne mai rikitarwa.
Akwai gwaji sama da 300 da ake gudanarwa a cikin Afrilu 2020.
An amince da gwaji guda bakwai da aka yi a matsayin magani ga zazzabin cizon sauro, ciki har da bincike hudu kan hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da aka canza manufa sun shafi yawancin binciken China, tare da gwaji na uku na uku na remdesivir don wasu ƙasashe da za a bayar da rahoto a ƙarshen Afrilu.
An samar da nazarin ci gaban asibiti don alluran rigakafin COVID-19 da magungunan da ake so, har zuwa Afrilu 2020. Wasu magungunan riga-kafi na yanzu ana nazarin su don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade tare da interferon beta.
Akwai hujja na ɗan lokaci don ingancin remdesivir har zuwa Mach 2020.
An lura da ci gaban asibiti a cikin marasa lafiya da aka kula da su tare da amfani da remdesivir a hankali.
An gudanar da gwajin gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda ake amfani da shi don magance zazzabin cizon sauro da aka yi nazari a China a watan Fabrairun 2020, ya ba da sakamakon farko.
Duk da haka, akwai kira ga wani m review na bincike.
Hukumomin Koriya da China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayoyin Cutar Wuhan, yayin da take ba da shawarar auna gram ɗaya a rana, ta yarda cewa ninki biyu na allurai suna da haɗari kuma suna iya zama masu mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine a cikin hikimar likitocin da ke kula da waɗanda ke da cutar COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don lalata SARS-CoV-2 a cikin vitro.
An ba da shawarar yin nazarin in vivo na gaba bayan nuna ƙarancin ƙarancin ƙwayar cuta a cikin SARS-CoV-2. Nazarin ya nuna cewa haɓakar furotin na farko ta hanyar serine protease transmembrane 2 (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da manyan iyakoki waɗanda ke hana ƙungiyar likita amfani da waɗannan hanyoyin ba tare da ƙarin bincike ba.
Guguwar cytokine na iya zama matsala a mataki na gaba don COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine yana da halayen antisytocin. Tocilizumab an haɗa shi cikin jagororin magani ta Hukumar Kiwon Lafiyar Kasa ta China bayan kammala ƙaramin bincike.
Ana gudanar da gwajin gwaji na biyu a Italiya bayan ya nuna sakamako mai kyau a cikin mummunan cuta.
Haɗe tare da gwajin jini na ferritin na jini don gano guguwar cytokine, wannan yana nufin yaƙar ci gaban, wanda ake tsammanin shine sanadin mutuwa ga wasu mutanen da ke kamuwa da cutar.
An yarda da mai karɓar mai karɓar interleukin-6 ta FDA bisa ga nazarin shari'ar da aka yi a baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan CART a shekara ta 2017.
Har zuwa yau, babu wata hujja ta hanyar sarrafawa ta hanyar da aka yi amfani da ita cewa tocilizumab magani ne mai tasiri ga CRS.
Ana binciken canja wurin ƙwayoyin cuta da aka ƙera da kuma ƙwayoyin cuta da tsarin garkuwar jiki ya samar ga waɗanda suka warke daga COVID-19 zuwa ga mutanen da ke buƙatar su a matsayin hanyar da ba ta da rigakafi don rigakafin rigakafi.
An gwada wannan dabarar a kan SARS ba tare da wani sakamako mai kyau ba.
Rushewar kwayar cuta wata hanya ce ta aiki wanda za'a iya ɗauka cewa maganin rigakafi na wucewa zai iya zama matsakaiciyar kariya ga SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar ƙwayoyin cuta na ƙwayoyin cuta da kuma / ko phagocytosis mai yiwuwa.
Sauran nau'ikan maganin rigakafi na rigakafi, alal misali, ta amfani da ƙwayoyin rigakafi na monoclonal suna cikin ci gaba.
Samun magani na sake dawowa, wanda ya ƙunshi ɓangaren ruwa na jini daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga wannan kwayar cutar za a iya haɓaka don saurin aiwatarwa.
Cutar coronavirus, wata ƙungiya ce ta cututtuka masu alaƙa.
Li Wenliang, likita a asibitin tsakiya na Wuhan, daga baya ya kamu da cutar kuma ya mutu sakamakon COVID-19 bayan ya wayar da kan jama'a game da yaduwar kwayar cutar.
